University of Kentucky

UKnowledge
University of Kentucky Doctoral Dissertations

Graduate School

2009

PHYSIOLOGICAL GENOMICS OF SPINAL CORD AND LIMB
REGENERATION IN A SALAMANDER, THE MEXICAN AXOLOTL
James Robert Monaghan
University of Kentucky, James.Monaghan@uky.edu

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Monaghan, James Robert, "PHYSIOLOGICAL GENOMICS OF SPINAL CORD AND LIMB REGENERATION IN
A SALAMANDER, THE MEXICAN AXOLOTL" (2009). University of Kentucky Doctoral Dissertations. 703.
https://uknowledge.uky.edu/gradschool_diss/703

This Dissertation is brought to you for free and open access by the Graduate School at UKnowledge. It has been
accepted for inclusion in University of Kentucky Doctoral Dissertations by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

ABSTRACT OF DISSERTATION

James Robert Monaghan

The Graduate School
University of Kentucky
2009

PHYSIOLOGICAL GENOMICS OF SPINAL CORD AND LIMB REGENERATION
IN A SALAMANDER, THE MEXICAN AXOLOTL

________________________________
ABSTRACT OF DISSERTATION
________________________________

A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in the College of Arts and Sciences at the University of Kentucky

By
James Robert Monaghan
Lexington, KY
Director: Dr. S. Randal Voss, Associate Professor of Biology
Lexington, KY
2009
Copyright © James Robert Monaghan 2009

ABSTRACT OF DISSERTATION

PHYSIOLOGICAL GENOMICS OF SPINAL CORD AND LIMB REGENERATION
IN A SALAMANDER, THE MEXICAN AXOLOTL
Salamanders have a remarkable ability to regenerate complex body parts including the
limb, tail, and central nervous system. Although salamander regeneration has been
studied for several hundred years, molecular-level studies have been limited to a
relatively few important transcription factors and signaling molecules that are highly
conserved among animals. Physiological genomic approaches were used here to
investigate spinal cord and limb regeneration. Chapter 2 reports that hundreds of gene
expression changes were identified during spinal cord regeneration, showing that a
diverse injury response is activated in concert with extracellular matrix remodeling
mechanisms during the early acute phase of natural spinal cord regeneration. Chapter 3
presents results that identify the salamander ortholog of mammalian Nogo-A, a gene
known to inhibit mammalian nerve axon regeneration. Nogo-A gene expression was
characterized during salamander development and adulthood in order to address the roles
of Nogo-A in the nervous system. Chapters 4 and 5 use physiological genomic
approaches to examine limb regeneration and why this process is dependent upon an
intact nerve supply. Results presented in Chapter 4 showed that many processes regulated
during early limb regeneration do not depend upon nerve-derived factors, but striking
differences arise between innervated and denervated limbs by 14 days after amputation.
Chapter 5 identified genes associated with peripheral nerve axon regeneration and
identified gene candidates that may be secreted by nerves to support limb regeneration.
Lastly, chapter 6 characterizes the expression of a developmentally important family of
genes, matrix metalloproteinases, during tail regeneration. These results suggest that
matrix metalloproteinases play multiple roles throughout the regeneration process.
Primarily, this dissertation presents data from the first genomic studies of salamander
regeneration. The results suggest genes such as matrix metalloproteinases, and molecular
pathways such as the Wnt and FGF signaling pathways that can be exploited to enhance
regenerative ability in humans.
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CHAPTER 1
INTRODUCTION
“But if the above-mentioned animals (salamanders), either aquatic or amphibious,
recover their legs, even when kept on dry ground, how comes it to pass, that other land
animals, at least such as are commonly accounted perfect and are better known to us, are
not endued with the same power?...Should the flattering expectation of obtaining this
advantage for ourselves be considered entirely as chimerical?”
Lazzaro Spallanzani, 1768
This question, which has motivated and perplexed scientists for centuries, remains
unanswered. Formal studies of salamander (Urodele) regeneration trace back at least to
the 1760’s, when Lazzaro Spallanzani and Charles Bonnet described the phenomenon of
tail, limb, and eye regeneration in newts (Dinsmore, 1996). Since this time, it has become
widely appreciated that the salamander’s remarkable regenerative abilities are
unparalleled among vertebrates. Much progress has been made in describing how
salamander regeneration is accomplished at the morphological level. However, only
recently have resources and technologies been developed to allow specific genes and gene
functions to be studied in salamanders. In particular, microarray analysis, high-throughput
sequencing, feasible transgenic and knockdown approaches, and bioinformatic databases
are now available to re-address centuries old questions for the first time at the genomic
level. The studies described in this dissertation address several salamander regeneration
paradigms, including spinal cord regeneration, limb regeneration, wound healing, and the
neural dependence of limb regeneration. The results of these studies provide some of the
first unbiased insights into how salamanders re-grow a variety of tissues following injury.
The hope is that someday we will soon be able to translate the secrets of salamander
regeneration to clinical therapies in humans.
Spinal cord regeneration
The salamander spinal cord offers a promising model of central nervous system
(CNS) regeneration because it is capable of functional recovery after transection, crush,
and amputation injuries. However, it is unclear why salamanders have such a high
capacity for spinal cord regeneration (SCR) while mammals do not. One difference
between salamander and mammalian spinal cord injury (SCI) is that salamanders
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regenerate large numbers of neurons from progenitor cells following SCI while mammals
do not (Bareyre, 2008; Pinto and Götz, 2007; Ferretti et al., 2003; Chernoff et al., 2003).
Results presented in Chapter 2 attempt to address this problem by comparing gene
expression changes that take place during salamander SCR to gene expression changes
that take place after mammalian SCI. It is also possible that salamanders can regrow
nervous system tissue so readily because their neurons have a higher intrinsic capacity to
regenerate axons than mammalian neurons. We attempt to identify genes associated with
salamander axon regeneration by identifying up-regulated genes in sensory neurons
during axon regeneration. Lastly, molecules known to inhibit regeneration in the
mammalian CNS may not be present in the salamander CNS. We address this problem by
identifying and characterizing the salamander ortholog of a gene that is inhibitory in
mammals, Nogo-A. To develop the salamander model further, studies are needed to
address these and other aspects of CNS repair, and from this information, determine the
bases of a natural regenerative response.
A striking feature of salamander SCR is the activation of cells that line the central
canal of the spinal cord (Egar and Singer, 1972; Nordlander and Singer, 1978). These cells
have traditionally been called ependymoglia (Chernoff et al., 2003; Egar and Singer,
1972), but are structurally similar to mammalian radial glia seen during development
(Holder et al., 1990; Mchedlishvili et al., 2007). Upon SCI, ependymoglia migrate to close
off the exposed spinal cord lumen, proliferate, and eventually differentiate into new
neurons (Norlander and Singer, 1978; Benraiss et al., 1999; Echeverri and Tanaka, 2002;
Mchedlishvili et al., 2007). Ependymoglia-like cells seem to be critical in all animals
capable of SCR including salamanders, zebrafish, anuran larvae, and lizard tails, although
cell-tracking studies are severely lacking in all of these models (Reimer et al., 2008;
Chernoff, 1996; Chernoff et al., 2003). In the future, it will be necessary to know what cell
types ependymoglia are capable of differentiating into and the signaling mechanisms that
regulate their activities. Experiments described in chapter 2 present some early efforts in
identifying the early gene expression changes after SCI that may contribute to
ependymoglia activation.
The extracellular environment of the injured mammalian spinal cord is thought to
be inhibitory to regeneration. Investigations aimed to promote human SCR have mainly
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focused on circumventing these inhibitory properties (Silver and Miller, 2004; Schwab,
2002; Horner and Gage, 2000). Several factors contribute to the hostile CNS environment
including glutamate excitotoxicity, astrocytic gliosis, inhibitory myelin products, and
toxic metabolic byproducts (Profyris et al., 2004 for review). Salamanders may be capable
of SCR because they can naturally circumvent some or all of these injury byproducts.
Indeed, a gliotic scar does not form after SCI, but the contribution of the other
components is poorly understood. Inhibitory myelin products are thought to be major
contributors to the inhibitory environment (Ramer et al., 2005). Nogo-A, or Reticulon 4A,
in particular has received considerable attention as a target for clinical intervention
(Buchli and Schwab, 2005; Freund et al., 2006, 2009). It has been proposed that
salamanders may have a higher regenerative ability because Nogo-A is absent in the CNS
(Schwab, 2004; Oertle et al., 2003; Klinger et al., 2004; Chernoff et al., 2003). There is
also evidence that other inhibitory myelin breakdown products, specifically myelinassociated glycoprotein, and the inhibitory molecule Tenascin-R are quickly eliminated
from the injury site. We address the first hypothesis in Chapter 3 by providing evidence
that Nogo-A is present and expressed in the salamander CNS. This chapter concludes with
a discussion of the possible roles of Nogo-A in the salamander nervous system.
The prospect of using information obtained from vertebrates capable of SCR for
therapeutic treatments to SCI is appealing. This realization will be impossible without
understanding how the salamander performs such feats. The results presented here address
some of the most relevant questions related to these questions. Future studies will be
needed to build upon these results using anatomical, functional, and genomic approaches
to tease apart the complex process of building new neural tissue.
Limb Regeneration
The second model addressed in this dissertation is limb regeneration. Limb
regeneration was chosen to study because it is the best characterized model of
regeneration at the morphological level, but little gene expression data has been collected
to date. The goal of our work is to fill this knowledge gap by performing physiological
genomic techniques on regenerating limbs.
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Limb regeneration is possibly the most extreme example of regeneration in
vertebrates. It is an amazing feat to us humans that an animal can regenerate entire
appendages that have been cut or bitten off. Hundreds of years of observation have given
us a framework upon which we can build new understanding using the techniques and
tools of modern biology. Below, I will review this framework and then describe how work
presented in this dissertation builds upon this framework.
Amputated limbs recruit local cells to participate in regeneration. Following
amputation, cells just proximal to the amputation surface are coaxed into migrating to the
injury site, become highly proliferative, and form a mass of mesenchymal-type cells
termed the blastema. The blastema is a self-organizing structure capable of re-growing
into a new limb. The blastema is the fundamental element of a regenerating limb. Two of
the major components needed to form a blastema are a functional wound epidermis, and
an adequate supply of innervation at the amputation site. Understanding the role of each of
these components are major focal areas in the field of regenerative biology.
Wound healing and the wound epidermis
Critical events necessary for limb regeneration take place only hours after limb
amputation. A fibrin clot forms over the wound stump shortly after amputation. Basal
keratinocytes proximal to the stump then lose their hemidesmosomes that connect them to
the basal lamina and begin to migrate over the fibrin clot (Repesh and Overpriller, 1978,
1980; Norman and Schmidt, 1967). The keratinocytes meet in the wound epicenter and
start to pile up within the first 24 hours. Preventing the formation of a healthy wound
epithelium (WE) inhibits regeneration, demonstrating that the WE is essential to
regeneration (Goss, 1956; Mescher, 1976; Tassava and Garling, 1979; Thornton, 1957;
Lheureux, 1983). Once the WE is formed, continued migration of cells from the proximal
epidermis and cell proliferation thicken the WE to create a specialized structure termed
the apical epidermal cap (AEC).
The WE/AEC is thought to play multiple roles during regeneration. An
unequivocal role of the WE is to phagocytose wound debris and either expel or dissolve it
(Reviewed by Carlson, 2007). Singer and Salpeter (1961) showed that implantation of
large and small debris are taken up by the WE into the intercellular space as well as inside
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epidermal cells and extruded from the blastema. Extrusion of normal cellular debris from
dying cells has also been clearly observed by microscopy (reviewed by Singer and
Salpeter, 1961). A second hypothetical role of the WE/AEC is to promote histolysis of
underlying tissues, which initiates dedifferentiation and blastema formation. Tissue
histolysis does not take place if a functional WE is not formed (Adova and Feldt, 1939;
Carlson, 1967; Reviewed by Singer and Salpeter, 1961 and Carlson, 2007). This histolytic
property has been associated with matrix metalloproteinases (MMPs) including
MMP3/10a and b, newt-specific MMPe, MMP9, and newt collagenase (Miyazaki et al.,
1996; Kato et al., 2003; Yang et al., 1999; Vinarsky et al., 2005). Results presented in
Chapter 6 support this hypothesis by showing that two collagenases, MMP9, and
MMP3/10a are expressed in the WE during tail regeneration.
A third role of the WE/AEC may be to support blastemal cell growth. Biolly and
Albert (1986; 1990) showed that culturing blastemal cells supplemented with crude
protein extract isolated from WE can increase the mitotic index by 11x, which was
significantly more mitogenic than either blastemal mesenchyme or nerve extract. There is
strong evidence that fibroblast growth factors (FGFs) are produced by the wound
epithelium to support blastema cell proliferation. These include the localization of FGFs
1, 2, 8, and 10 to the WE, the localization of FGF Receptor 1 to blastemal cells, and the
observation that exogenous FGF can induce blastema cell proliferation when applied in
vitro or in vivo (Biolly et al., 1991; Mullen et al., 1996; Han et al., 2001; Christensen et
al., 2001; Campbell and Crews for review, 2008).
Nerve-dependency of limb regeneration
Amputated salamander limbs also need an adequate supply of nerves to regenerate.
About 50 years after Spallanzanni described salamander limb regeneration, Todd (1823)
showed that the limb does not regenerate when the nerve supply is compromised. His
observations are clearly explained by the following quote:
“If the sciatic nerve be intersected at the time of amputation, that part of the stump below
the section of the nerve mortifies [necroses]…If the division of the nerve be made after
the healing of the stump, reproduction [regeneration] is either retarded or entirely
prevented.”
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Tweedy John Todd (1823) J Sci Lit Arts 16, 84-96.
Anatomical, immunological, and retrograde staining of neurons has shown that
nerve fibers quickly grow from the severed end of brachial nerves into the injured tissues
and WE (Singer, 1949; Thornton, 1970; Koussoulakos et al., 2003; Satoh et al., 2008). It
is hypothesized that nerve fibers supply a factor or set of factors that support the
proliferation of blastemal cells during the early phases of regeneration. This hypothesis is
based upon the observation that spinal ganglia extracts are capable of supporting blastema
cell proliferation in vivo and in vitro (Boilly and Albert, 1988; Globus and VethamanyGlobus, 1977; Mescher and Loh, 1981; Reviewed by Dinsmore and Mescher, 1998).
Removing the nerve supply shortly before or during the first few weeks after amputation
leads to a loss of cell proliferation and regenerative failure. Two critical questions need to
be answered for us to understand the role of nerves during limb regeneration:
1) What is the neurotrophic factor (NTF) or NTFs secreted from regenerating peripheral
nerve axons that support regeneration?
2) What are the cellular and molecular targets of the NTF(s) in the injured tissues?
The NTF(s) has not been identified to date. Multiple gene candidates have been
proposed and supported experimentally including fibroblast growth factors (Mullen et al.,
1996, but see Dungan et al., 2002; Satoh et al., 2008), substance P (Globus et al., 1991),
neuregulin (Wang et al., 2000), and transferrin (Mescher et al., 1997), but no candidates
have been accepted by the community as the neurotrophic factor. Specifically, Mullen et
al. showed that FGF2 is expressed in sensory neurons and the wound epidermis.
Implanting beads soaked in FGF2 could also rescue denervated limbs to regenerate, but
similar experiments with FGF1 failed to rescue denervated limbs (Dungan et al., 2002).
Substance P has been localized to neuronal cells and the regenerating limb, decreases
abundance following denervation, and is mitogenic in cultured blastemal cells, but has not
been tested for its ability to rescue denervated limbs (Globus et al., 1991). Neuregulin is
expressed in dorsal root ganglia and can increase blastema cell proliferation in denervated
limbs, but did not rescue regeneration in denervated limbs. Lastly, transferrin is expressed
by sensory neurons, released from growth cones, and support blastemal cell growth in vivo
and in vitro (Mescher et al., 1997). Although each of these candidates is promising, a
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comprehensive study is needed to address whether these genes or a combination of them
can be definitively identified as the neurotrophic factor.
Several criteria are known about the NTF(s) that may assist in narrowing down
candidate molecules in future studies. It is hypothesized that sensory, motor, and
sympathetic nerves all produce the NTF(s), but sensory neurons are the major contributors
of the NTF because they contribute more axons to the blastema (Singer, 1978 for review;
Koussoulakos et al., 2003). The NTF(s) is produced in the neuronal cell body, transported
down the axon, possibly by fast axonal transport, and released at the synapse (Scadding,
1988; Wallace, 1972; Kiffmeyer et al., 1991). The NTF(s), and hence the stimulatory
properties of axons, are increased following nerve injury or limb amputation (Singer,
1952; Maier et al., 1984; Boilly and Albert, 1988; Boilly and Bauduin, 1988). Lastly, the
NTF(s) should not be produced in the blastema and down-regulation should mimic
denervation. Limb regeneration should also be rescued with local expression of the NTF
following denervation. These criteria should be kept in mind when determining the role of
nerves during regeneration (Brockes, 1984).
The cellular and molecular targets of the NTF(s) are largely unknown. Recent
experimental evidence support multiple cellular targets including the WE (Satoh et al.,
2008), Schwann cells (Kumar et al., 2007), endothelial cells (Smith and Wolpert, 1975;
Rageh et al., 2002), and blastemal cells (Maden, 1978; Vethamany-Globus, 1978). It will
be important to find out whether the loss of blastemal cell proliferation following
denervation is directly or indirectly downstream of the NTF. Kumar et al., (2007) have
recently identified a downstream molecular target [Newt Anterior Gradient (nAG)] that
may do the bidding of the NTF. nAG is a secreted mitogen of blastemal cells that is
expressed in Schwann cells and skin glands shortly after injury. Denervation at the time of
amputation abrogates expression in these cell types. Expression of nAG using DNA
constructs in denervated limbs can rescue regeneration to the digit stage, identifying nAG
as a likely downstream molecular target of the NTF. Alternatively, Satoh et al (2008) have
proposed that the nerves target the WE, which then do the bidding of the NTF. A
promising strategy for identifying the downstream nerve target is to sample differentially
regulated genes between innervated and denervated limbs. mRNA localization of these
differentially regulated genes with in situ hybridization would likely identify the
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downstream targets of the nerves. We use physiological genomic strategies in chapter 4 to
identify these differentially regulated genes and the possible downstream targets for
nerves. Results from this chapter show that the nerve has little affect on the early events of
limb regeneration, but has profound affects when the blastema begins to form. Chapter 5
attempts to identify the NTF as well as genes that are upstream of the NTF. In this
experiment, we sampled differentially expressed genes in dorsal root ganglia following
limb amputation. Several new gene candidates were identified that could be the NTF and
transcription factors that may be associated with axon outgrowth of the peripheral nerve or
induce expression of the NTF were identified. Overall, these experiments give the most
detailed molecular description of how the NTF may work. The next steps will be to
characterize both the upstream and downstream components of the NTF using in situ
hybridization because knowing which cell types they are expressed is essential for us to
understand how the NTF affects limb regeneration.
All of the work presented in this dissertation is descriptive in nature, but it is
necessary for understanding how a salamander can regenerate a spinal cord or limb.
Experiments of the past have suggested that both of these regeneration paradigms need
cellular and molecular events to take place that are unique to the salamander. We attempt
to identify these events by characterizing the expression pattern of thousands of genes
simultaneously during regeneration and then compare these patterns to non-regenerating
tissues. Overall, we found that both spinal cord (Chapter 2) and limb regeneration
(Chapter 4) are global processes that involve thousands of genes. We also found that some
gene expression signatures of the wound response are similar between regenerating spinal
cord, non-regenerating mammalian spinal cords, regenerating limbs, and non-regenerating
denervated limbs. The truly regeneration-specific gene expression patterns become
apparent days after the injury takes place. Future experiments should focus on where these
genes are expressed, how early do they become regeneration-specific, and are they
necessary for regeneration to take place. The studies presented here lay the groundwork
for researchers to address the role of these genes during regeneration and whether this
knowledge can be translated into human therapies.
Copyright © James Robert Monaghan 2009
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CHAPTER 2
EARLY GENE EXPRESSION DURING NATURAL SPINAL CORD
REGENERATION IN THE SALAMANDER AMBYSTOMA MEXICANUM
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Introduction
Salamanders have a remarkable ability to regenerate complex body parts including
the limb, tail, lens, and CNS. Although salamander regeneration has been studied for
several hundred years (Spallanzani, 1768; Müller, 1864), molecular-level studies have
been limited to a relatively few important transcription factors and signaling molecules
that are highly conserved among vertebrates, and in some cases metazoans (e.g. Schnapp
et al. 2005; Christensen et al. 2002; Carlson et al. 2001; Caubit et al. 1997; Torok et al.
1999). Broader assessments of gene expression during salamander regeneration may
identify mechanisms that can be exploited to enhance regenerative ability in humans.
Salamanders regenerate their spinal cords and regain full movement and function
after tail amputation. Within a few hours of amputation, injury responses are initiated to
increase cell survival and transform the tissue-damaged environment into one that is
permissive for repair and subsequent regeneration. It is possible that the unrivaled
regenerative ability of salamanders is due in part to this early injury response phase of
regeneration, but very little is known about early response genes and associated biological
processes. Most attention has been directed to understand cellular and developmental
changes during the dramatic and conspicuous de-differentiation and re-patterning phases
of regeneration. During de-differentiation, cells of mesodermal origin (muscle, dermal
fibroblasts, and cartilage) re-enter the cell cycle and proliferate to form a mass called the
blastema (Hay and Fischman, 1961). Blastemal cells subsequently re-differentiate into
mesodermal tissues but apparently do not contribute to the regenerating spinal cord.
Epithelial cells (ependymoglia) of the ependymal lining that surrounds the central canal of
the spinal cord re-form neural tissues of the regenerating spinal cord (Nordlander and
Singer, 1978). The signals that initiate and maintain the proliferative response of
ependymoglia are largely unknown, however recent studies implicate some of the same
highly conserved genes that are known to regulate the proliferation and differentiation of
neural stem cells among vertebrates including sonic hedgehog, FGFs, epidermal growth
factor, (O’Hara and Chernoff, 1994; Zhang et al. 2000, 2002; Schnapp et al. 2005). This
suggests that some aspects of salamander spinal cord regeneration may be shared with
organisms that have little or no potential for neural regeneration. Analyses of gene
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expression in salamanders may point to key similarities and differences that are associated
with regenerative ability.
We designed a custom Affymetrix GeneChip and performed the first microarray
analysis of spinal cord regeneration in the Mexican axolotl (Ambystoma mexicanum). We
sampled regenerating spinal cord tissue at five early time points after amputation and
identified differentially expressed genes and temporal patterns of gene expression. We
compared our lists of significantly regulated genes to lists that have been similarly
compiled from microarray studies of spinal cord injury in rat. Our results highlight genes
and gene expression patterns that are associated with the salamander’s natural ability to
regenerate spinal cord.
Materials and Methods
Animals, tissue collection, and RNA isolation
The handling and surgical manipulation of all salamanders was carried out
according to the University of Kentucky Animal Care and Use guidelines (IACUC
#00609L2003). The caudal 1/3 of the tail was amputated from 225 Mexican axolotl sibs
(mean snout-vent length = 6.2 cm) from an inbred Voss laboratory strain. Spinal cord
tissue was collected 1.0 mm rostral to the injury plane at the time of spinal cord
transection (day 0), and also on 1, 3, 5, and 7 days post amputation. The tail blastema was
removed prior to sampling however it is likely that some infiltrating blastemal cells were
represented in the day 1-7 samples. Total RNA (mean = 1.7µg) was extracted from pools
of nine tissues for each of five replicates that were collected at each time point. Probe
labeling, hybridization, and scanning for the 25 RNA samples were performed by a single
staff member of the University of Kentucky Microarray Core Facility.
Development of a microarray platform
A custom Ambystoma Affymetrix GeneChip was designed from curated expressed
sequence tag (EST)s assemblies for A. mexicanum and A. t. tigrinum as described in Page
et al. (2006). These ESTs are enriched for genes expressed in neural and regenerating
tissues (Putta et al. 2004). Briefly, the array contains 4,844 total probe sets, 254 of which
are controls or replicate probe sets. Of the remaining 4,590 probe sets, all but 188
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correspond to unique A. mexicanum contigs, of which 2,960 are significantly identical in
nucleotide composition (e-7; BLASTX) to a human sequence in the non-redundant,
RefSeq protein database. Significant salamander-human blast hits were considered gene
orthologs in our analyses and we assumed that salamander-human orthologs have similar
gene functions or ontologies. Raw data files can be obtained at www.ambystoma.org.
Quality Control and Low Level Analyses.
We used the Bioconductor package affy (www.bioconductor.org) that is available
for the statistical programming environment R (www.r-project.org) to perform quality
control and preprocessing procedures at the individual probe level (Bolstad et al. 2005a).
These procedures included: (1) generating matrices of M versus A plots for all replicate
arrays, (2) investigating measures of central tendency, measures of dispersion, and the
distributions of all 25 arrays via boxplots and histograms, (3) viewing images of the log2
(intensity) values for each array to check for spatial artifacts, and (4) viewing an RNA
degradation plot (Bolstad et al. 2005b) that allows for visualization of the 3’ RNA
labeling bias across all arrays simultaneously. In addition, we used ArrayAssist Lite
software (Stratagene, La Jolla, CA) and the MAS5.0 algorithm to assess several quality
control measures that are recommended by Affymetrix (www.affymetrix.com) such as
average background (mean = 61.5, range = 55-81.5), noise (mean = 4.23, range = 2.896.94), and percent present (mean = 84.7% range = 81.2-87.0%). This high number of
present probe sets likely reflects the biased selection of regeneration-associated genes and
high quality contigs for probe set design. Next, the repeatability of probe set estimates of
hybridization intensity was evaluated between arrays. We examined the correlation of
hybridization intensities across all probe sets among the biological replicates for each
regeneration time point (mean r = 0.994; range r = 0.983-0.998). These results
demonstrate that we were able to obtain a high level of repeatability. We processed our
data similarly to the methods of Choe et al. (2005) to determine a probe set intensity
value. Briefly, our processing method consisted of using the MAS 5.0 background
correction algorithm, the quantiles algorithm for probe-level normalization, the MAS 5.0
algorithm for perfect match/mismatch correction, the median polish algorithm for
expression summary generation, and a loess normalization at the probe set level using the
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GoldenSpike package for R (Choe et al. 2005; www.ccr. buffalo.edu/ halfon/ spike/
index.html).
Detection of differentially expressed genes and data filtration.
Microarray platforms may not accurately or precisely quantify genes with low
intensity values (Choe et al. 2005; Draghici et al. 2006). Because low intensity genes
contribute to the multiple testing problem that is inherent to all microarray studies, we
filtered 1,203 probe sets whose mean intensity across all 25 arrays were smaller than or
equal to the mean of the lowest quartiles across all arrays (mean = 6.44, SD = 0.09; data
presented on a log2 scale). Probe sets (3641) were then tested for differential expression
via a one-way fixed effect linear model (intensity = day sampled) using the Fs test of Cui
et al. (2005) and J/MAANOVA software (www.jax.org/ staff/ churchill/ labsite/
software/anova/index.html). Initially, we adjusted for multiple testing by setting the false
discovery rate (FDR) to 0.01 using the step-up algorithm of Benjamini and Hochberg
(1995). As is shown in Figure 2.1a, upon performing this FDR correction, 2771 probe sets
of the 3,641 probe sets tested (76.11%) were selected as differentially expressed. We then
took a more conservative approach to our first pass at selecting differentially expressed
genes by setting the family-wise error rate (FWER) to 0.01. Upon adjusting the FWER to
0.01, 1,273 of the 3,641 genes tested (34.96%) were selected as differentially expressed
(Figure 2.1b). In order to identify a smaller subset of probe sets, we prioritized probe sets
that were selected as differentially expressed that exhibited: (1) a 2-fold change at any
time point relative to day zero and (2) Fs values that were in the upper 50% of these 1,273
genes (Fs > 28.36), leading to a total of 376 probe sets. The intensity values of three probe
sets pairs designed for the same contigs as well as probe sets corresponding to the same
human gene were combined, yielding a final short list of 360 unique genes (Table 2.1).
Candidate gene lists may differ when different preprocessing algorithms are used
to identify statistically significant genes from oligonucleotide microarrays (Millenaar et
al. 2006). To address this concern, we compared the 376 candidate probe set list above to
a 646 probe set list that was generated using only the robust Robust-Multiarray Averaging
algorithm (Irizarry et al. 2003), One-way ANOVA (FDR = 0.01), and a 2-fold change
criterion. Only 11 of the 376 candidate probe sets (2.9%) were unique, indicating that our
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methodology for identifying candidate genes is largely concordant with other statistical
approaches.
Identification of gene expression patterns
We used the following criteria to define temporal gene expression patterns for the
360 genes that met statistical and fold-level criteria. For each gene we assigned a score to
qualify the mRNA abundance at each post-amputation sample time (d1, d3, d5, and d7). A
gene received a score of non-significant (N) for each sample time that mRNA abundance
was < 2 fold deviant of the d0 estimate. We refer to the d0 estimate as the baseline
estimate of mRNA abundance. A gene received a score of up-regulated (U) or downregulated (D) for the first post-amputation sample time that mRNA abundance deviated by
> 2 fold from baseline. For subsequent sample times, each gene received one of three
possible scores: C, U, or D. A score of constant (C) was assigned if the fold level estimate
was < 2 fold deviant of the previous U or D estimate (C was never assigned after N), and
> 2-fold deviant from baseline. A score of U or D was assigned if mRNA abundance
deviated again by > 2 fold. Using this scoring system, a gene received a score of U, D, or
N for d1, and U, D, N, or C for d3, 5, and 7. A complete breakdown of the 360 changed
genes is shown in Table 2.2. To annotate genes, we used multiple databases (GO, KEGG,
IHOP, OMIM, etc.) and searched the literature for information about the expression and
functions of each gene that we identified as significant in our study. We biased our
annotations to emphasize possible gene functions that have been described in regeneration
and spinal cord injury research fields.
Identification of genes expressed differently between salamander regeneration and rat
spinal cord injury
A bioinformatics approach was used to identify gene orthologs that are expressed
similarly or differently after salamander tail amputation versus rat spinal cord injury. We
used current (May 2006) human Entrez Gene ID’s that were assigned to each annotated
probe set on the Ambystoma GeneChip to identify all presumptive salamander orthologs
on RatU34A, B, and C GeneChips. To accomplish this cross-referencing task, we used
Resourcerer (Tsai et al. 2001), a database that allows orthologous genes to be identified
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among species-specific microarray resources. This yielded a list of 1,036 probe sets
between the Ambystoma and RatU34 GeneChips that presumably correspond to 662
unique, orthologous genes. We compared the expression pattern of each of these genes
using results from this study and published studies that profiled gene expression after SCI
in rat, using RatU34 GeneChips (Song et al. 2001; Carmel et al. 2001; Aimone et al.
2004; De Biase et al. 2005). De Biase et al. (2005) provide a table that compares specific
details of these rat SCI microarray studies. The rat studies used thoracic T8-10 contusion
models (MASCIS, OSU, and weight drop methods) and tissues were sampled at and
flanking the impact site during the first 48 hours post-injury; Aimone et al. (2004) also
sampled 7 and 35 days after injury. For each gene, we qualified gene expression as either
significantly up, significantly down, or non-significant. We used statistical and fold-level
criteria (FWER < 0.01; > 2-fold change) to score salamander genes for these criteria. If a
gene was reported as significantly regulated in the rat studies, we recorded it as such;
otherwise we recorded it as non-significant.
Quantitative Real-Time PCR (QRT-PCR)
Ten genes from the microarray experiment were selected for validation by QRTPCR. Genes were selected based on technical and biological rationale. Technically, we
wanted to validate genes that yielded a broad range of relative fold change estimates by
microarray analysis and included both possible directions of differential expression. These
genes also exhibited a range of hybridization intensity values; for example, the average
intensity value of hairy enhancer of split 1 ranked among the bottom 37% of all probe sets
while galectin 1 (lgals1) ranked among the top 95%. Biologically, we selected genes that
are of interest in regenerative biology and spinal cord injury research fields. A BioRad
iScript cDNA synthesis kit (Hercules, CA) was used to synthesize cDNA templates from
three d0 and d3 RNA samples from microarray analysis. Primers were designed with
Primer3 (Rozen and Skaletsky, 2000) and used to amplify DNA fragments from the same
gene regions that were used to design corresponding GeneChip probe sets (Table 2.3).
Reactions included cDNA that was synthesized from 10ng total RNA, 300nM primers,
and iQ SYBR-Green real-time PCR mix and run on a BioRad I Cycler QRT-PCR system
(BioRad). The three replicates were normalized against a gene that showed no significant
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gene expression change in the microarray experiment (glyceraldehyde-3-phosphate
dehydrogenase, MC01187). PCR efficiencies for each primer were incorporated into the
relative fold change calculations according to Pfaffl (2001). Student’s t-tests were
performed using the three normalized biological replicates for d0 and d3 samples.
In situ hybridization (ISH)
Digoxygenin (DIG)-labeled RNA probe production and ISH were performed as
described by Hirota et al. (1992) with minor modifications. RNA probes were synthesized
by in vitro transcription using 300-350 base pair PCR products as template and included
SP6 or T3 RNA polymerase promoters appended to the 5’ ends (Table 2.3). PCR products
were cleaned using Qiagen PCR purification columns before performing in vitro
transcription. Axolotl tissues were collected three days after tail amputation and fixed at
4ºC in 1x PBS, 4% paraformaldehyde overnight. Bone was decalcified by incubating the
tissue in 500 mM EDTA (pH8.0), 1xPBS for at least two days, cryoprotected overnight in
30% sucrose, and sectioned to 16µm using a Microm 500HM cryostat. Hybridization,
washing, and colorimetric detection with NBT/BCIP were performed on a Tecan Genesis
Workstation 200 liquid handling robot with a Genepaint® hybridization station (Zurich,
Switzerland). Microscopy was performed using an Olympus IX81 microscope and images
were acquired with an Olympus DP70 camera.
Results
Histology of the spinal cord during the first week after tail amputation
We performed histology on tails collected at day 1, day 3, day 5, and day 7 to relate
our experiment to previous morphological descriptions of urodele spinal cord and tail
regeneration (Piatt, 1955; Stensaas, 1983; Iten and Bryant, 1976). Upon amputation of the
salamander tail, the spinal cord regresses approximately 0.5 mm rostral to the amputation
plane and a clot, including a large number of leukocytes, forms at the wound site (Figure
2.2A; Iten and Bryant, 1976; Jones et al., 1993). By day 7, the clot is replaced by a
mesenchymous cell-mass called the blastema and the blastema forms while there is
extensive extracellular matrix remodeling and bone degeneration (arrows, Figure 2.2A, C,
E, G). Also throughout the first week, cell death occurs rostral to the injury plane and cell
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proliferation of inflammatory cells is apparent, but little cell division is observed among
ependymal cells (Figure 2.2B; Zhang et al., 2003; Stensaas, 1983). By day 3, rostral axons
begin to degenerate and ependymal cells migrate to close off the lumen of the spinal cord,
thus creating a terminal bulb (Figure 2.2B, C, D, E; Egar and Singer, 1972; data not
shown). Ependyma become highly proliferative by day 7, increasing ependymal tube
thickness and extending the tube along the length of the regenerating tail (Zhang et al.,
2000). Following the first week of regeneration, ependymal cells differentiate into new
CNS neurons and peripheral ganglia, reconnecting the spinal cord to the body periphery
and recovering function (Koussoulakos et al., 1999).
Identification of differentially expressed genes and gene expression patterns
We identified 360 probe sets as detecting significantly different mRNA
abundances between d0 and another time point (d1-7), using statistical and fold change
thresholds (ANOVA p < 0.01; FWER of 0.01; Fs > 28.36; > 2-fold). More than half of
these probe sets (n = 210) correspond to salamander sequences (genes) that show high
sequence identify to a presumptive human protein-coding locus; the remainder correspond
to anonymous EST contigs that do not align to human genes. In comparison to d0
(baseline) mRNA levels, most genes exhibited significantly different mRNA abundances
at two or more post-amputation time points. This temporal variability did not yield an
extensive list of gene expression patterns. Although a total of 100 different gene
expression patterns were possible under our scoring system, only 32 different patterns
were observed and over 85% of all genes were classified into ten categories (Table 2.1;
Table 2.2). Eight of the top ten categories identified groups of genes in which mRNA
abundance increased or decreased at a particular time point, and afterward the level
remained constant through d7. Transcript levels for a few genes did increase or decrease
by > 2 fold among post-amputation time points, however only three genes yielded a
temporal expression profile that deviated significantly from baseline in both up- and
down-regulated directions during the seven day period (UNND; Table 2.1). Thus, the
majority of the gene expression profiles that we examined consisted of a single,
significant deviation from base line levels followed by relatively constant mRNA
abundance. It is likely that many of the uniquely expressed genes at d7 are regulated at
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later time points because only 43 of the 360 genes exhibited transcript levels at d7 that
approximated baseline. Clearly, we only sampled the initial phases of a continuous gene
expression program that extends beyond d7. However, our experiment does precisely
sample discrete phases of gene expression variability during this temporal process. For
example, Figure 2.3 illustrates that gene expression profiles of samples collected at d1 are
much more similar to each other than samples collected at d0, as well as d3, 5, and 7.
Below, we describe major gene expression patterns in greater detail. We also highlight
some of the genes and gene functions that were found in each of the major gene
expression categories. Finally, we compare the expression of salamander genes to
presumptive rat orthologs that have been examined in microarray studies of spinal cord
injury.
Gene expression patterns
Overall, a greater number of genes were up-regulated above baseline during the 7day period (n = 238 compared to n = 125). The majority (n = 134) were significantly upregulated at the first sample time after amputation (d1) and half of these genes (UCCC: n
= 64) registered constant mRNA abundances above baseline at all subsequent postamputation sample times (d3, d5, and d7). A substantial number of the d1 up-regulated
genes showed decreasing mRNA abundances at later sample points. Some of these genes
yielded mRNA abundances at d3 (UNNN: n = 20), d5 (UCNN: n = 5) or d7 (UCCN,
UDNN: n = 5) that approximated d0 levels, while others remained above baseline
(UDCC, UCDC, UNNU, UDDC: n = 22). The early group of up-regulated genes suggests
that a diversity of regulatory pathways and biological processes are activated within the
first 24 hours after tail amputation. In addition to genes that presumably function in
wounding, stress, inflammation, and immunity, this group includes genes that function in
tissue remodeling, apoptosis, ion transport, cell-cell interactions, cell migration, vitamin B
economy, lipid metabolism, and cytoskeleton dynamics (Table 2.1). Several different
regulatory networks are implicated directly or indirectly among these d1 up-regulated
responses, including MAPK, WNT, v-MYC, TNF, v-YES, RAS, and TGF-beta.
Other groups of genes were up-regulated for the first time at d3, 5, and 7 (n = 104).
The majority of the d3 and d5 genes maintained high, constant mRNA levels at
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subsequent time points (NUCC: n = 24, NNUC: n = 44). Gene functions that were
observed among d1 up-regulated genes were also represented among d3-7 up-regulated
genes. However, the distribution of genes among these functional categories was very
different. In particular, fewer injury response genes and a greater number of extracellular
matrix (ECM) and cytoskeleton-associated genes were observed compared to d1 upregulated genes. Also, a greater number of cell cycle related genes were observed (e.g.
NNUC, cell cycle = 14) as well as genes that presumably function in DNA replication,
metabolism, chromatin assembly, and cytokinesis. These results suggest that the
regeneration gene expression program transitions during the first seven days from an
injury responsive phase to one that is defined primarily by the up-regulation of genes that
function in cell division. Throughout both injury response and cell proliferation phases,
genes that function in tissue remodeling are significantly regulated.
Relative to the total number of up-regulated genes, a much smaller number of
genes (n = 125) were down-regulated significantly below baseline levels during
regeneration. In contrast to the up-regulated gene set, very few of these genes were downregulated at d1 (DCCC, DCNN, DNNN, DCDC = 12). Also, the magnitude of the foldlevel changes was generally lower than those measured for significantly up-regulated
genes (mean of maximum up-regulated fold changes = 6.61; down-regulated = -3.07). The
largest number of down-regulated genes was observed at d3 (n = 45) and this was
followed by additional groups of down-regulated genes at d5 (n = 29) and d7 (n = 35). In
general, many genes with neural related functions were down-regulated, including those
that function in ion transport, glutamate metabolism, glutamate binding, neuroprotection,
neurotransmission, neurogenesis, and lipid metabolism. Several functional categories that
were observed among up-regulated genes were also observed among down-regulated
genes, including apoptosis, cytoskeleton, ECM, signal transduction, and heat shock (Table
2.1). The overall pattern indicates that fewer genes are down-regulated during the first
seven days of regeneration, and down-regulated genes show significantly lower mRNA
abundances at d3, after the early up-regulation of genes at d1.
Some gene expression patterns were more complicated than linear, directional
responses, involving changes in mRNA abundance that fluctuated both above and below
the baseline. Some of these genes with complex expression patterns (UDCC, UCDC,
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NUCN, UDDC, NDCD, UUCD) may function in the regulation of biological processes
during regeneration. These include genes that function in ECM remodeling (matrix
metalloproteinase [mmp] 1, mmp13, tissue inhibitor of metalloproteinase 1 [timp1]),
coagulation (tissue factor pathway inhibitor 2), vitamin B transport (intrinsic factor,
transcobalamin 1), cell proliferation (v-Ha-ras viral oncogene, hypothetical protein
FLJ20303), transcriptional regulation (jun-b proto-oncogene), and cell signaling (latent
TGF beta binding protein; chromosome 8 orf 4; secreted frizzled-related protein 2
[sfrp2]).
Gene expression after spinal cord injury: salamander verses rat
To identify similarities and differences between the salamander and mammalian
spinal cord injury response, we compared our gene expression results to published results
from the rat spinal cord microarray literature. Specifically, we compared the expression of
662 presumptive rat–salamander orthologous genes that are represented on both the
Ambystoma and rat Affymetrix GeneChips. The resulting list of gene orthologs represents
an unbiased sampling of ~24,000 transcripts on the rat arrays and 4,590 transcripts on the
salamander array. Although the majority of gene orthologs were not significantly
regulated (n = 553), we identified many similar and dissimilar gene expression responses
between these organisms. Eleven genes are up-regulated in both species, with no common
genes down-regulated. There were 46 and 41 uniquely up-regulated genes in the
salamander and rat, respectively. Overall, the majority of dissimilarities between the rat
and salamander injury response were changes in one animal and not the other (n = 126)
rather than opposite gene expression changes between animals (n = 2; Table 2.5).
Quantitative Real-time QRT-PCR
Using QRT-PCR, we estimated fold change between d0 and d3 for ten genes from
the microarray experiment (Table 2.4). All of the transcripts that met statistical and fold
level criteria from the microarray analysis registered significant differences in mRNA
abundance by QRT-PCR (6/10). Overall, we were able to verify nine of the ten gene
changes in the correct direction with close agreement in most cases. We only failed to
replicate the microarray estimate for sox3, which was not significant by QRT-PCR and
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registered such a low fold change that it was excluded from the short list of microarray
gene candidates. Thus, for all genes that met our stringent statistical and fold level criteria,
and three genes that did not, QRT-PCR validated microarray estimates of gene expression
with very good precision.
Spatial analysis of mRNAs using in situ hybridization
Ten genes that were significantly regulated during spinal cord regeneration were
examined further by ISH. We probed tissues that were collected three days after tail
amputation to localize expression among cell types that were within 1 mm from the end of
the regenerating spinal cord. Figure 2.4 illustrates the diverse patterns of spatial
expression observed with hybridization found in cells resembling ependymoglia, neurons,
and immune cells. All genes but fibroblast growth factor binding protein used for in situ
hybridization were up-regulated after injury. Assuming that these genes are not expressed
in uninjured tissue, these results show that the general increase in mRNA abundance as
determined from microarray analysis can be replicated and localized to specific cell
populations and tissues of the spinal cord using ISH.
Discussion
We built a custom Affymetrix GeneChip and profiled gene expression during the
early phases of natural spinal cord regeneration in a salamander model (Ambystoma
mexicanum). Our results show that regeneration involves significant changes in mRNA
abundance for many genes that are represented on the array. The overall list of 1,273
genes that met a very stringent statistical criterion is available as a new resource for
regeneration and spinal cord injury research fields (www.ambystoma.org). The large
number of genes on this list, which were identified using a custom microarray with
enriched gene content, shows that thousands of genes are significantly regulated during
the first few days of natural spinal cord regeneration. We used additional statistical and
fold change criteria to sample a smaller sub-group of candidate genes to describe gene
expression patterns and biological functions. The presumptive functions of this smaller list
of genes suggest the operation of many biological processes that change temporally during
spinal cord regeneration. Below we discuss up- and down-regulated genes and gene
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functions that may be important in the regenerative response. In particular, we compare
our gene expression results to several studies that have examined rat spinal cord injuries
using microarrays.
Up-regulated gene responses
Similar gene expression changes are often observed after tissue injury, regardless
of the type of injury or specific tissue type examined. With respect to CNS tissue injury in
mammals, an early acute phase is characterized in part by the expression of transcription
factors and immune response genes. Our study identified several genes that change by d1
in salamander spinal cord that are also expressed during the mammalian CNS acute injury
response (Vazquez-Chona et al. 2005; Bareyre and Schwab, 2003). These include jun-B
proto-oncogene, interferon regulatory factor 1, heme oxygenase 1, and apolipoprotein E
(apoE). Overall, many of our d1 and d3 up-regulated genes encode proteins that
participate in immune response functions, including lymphocyte, platelet and monocyte
activation, macrophage differentiation and migration, cell adhesion, thrombosis,
coagulation, inflammation, oxidative and metabolic stress, and apoptosis. In addition to
immune response genes, we also observed up-regulation of genes that function in
transport and binding of vitamin B and lipids, and ECM remodeling. While processes like
vitamin B homeostasis have received little attention in regeneration and injury fields
(Bauer, 1998), lipid turnover and MMP activity is well documented to be associated with
regeneration (Vance et al. 2000; Vinarsky et al. 2005). In A. mexicanum, MMP1, MMP2,
and MMP9 activity is associated with proliferating ependymal cells after 2-3 weeks of
regeneration (Chernoff, 2000). Our study shows that mmps 1, 3, 9, 13, 27, and timp1 are
all highly up-regulated by 24 hours after injury, which is the first association of mmps 13
and 27 with regeneration in urodeles. MMPs are also up-regulated in rodents after SCI and
high levels appears to contribute to secondary injury (Noble, et al., 2002; Wells et al.,
2003). Although application of MMP inhibitors may increase functional recovery after
SCI, our results emphasize the beneficial effects of MMPs and the need to quantify the
timing and amount of their delivery; clearly, MMP up-regulation and high MMP transcript
levels after spinal cord amputation are characteristic of natural regeneration in A.
mexicanum. In general, our results show a robust and diverse gene expression response is
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activated during the acute phase of natural spinal cord regeneration, and this response
includes genes whose functions are thought deleterious to recovery after SCI in mammals.
The majority of the early-activated genes were up-regulated throughout the first
seven days, extending into a subsequent phase of cell cycle-related gene expression at d5.
The accumulation of mRNAs that increase during the first seven days of regeneration
suggests a temporal change toward biological processes that are associated with cell
division. Many genes up-regulated at d5 (NNUC) are associated with mitotic cell cycle
regulation including four genes involved in the G2/M transition and six associated with
mitosis (Table 2.1). These gene expression changes maybe associated with the early
proliferation of blastemal and ependymal cell populations, which are known to expand
after the first week of regeneration (Lo et al. 1993; Zhang et al. 2003). Cell cycle-related
genes are also up-regulated early after rat spinal cord injury, but the functions of these
genes are associated primarily with S-phase and DNA repair and expressed in damaged or
apoptotic neurons, not proliferating cells (Di Giovanni et al. 2003). Thus, within a few
days after spinal cord injury, cell-cycle gene expression is biased towards cell death
pathways in mammals but cell survival and proliferation pathways in salamanders. This
observation could explain the cell proliferation of neural progenitors in the salamander,
which is likely necessary for the spinal cord to regenerate.
Down-regulated gene responses
In comparison to up-regulated genes, there were fewer down-regulated genes and
most showed gradual changes over time. Multiple genes were down-regulated whose
products are associated with neural functions, including axon guidance, ion transport,
glutamate metabolism, neuroprotection, and neurotransmitter signaling. Changes in
neural-related gene expression patterns may reflect the damage or loss of neural cell types
verses the survival, infiltration, and proliferation of other cell types. This explanation has
been advanced to explain the down-regulation of genes after mammalian spinal cord
injury, where there can be extensive tissue damage and cell loss (Profyris et al. 2004).
Indeed, even in the regenerating salamander, there is local spinal cord tissue loss after
injury (Figure 2.2B; Zhang et al. 2003; Stensaas, 1983). Thus, in both mammals and
salamanders, many of the down-regulated gene expression patterns may reflect the
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stochastic nature of cell survival at the injury site. However, we did observe significant
down-regulation of several genes that are associated with glutamate metabolism and
transport, that are up-regulated after CNS injury in mammals. This suggests the possibility
that some genes are actively and uniquely repressed during salamander regeneration. It is
also possible that the down-regulation of these genes is associated with the switch from
neuronal signaling to neuronal axon outgrowth.
Identification of genes expressed differently between salamander regeneration and
rat spinal cord injury
We compared genes that changed during early salamander spinal cord regeneration
to gene lists that were compiled from microarray studies of spinal cord injury in rats. We
acknowledge that this comparison is potentially confounded by several sources of
variation including experimental, technical, statistical, tissue, and organismal differences.
However, as we described above, some of the same genes that are expressed early after
mammalian CNS injury are also up-regulated during spinal cord regeneration in
salamander. If similar gene expression programs underlie homologous tissues, then
comparisons of homologous tissues among distantly related organisms may filter
conserved gene expression responses and help identify uniquely regulated genes. Some of
the uniquely regulated genes from salamander are associated with regeneration in other
organisms and tissues including amphibian limb regeneration (cytokeratin 18 [ck18],
Corcoran and Ferretti, 1997; msx1, Beck et al. 2003; msx2, Carlson et al. 1998; and
mmp9, Yang et al. 1999), fish tailfin regeneration (ck18 and periostin, Padhi et al. 2004),
and annelid epimorphic regeneration (phosphoribosylaminoimidazole carboxylase,
Myohara et al. 2006). Several other up-regulated genes are associated with mammalian
liver regeneration, including follistatin ( fst; Borgnon et al. 2005), cystathionase
(Teshigawara et al. 1995), laminin alpha 1 (Kikkawa et al. 2005), transglutaminase 1
(Ohtake et al. 2006), and uncoupling protein 2 (Horimoto et al. 2004). Furthermore, eight
cell cycle genes, a necessary process for true tissue regeneration, are present within this
unique salamander gene list including cell division cycle 2, kinesin family member 11, and
mitotic arrest deficient-like 1. Up-regulation of the same gene orthologs across multiple
regeneration paradigms suggests that regeneration is definable across taxa and tissues by
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distinct gene expression patterns. Further studies are needed to determine if a conserved
group of genes function in molecular pathways that are required for regeneration.
Molecules that regulate morphogenic signaling
Morphogenic molecules such as sonic hedgehog (SHH), bone morphogenic
proteins (BMPs), WNT factors, and fibroblast growth factors (FGFs) have been associated
with regeneration because they establish positional identity, control cell proliferation, and
regulate cell fate during development (Vergara et al. 2005; Whitehead et al. 2005;
Schnapp et al. 2005; Niemann, 2006). In this study, we identified changed genes that code
for extracellular molecules that participate in BMP, WNT, and FGF signaling. Fst, a
protein that regulates dorsal-ventral patterning of the developing vertebrate CNS through
BMP inhibition, is up-regulated during the first week of regeneration (Table 2.4; NUCC;
Lee and Jessel, 1999). mRNAs for sfrp2, a secreted WNT antagonist that blocks ligand
binding to frizzled receptors (Kawano and Kypta, 2003), is also highly up-regulated
(Table 2.4; UUCD; Figure 2.4G-H). Furthermore, wnt5A demonstrates a 3.86 fold
increase in expression (UCCC), suggesting a network of pro- and negative WNT signaling
during regeneration. Lastly, fibroblast growth factor binding protein 1, a secreted
molecule that sequesters FGF ligands from the ECM (Tassi et al. 2001) is down-regulated
6.42 fold at 24 hours (DCCC; Figure 2.4S-T). These large gene expression changes
suggest that BMP, WNT, and FGF signaling pathways are all altered during early spinal
cord regeneration. Further studies with each of these molecules and their corresponding
binding substrates will be needed in order to assess their possible roles during
regeneration.
Conclusion
The salamander’s unique ability to regenerate complex body parts has long been
recognized as an important model in developmental biology, however salamanders have
received relatively little attention from researchers of mammalian spinal cord injury. Our
study shows that genomic and bioinformatics resources are now available to associate
gene expression changes with cellular and molecular aspects of natural spinal cord
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regeneration. The emerging salamander perspective on regeneration promises to extend
existing research paradigms and may suggest novel therapies for CNS injury in humans.
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Symbol
Function
Unk; n = 30
UCCC = 64
MYO1B
actin binding
TAGLN
actin binding
ADFP
lipid metabolism
TNFAIP8
anti-apoptotic
ETHE1
anti-apoptotic
LGALS1
apoptosis
GADD45G
apoptosis
GADD45B
apoptosis
EFHD2
calcium binding
AGC1
unknown
MYC
cell cycle
CTSL
cysteine protease
CTSK
cysteine protease
TUBB6
cytoskeleton
FBP1
glycolysis
B3GNT5
glycosylation
TGFB1
growth factor
TYROBP
immune response
SLC11A1
immune response
MPEG1
immune response
CXCR4
immune response
LGALS3BP
immune response
CYBB
immune response
ANKRD1
injury response
FTH1
iron homeostasis
ATP6V0D1
proton transport
C1ORF33
ribosomal
MAP2K3
signal transduction
MMP9
tissue remodeling
MMP1
tissue remodeling
LYN
tyrosine kinase
TMEM49
unknown
FLJ2262
unknown
WNT5A
WNT signaling
Unk; n = 14
NNUC = 44
GLRX
antioxidant
LGALS3
carb. binding
Table 2.1 continued to right

Symbol
Function
KIF11
cell cycle; M
CCNB3
cell cycle; G2/M
PLK1
cell cycle
RFC2
cell cycle; S
PCNA
cell cycle; S
MCM7
cell cycle; S
STK6
cell cycle; M
CCNA2
cell cycle
CDC2
cell cycle
CHEK1
cell cycle
MAD2L1
cell cycle; M
CDC20
cell cycle; M
AURKB
cell cycle; M
CDCA8
cell cycle; M
KRT18
cytoskeleton
CALD1
cytoskeleton
FEN1
DNA metabolism
SLBP
mRNA processing
CKAP4
inflammation
KPNA2
intracellular transport
VRK1
Kinase
COL12A1
ECM component
UCP2
neuroprotection
CTSK
Protease
OLFML2B
signal transduction
CNIH4
Unknown
CCDC82
Unknown
RPL38
ribosomal
Unk; n = 22
NDCC = 42
KRT7
cytoskeleton
KIF21A
cytoskeleton
SLC1A2
glutamate transport
SLC1A3
glutamate transport
HSPA8
heat shock
TTR
hormone transport
SLC12A2
ion transport
KCTD3
ion transport
FDPS
lipid metabolism
Table 2.1 continued on next page
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Table 2.1 continued
Symbol
Function
Symbol
Function
FAAH
lipid metabolism
NASP
histone transport
COL8A1
ECM component
COL2A1
ECM component
FBN2
ECM component
LAMA1
ECM component
GSTM4
metabolism
DAG1
ECM component
GRM3
neurotransmission
P2RY2
neuronal diff.
PADI3
protein metabolism
NUP107
nuclear transport
APCDD1
signal transduction
ANP32E
phosphotase inhib.
TJP1
signal transduction
PAICS
purine metabolism
APC
signal transduction
CTPS
pyrimidine bio.
MAPRE3
structural protein
SSB
mRNA processing
CRYAB
structural protein
EXOSC2
rRNA processing
Unk; n = 17
RANBP1
signal transduction
NNND = 35
PDCD4
apoptosis
TPRT
ubiquinone bio.
APP
apoptosis
C6ORF115
unknown
CCNI
cell cycle
CCDC58
unknown
SPTAN1
cytoskeleton
NNDC = 27 Unk; n = 8
SPTBN1
cytoskeleton
CDKN1C
negative cell prolif.
PYGM
glycogen metabolism
MLF1
cell differentiation
FABP7
lipid metabolism
KRT6L
cytoskeleton
CHPT1
lipid metabolism
ABLIM1
cytoskeleton
mitochondrial
glutamate
SLC25A4
transport
GLUD1
catabolism
GPM6B
neurogenesis
ATP1B3
ion transport
AHNAK
neurogenesis
FXYD3
ion transport
GSTM1
neuroprotection
PRKAG2
lipid metabolism
GSTP1
neuroprotection
COX4I2
metabolism
GABARAPL2 neurotransmission
BHMT
metabolism
PBP
protease inhibitor
PCBD
metabolism
CALCA
signal transduction
CKMT1A
metabolism
TRAPPC6B
transport
SERPINI1
neurogenesis
C11ORF74
unknown
ABAT
neurotransmission
Unk; n = 7
TM4SF2
protein bio.
NNNU = 28
KIFC1
cell cycle; M
GNB5
signal transduction
CHC1
cell cycle; G2/M
POLR2L
transcription
RPA2
cell cycle
C6ORF110
unknown
MCM6
cell cycle; S
FAM79A
unknown
CTH
cysteine synthesis
NUCC = 24 Unk; n = 6
CALD1
cytoskeleton
TAGLN
actin binding
Table 2.1continued on right
Table 2.1 continued on next page
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Table 2.1 continued
Symbol
Function
Symbol
Function
ASAH1
apoptosis
PUS1
tRNA processing
UHRF1
cell cycle; S
FLJ36031
unknown
CDK4
cell cycle; G1/S
TGM1
injury response
KIAA0101
cell cycle; S
IFIH1
immune response
PPGB
cellular transport
UUCC = 12 Unk; n = 8
LGMN
cysteine protease
F13A1
wound healing
CSTB
protease inhibitor
MARCO
immune response
RRM2
DNA metabolism
FABP2
lipid metabolism
ANXA1
inflammation
GPNMB
negative cell prol.
THBS2
ECM component
UDCC = 10 Unk; n = 6
GLB1
metabolism
TFPI2
coagulation
ATP6V0E
proton transport
MMP1
tissue remodeling
RPL31
ribosomal
GIF
vitamin B transport
APOE
lipid metabolism
C8ORF4
WNT signaling
METTL2
ubiquinone biosynthesis
Unk; n = 3
UCDC = 8
CCDC43
unknown
HMOX1
heat shock
ANGPTL2
growth factor
MMP13
tissue remodeling
Unk; n = 7
MMP1
tissue remodeling
UNNN = 20
BYSL
cell adhesion
TIMP1
tissue remodeling
GLN3
cell cycle; G1/S
JUNB
transcription
DUSP1
heat shock
Unk; n = 5
DCCC = 6
IRF1
immune response
CYP2A13
metabolism
HSPA5
injury response
UCCN = 4
SLC30A1
ion transport
LTB4DH
antioxidant
AGXT2L1
metabolism
TXNDC2
antioxidant
DKC1
ribosomal
TXN
antioxidant
RPS6KA1
signal transduction
BTBD3
protein binding
Unk; n = 7
Unk; n = 2
UNNN = 20
DCNN = 4
BYSL
cell adhesion
RGMA
axon guidance
GLN3
cell cycle; G1/S
FHL1
protein binding
DUSP1
heat shock
UCNN = 5
IRF1
immune response
CES1
neuroprotection
HSPA5
injury response
USP2
protein breakdown
SLC30A1
ion transport
RAP2B
signal transduction
AGXT2L1
metabolism
SAT
polyamine homeostasis
DKC1
ribosomal
CD63
signal transduction
RPS6KA1
signal transduction
Unk; n = 2
UNNU = 3
Table 2.1 continued on right
Table 2.1 continued on next page
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Table 2.1 continued
Symbol
Function
NOL5A
ribosomal
NUCN = 3
HRAS
cell proliferation
NSUN2
cell proliferation
LTBP1
TGF-beta signaling
Unk; n = 3
UNND = 3
NNUU = 2
COL11A1
ECM component
POSTN
skeletal development
Unk; n = 2
NUNN = 2
Unk = 2
UNUC = 2
UDDC = 1
TCN1
vitamin B transport
NDCD = 1
AGR2
cell survival
NUCU = 1
FLJ1472
unknown
UUCD = 1
SFRP2
WNT signaling
UDNN = 1
IL8RB
immune response
DCDC = 1
KRT5
cytoskeleton
NDCC; DNNN; NDCN
NDNN; NNDD; NNDN
Unk; n = 1
Table 2.1. Gene symbols and functions for 360 changed salamander genes during the first
week of spinal cord regeneration. Each column contains highlighted categories that
describe gene expression patterns on day 1, day 3, day 5, and day 7 compared to basal
gene expression (d0). Gene symbols are found under each category.
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Table 2.2. Distribution of gene expression patterns for 360 significantly regulated
salamander genes during spinal cord regeneration.
Pattern
UCCC
NNUC
NDCC
NNND
NNNU
NNDC
NUCC
UNNN
UUCC
UDCC
UCDC
DCCC
UCNN
UCCN
DCNN
UNND
UNNU
NUCN
NUNN
NNUU
UNUC
DNNN
NDCD
NNDN
NNDD
NDNN
NDCN
UUCD
UDNN
UDDC
NUCU
DCDC

N
64
44
42
35
28
27
24
20
12
11
8
6
5
4
4
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1

Description
up D1, above baseline D1-7
baseline D1-3, up D5, above baseline D5-7
baseline D1, down D3, below baseline D3-7
baseline D1-5, down D7
baseline D1-5, up D7
baseline D1-D3, down D5, below baseline D5-7
baseline D1, up D3, above baseline D3-7
up D1, baseline D3-D7
up D1 and D3, above baseline D1-7
up D1, down D3, above baseline D1-7
up D1, down D3, above baseline D1-7
down D1, below baseline to D1-7
up D1, above baseline D1-3, baseline D5-7
up D1, above baseline D1-5, baseline D7
down D1, below baseline D1-3, baseline D5-D7
up D1, baseline D3-D5, below baseline D7
up D1 and D7, baseline D3-D5
baseline D1, up D3, above baseline D5, baseline D7
baseline D1, up D3, baseline D5-7
baseline D1-D3, up D5 and D7
up D1 and D5, baseline D3, above baseline D5-7
down D1, baseline D3-D7
baseline D1, down D3 and D5, below baseline D3-7
baseline D1-D3, down D5, baseline D7
baseline D1-D3, down D5 and D7
baseline D1, down D3, baseline D5-7
baseline D1, down D3, below baseline D5, baseline D7
up D1 and D3, down D7, above baseline D1-7
up D1, down D3, above baseline D1-3, baseline D5-7
up D1, down D3 and D5, above baseline D7
baseline D1, up D3 and D7, above baseline D3-7
down D1 and D5, below baseline D1-7
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Table 2.3. Primer sequences for QRT-PCR and in situ hybridization analysis. Forward
ISH primers were appended with an SP6 RNA polymerase promoter and reverse primers
with a T3 promoter at the 5’ end (MC02287 and MC01277 are opposite). Promoter
equences are SP6: 5’-ATT TAG GTG ACA CTA TAG AAG AG-3’ and T3: 5’-AAT
TAA CCC TCA CTA AAG GGA GA-3’.
Sal ID
MC03237
MC00341
MC01765
MC03278
MC01583
MC02459
MC01067
MC01275
MC01620
MC02501
MC01187

Forward Primer
5’-GGCAAACTGCCTCTCCTT-3’
5’-TTTCTGGACAGCCACTGC-3’
5’-CCTGATGGGGATCATCG-3’
5’-TGCATCAAAGCCAAGTCC-3’
5’-ATCCCGGAGAACAAGAGC-3’
5’-CAACGAGTGCATGAACGA-3’
5’-TGAGACCAATGCCTTTGC-3’
5’-GAGGCCAGAAAACCCAGA-3’
5’-TGGCCTGACCAGTAACGA-3’
5’-TCCATCCATGTCCTCTGC-3’
5’-CCAGGCGGCAGGTCAAGTCAAC-3’

MC02287
MC00365
MC00145
MC02339
MC01583
MC01706
MC00018
MC01275
MC01182
MC01277

in situ hybridization primers
5’-GCGCACGATGTCTTTCTGTA-3’
5’-GCGGTGGTACTCCAACTCAT-3’
5’- CGGCTTAGCCAGAAAATGAG-3’
5’- GTGGTTTCAGCAAAGCCAAT-3’
5’- GGCAAGATCATGGCTGAAAT-3’
5’- CAAGCCGCAGTATCATGTTG -3’
5’- TTTGGGAGCGAAGAAGAAAA-3’
5’- GAACGCTTGGTCTGGTAAGC-3’
5’-AAATTCCAATGCAAGTTGGG-3’
5’-ACGCCGTTCAGCTTGTAGAT-3’
5’-ACAACTCAGCCTGGACCATC-3’
5’- GTCTTTCACCCATTGCAGGT-3’
5’-ACATGGAGGACACCAAAAGC-3’
5’-AGCTCTGGAGTTCAGCTGGT-3’
5’-TATTAAGGGCCACGTTCCAG-3’
5’-TATGGAAGCCCTCCACAGAC-3’
5’-GTGCTGCAGGATGTCAAGAA-3’
5’-GCTGGTGTCTTCCTCTCTGG-3’
5’- AATCCAGCCACATCCTTCAC-3’
5’- GGCGCACCACATACACATAC-3’
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Reverse Primer
5’-CCTGTGGTTTTCCCATGA-3’
5’-TTTCTGGACAGCCACTGC-3’
5’-GTGCAGCCGGTACTTGTC-3’
5’-CCTCGGTTCACCTTGAAA-3’
5’-CATCCTTGAGCCAGAGCA-3’
5’-GCCAGACAGGTGGCCTA-3’
5’- GAGCCCCAGAAGCAGAGT-3’
5’-CCGGTTTGGAAATTTCATC-3’
5’-AAGTCCCATTCAGCACCA-3’
5’-CTGTTTGCGATTGCATGA-3’
5’-GTCGGCAAGGTCATCCCAGAGC-3’

Table 2.4. Comparison of microarray versus real-time PCR estimates of fold change for
ten genes that were quantified on d0 and d3. *In the list of 360 genes that met statistical
and fold level criteria.
** Significant fold change difference between d0 and d3 according to real-time PCR
(student’s unpaired t-test, P < 0.05).
Sal ID
Gene Name
MC01620
SOX2
MC02459
HES1
MC02501
SOX3
MC03278
FST
MC01765
CXCR4
MC01067
CD63
MC00341
TGFB1
MC01275
LGALS1
MC01583
SFRP2
MC03237
AGC1

Microarray Real Time
-1.7
-1.86**
-2.15
-1.35
-1.92
1.14
3.09
3.45**
3.17*
4.19**
2.17*
4.77**
3.69*
5.43**
2.55*
10.5**
17.95*
23.8**
56.84*
42.9**
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Table 2.5
Sal ID
Symbol
Up sal. and rat; n=11
MC02474 LGALS3BP
MC01211 HMOX1
MC01277 LGALS3
MC01006 ATP1B2
MC01230 IRF1
MC03756 NIP7
MC01354 GPNMB
TC01086
TIMP1
MC03344 CNIH4
MC04256 C8ORF4
MC00018 APOE
Up sal, N/C rat; n=46
MC00197 TGM1
MC04407 SLC30A1
MC00663 ARG2
MC02499 SGK
MC03162 LTB4DH
MC00337 LTBP1
MC01521 RAC2
MC00770 DKC1
TC00995
RPA2
MC02792 NOL5A
MC03278 FST
MC01728 UCP2
MC01639 SSB
gi|1139526 MSX1
MC01194 GLRX
MC04782 WDR75
MC02823 PAICS
MC01405 PIM1
MC02564 MPHOSPH10
MC01526 RANBP1
MC04306 NUP107
MC00145 KRT18
MC00535 RPL38
Cont. in next column

Sal ID
Symbol
MC00222
GLB1
MC01541
RGS10
MC02123
KIF11
MC01119
CTH
MC02344
GIF
MC02468
LAMA1
MC01297
MAD2L1
MC02065
DAG1
MC04570
CRELD2
MC01751
VRK1
MC02308
PLK1
MC01068
CDC2
MC00594
RRM2
MC04538
VKORC1L1
MC01709
TYROBP
MC05477
OLFML2B
MC07609
MPS1
MC03420
ANKRD1
MC02287
MMP9
MC02182
ATP6V0D1
gi|40809686 MSX2
MC02833
POSTN
MC00043
F13A1
D. rat, N/C sal.; n=18
MC01716
UBE2G1
MC02022
RNF14
MC02955
TMED2
NP_002133 HOXA9
MC00031
COL1A2
MC01720
UBE2L3
MC03866
LOC51255
MC00030
COL1A1
MC01092
COL2A1
MC00212
COL5A2
MC05202
YWHAZ
MC00423
IGF1R
Cont. in next column
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Sal ID
Symbol
MC01940 ATIC
MC00862 GSTA1
MC04981 FKBP1A
MC03940 OTUB1
MC01364 OCLN
MC04214 DDIT4
D. rat, up sal; n=1
MC02177 RAB11A
D. sal., N/C rat; n=21
MC00837 FAAH
MC00399 CYP2A13
MC01099 COL8A1
MC02628 FXYD3
MC00345 ADH1A
MC02307 SERPINI1
TC00019
APC
MC03555 MAST3
MC01037 BHMT
MC00741 CSRP3
MC01503 PTPRR
MC04857 COX4I2
MC04494 MLF1
MC01631 SPTBN1
TC00539
FABP7
MC05220 GSTM5
MC04424 MID1IP1
MC00251 AK1
MC05114 C11orf74
MC00841 FHL1
MC01620 SOX2
Up rat, N/C sal.; n=41
MC04731 HNRPD
MC04672 SEC13L1
MC01058 CBR1
gi|5199142 LDHA
MC01272 LDHB
Cont. on next page

Sal ID
Symbol
Sal ID
Symbol
MC03456
C9ORF10 MC00282 TP53
MC01484
PSMD8
Up rat, D. sal.; n=1
MC04823
ELOF1
TC00219 APP
MC02100
HNRPAB
MC00811
EIF4A1
MC01697
TPT1
MC00919
HSPB1
MC00523
RPL28
MC04974
HTRA3
MC03977
NOLA2
MC04373
RPL36A
MC03396
CORO1C
MC03842
HSPC152
MC02234
GSTO1
MC00196
TGFBI
MC01786
DUSP11
MC05214
ANXA11
MC03882
FKBP11
MC04970
LRRC42
MC01722
UBE2N
MC00545
RPS3
MC02237
EIF4E2
MC05309
EMP3
MC01868
TRADD
MC01933
ANXA7
MC01392
PGD
MC01095
COL4A1
MC00332
GPX1
MC00274
HEXB
MC01711
RPS27A
MC03904
CHRAC1
MC03898
SMN1,SMN2
MC02876
HSPA8
gi|49473435 NPY
MC02061
CSPG3
cont. in next column

35

Table 2.5. Gene list for changed genes found on both the Ambystoma and rat U34
Affymetrix GeneChips. Genes were determined to be up-regulated, down-regulated, or not
changed (N/C) according to the criteria set by each rat microarray study.

36

Figure 2.1. Volcano plots showing the number of genes selected as differentially
expressed after spinal cord injury. False discovery rate was set to 0.01 (a) and the FWER
set to 0.01 (b). Genes selected by each of these respective criteria are gray and nonselected genes are black.
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Figure 2.2. Cross sections of regenerating spinal cords at days 1 (A-B), 3 (C-D), 5 (E-F),
and 7 (G-H) days after tail amputation. Mayer’s hematoxylin and Eosin were used to stain
chromatin blue and cytoplasm shades of red. Photos were taken for sections within which
the vertebrae were either fragmented or degenerating, and the central canal was clearly
defined. A-B) At day 1, hemorrhaging is apparent, the white matter degenerates, and there
are few neurons within the spinal cord grey matter. Leukocytes and erythrocytes are
present near the injury plane (stained deep red) with apoptotic bodies (arrowheads) near
the loosely interconnected ependymal cells (blue cells surrounding central canal; star).
Bone degeneration is minimal (A: arrow) and there is proliferation of leukocytes at the
injury site (B: arrow). Bone degeneration increases throughout the first week (A, C, E, G:
arrows). E-H) A mesenchymous mass of cells (blastema) surrounds the regenerating
spinal cord and ependymal cells project radial processes as the ependymal tube forms (D,
F, H: arrows).
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Figure 2.3. Two-dimensional plot of a principal component analysis (PCA) showing the
relatedness of each GeneChip. JMP statistical software was used to perform PCA on 25
GeneChips. A Pearson’s correlation coefficient matrix was made for 25 GeneChips using
intensity values for 376 changed genes. Principal component 1 (PC1; 80.35% of the
variation; eigenvalue 20.09) is displayed on the x-axis and Principal component 2 (PC2;
13.54% of the variation; eigenvalue 3.34) is displayed on the y-axis. The cumulative
variation accounted for by PC1 and PC2 is 93.89%. Twenty-five principal components
account for 100% of the variation in the dataset. Five biological replicate chips used for
each of the five time points are enclosed by an oval to illustrate their close proximity. ♦:
d0, n = 5; ■: d1, n = 5; ▲: d3, n = 5; ●: d5, n = 5; ▬: d7, n = 5.
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Figure 2.4. In situ hybridizations of d3 and d0 axolotl spinal cords. In situ hybridizations
were performed on d3 (A-R) and d0 (S-T) axolotl spinal cords using DIG-RNA probes
that correspond to significantly regulated genes from the microarray analysis. Anti-sense
probes are represented in columns 1 and 3, and sense control probes in columns 2 and 4.
ck18 (A-B), mmp9 (C-D), Annexin A1 (E-F), and sfrp2 (G-H) transcripts are all present in
ependymal cells near the end of the regenerating spinal cord. Inflammatory-like cells that
are found in the degenerating white matter are positive for ApoE (I-J), Ferritin-heavy
polypeptide (K-L), lgals1 (M-N), and lgals3 (O-P). Thioredoxin (Q-R) transcripts are
present in cells resembling ependyma as well as neurons of the injured spinal cord.
Fibroblast growth factor binding protein 1 (S-T) is highly expressed in lateral ependyma
and a subset of neurons in the uninjured spinal cord. Bar = 100 µm.

Copyright © James Robert Monaghan 2009
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Introduction
Salamanders are capable of axon regeneration after spinal cord injury. They
apparently perform this task by circumventing various inhibitory factors that have been
shown to limit CNS axon regeneration in mammals. Several different experimental
approaches using mammals show that CNS myelin inhibits the growth of axons that
would allow partial functional recovery after injury (Review by Schwab and Bartholdi,
1996; Huang et al., 1999; David and Aguayo, 1981; Caroni and Schwab, 1988). A wellestablished family of inhibitory factors in mammals are CNS myelin-associated molecules
including myelin-associated glycoprotein (MAG; Li et al., 1996), oligodendrocyte-myelin
glycoprotein (OMgp; Wang et al., 2002), and Nogo-A (GrandPre et al., 2000; Chen et al.,
2000). In contrast to mammals, axons of lower vertebrates such as fish (Gaze, 1970;
Review by Martin et al., 1994) and salamanders (Stensaas, 1977) successfully traverse the
lesion site, leading to full functional recovery. Several explanations for the fish and
salamander’s regenerative abilities have been proposed such as the possibility that
inhibitory myelin-associated molecules are not present in fish and salamanders, they are
cleared from the area early after injury, the membrane topology or expression is different,
or they are not inhibitory to the growth of axons in anamniotes (Schwab, 2004; Oertle et
al., 2003; Klinger et al., 2004).
Among the myelin-associated inhibitory molecules, Nogo-A has been best
characterized. The nogo gene (i.e. reticulon 4) is a member of the reticulon gene family.
Reticulon-like genes are found throughout eukaryotes (Oertle et al., 2003) and code for
proteins possessing a highly conserved membrane-spanning region at the carboxy
terminus called the reticulon homology domain (RHD). The reticulon proteins are
primarily located within the endoplasmic reticulon with multiple possible functions
including synaptic plasticity (McGee et al., 2005), vascularization (Acevedo et al., 2004),
apoptosis (Tagami et al., 2000; Watari and Yutsudo, 2003), amyloid-β regulation (He et
al., 2004), and vesicle trafficking (Steiner et al., 2004). Mammalian Nogo (mNogo) is of
primary interest to human health because it codes for a protein isoform (Nogo-A) found
on the cell surface of oligodendrocytes that contributes to the lack of axon regeneration in
the mammalian CNS (Review by Schweigreiter and Bandtlow, 2006; Dodd et al., 2005).
The nogo gene is processed to form three primary protein isoforms named Nogo-A, Nogo-
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B, and Nogo-C. All three isoforms contain a common carboxyl end that contains a highly
conserved reticulon homology domain. The Nogo-A isoform is the largest of the three
because it contains a large exon (2400 base pairs) that codes for a domain found to be
inhibitory to axon outgrowth. The Nogo-A isoform was first identified as being the
antigen of a monoclonal antibody (IN-1) capable of neutralizing the inhibitory nature of
mammalian CNS myelin (Caroni and Schwab, 1988; Chen et al., 2000; GrandPre et al.,
2000). Since this time, the inhibition of Nogo-A and its downstream signaling
mechanisms have become worthy candidates for clinical application to human CNS
trauma (Buchli and Schwab, 2005; Freund et al., 2006, 2009). Furthermore, a role of
Nogo-A in nervous system development other than myelin inhibition is starting to be
recognized including peripheral nerve axon guidance, neural differentiation, neurite
formation, and cortical development, (Brösamle and Halpern, 2008; Caltharp et al., 2007;
Mingorance-Le Meur et al., 2007; Richard et al., 2005, 2009; O’neill et al., 2004).
Understanding the evolutionary history of the Nogo-A isoform may broaden our
understanding of the normal roles Nogo-A has in the CNS. Recent work has shown that
the Nogo-A isoform is present in frogs (Klinger et al., 2004) but not fish (Diekmann et al.,
2005). The frog loses the ability to regenerate some CNS axons after metamorphosis,
while fish maintain regenerative ability throughout life; a characteristic that may be
possible because of the absence of Nogo-A. Furthermore, frog CNS myelin and not fish or
salamander myelin are inhibitory to axon growth in vitro (Lang et al., 1995). The
identification and characterization of this isoform in a vertebrate capable of CNS axon
regeneration throughout life has yet to be observed.
Here we report on the identification of the amniotic ortholog of Nogo-A in the
salamander Ambystoma mexicanum (axNogo-A). We demonstrate orthology via sequence
similarity and genetic linkage analysis. We show that axNogo-A mRNAs are enriched in
nervous system tissue throughout development. We also find that axNogo-A is expressed
in the nervous system well before myelin formation, suggesting an early role in nervous
system development. Thus, while the CNS of the Mexican axolotl is permissive to axon
growth, it contains transcripts of axNogo-A, an inhibitory molecule that is structurally
similar to mNogo-A orthologs from vertebrates that lack regenerative ability.
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Methods and Materials
Animals and RNA extraction
Wild-type adult axolotls and albino embryos were obtained from the Ambystoma
Genetic Stock Center (University of Kentucky) or the Voss lab and housed at 20-22ºC in
modified Holtfretter’s solution. Staging was according to Beetshcen and Gautier
classification (Armstrong and Malacinski, 1989). Animals were anesthetized using 0.01%
benzocaine (Sigma) before tissue collection. Tissue extraction was performed from adults
measuring 10-15 cm snout to cloaca and snap frozen in liquid nitrogen. RNA isolation
was performed using TRIzol reagent according to manufacturer instructions, followed by
an Rneasy column, quantified by spectrophotometry, and quality-assessed by
formaldehyde-gel electrophoresis.
Identification and Mapping of axNogo-A
Primers 5’-CTC CAC GCC CAG AGA TTG-3’ (F.1) and 5’-ACT GAG AGC
AGG GCC AAT-3’ (R.1) were used on axolotl brain and spinal cord for long distance
PCR. ExTaq long distance polymerase (Takara) was used with PCR parameters: 94ºC, 30
seconds, 65ºC 1 minute, 72ºC 5 minutes for 30 cycles. Nested PCR was performed using
a 1:1000 dilution of the above PCR product and 5’-AGC CAC CCT TAG CAG GAG AC3’ (F.2) and 5’CCA ATG CAA TGT ACG CTG AC-3’ (R.2). PCR parameters were 35
cycles at 94ºC for 45 sec, 65ºC for 45 sec, and 72ºC for 1 min (fig 1b). PCR product was
gel isolated using QIAquick gel isolation kit. A clone representing 1300bp of the 3’ end
was also isolated. Both were sequenced using Bigdye and assembled using Seqman II
DNASTAR software. Mapping of axNogo was performed according to Smith et al. (2005)
using the following primers: 5’-GAA GAC GAT GAA ACG ACT GAG AG-3’, 5’-CCG
CAG CGC CAG GTG ATG GTC GAG GAA-3’, and 5’-GGC TTC TTC CTC TCC TCA
AAA G-3’.
Sequence Alignment and Analysis
Rattus novegicus, Mus musculus, Homo sapien, Gallus gallus, and Xenopus laevis
Nogo-A sequences are found at NCBI (NP_114019, NP_918943, NP_065393,
NP_989697, and AAQ82646, respectively). Sequence assembly and open reading frame
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prediction of axolotl nogo-A was performed with DNASTAR. Sequence alignment was
performed using CLUSTALW and shaded for similarity using BOXSHADE. Protein
motifs were predicted using Motifscan (Pagni et al., 2007). Hydrophobic regions were
predicted using Tmpred, TMHMM (Krogh et al., 2001), and DAS transmembrane
prediction programs (Cservo et al., 1997).
RT-PCR
cDNA was produced using 1ug total RNA and the Bio-Rad ISCRIPT cDNA
synthesis kit. Templates for PCR included 10ng cDNA. PCR primers for nogo-A were
forward (5’-TGA TGG AAA AAC TGG GGA GA-3’) and reverse (5’-GGG GAT GTA
CGG AGT CTC AA-3’) giving a product of 991bps. EF-1α primers are described
elsewhere (Carlson et. Al., 2001). Primers have a modified T7 and T3 promoter added
onto each for subsequent digoxygenin RNA probe production. MBP primers were forward
(5’-TAA TAC GAC TCA CTA TAG GGA GGC CAG AAC CTT GGA ATC TGA-3’)
and reverse (5’-AAT TAA CCC TCA CTA AAG GGA GGA CAA CGG GGT TAT CCT
CAA-3’) giving a PCR product of 344bp. PCR parameters for nogo-A were 28 cycles of
94ºC for 45 sec, 55ºC for 45 sec, 72ºC for 45 sec, 24 cycles using the same parameters for
EF-1α, and 33 cycles at 94ºC for 45 sec, 60ºC for 45 sec, and 72ºC for 45 sec for MBP.
5ul of PCR product was analyzed on a 2% gel and visualized using a Gel Logic 100
Imaging system. Relative PCR product was compared with the control EF-1α.
In situ Hybridization
PCR products produced using primers F.3 and R.3 was cloned into a Promega
pGEM-T vector by the A-tailing procedure. Nogo-A digoxygenin RNA probe was
produced using PCR templates produce from M13 forward and reverse primers and T7 or
SP6 polymerase as described in Roche DIG-RNA labeling manual. Briefly, reactions were
incubated 2 hours at 37ºC, stopped by adding 2ul 200mM EDTA, ethanol precipitated,
and quantified using formaldehyde-gel electrophoresis. Tissue samples were fixed in 4%
paraformaldehyde/1XPBS overnight, decalcified in 0.5M EDTA/1xPBS for 4 days when
bone was in the tissue, cryoprotected by immersion in 10% sucrose/1xPBS for 1hr, 20%
sucrose/1xPBS, followed by 30% sucrose/1xPBS for 3hr to overnight. Tissues were then
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mounted in OCT medium, sectioned at 16um, and stored at -80ºC. Sections were
processed, hybridized, and washed as described elsewhere (Hirota et. Al., 1992).
Overnight incubation with NBT/BCIP gave sufficient signal for specific detection.
Sections were mounted with Permount, imaged using an AX-80 Olympus microscope, and
photographed using an Olympus DP-70 camera.
Results and Discussion
Cloning and identification of axNogo-A
It is of particular interest to understand the evolutionary history of the long exon
found within nogo. It has been suggested that the nogo-A isoform is not present in
amphibians or fish, which is in accordance with their ability to regenerate axons after CNS
injury (Schwab, 2004). Indeed, the nogo-A isoform is not present in the teleost fish
genome (Diekmann et al., 2005). In contrast, Klinger et al. has shown that the nogo-A
isoform is present and expressed in the CNS of anuran, Xenopus laevis (2003). In this
study, we unambiguously identify the mammalian nogo ortholog in the axolotl and show
that the axNogo-A isoform is present and expressed.
We identified a 1577 base pair contig from the Ambystoma Expressed Sequence
Tag Database (http://www.ambystoma.org) with high nucleotide sequence identity to
human reticulon 4 (BLASTX; 2e-74). The contig contained the presumptive full-length
coding sequence of the rtn-4B/nogo-B mammalian isoform; it lacked a large terminal exon
characteristic of the nogo-A isoform (Figure 3.1a). To obtain the characteristic nogo-A
exon, PCR was performed with primers F.1 and R.1, producing two fragments at 2625bp
and 183bp. These products were sequenced to identify the axNogo-A large exon. The
nested primers F.2 and R.2 were used to amplify the axNogo-A region yielding a 2349bp
PCR product (Figure 3.1b). The resulting DNA sequence was assembled with the nogo-B
contig to yield a 4024bp sequence with a predicted open reading frame of 1158 amino
acids. The predicted protein is highly identical to Human RTN4-A/Nogo-A (BLASTP;
3e-157). To provide additional evidence that our sequence was orthologous to amniote
nogo-A, we mapped the sequence to linkage group 13 (LG13) in the Ambystoma genome
(Smith et al., 2005). Few syntenic regions have been identified between LG13 and the
human chromosomal region where Nogo is located (Hsa 2p16.3). Therefore, we compared
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LG13 to the position of nogo in the chicken genome, which shows greater overall
conservation in gene order to Ambystoma. Eleven Ambystoma LG13 contigs, including
axNogo-A, map to chicken chromosome 3. This strongly suggests that axNogo is the
ortholog of the amniote nogo. Thus, two separate lines of evidence, sequence similarity
and gene mapping, indicate that the assembled contig is the amniote ortholog of nogo-A in
Mexican axolotl (here after referred to as axnogo-A).
The presence of nogo-A in both urodele and anuran amphibians indicate that its
origin is basal to their closest ancestor, believed to be during the Jurassic period
approximately 200 million years ago (Zardoya and Meyer, 2001). A loss or gain of
function in the inhibitory property of myelin must have occurred during the divergence of
these organisms because adult anuran spinal cord myelin has inhibitory activity in vitro,
while axolotl myelin is permissive to axon growth (Lang et al., 1995). It is also possible
that the myelin isolated from the axolotl in Lang et al. was from a region that does not
express inhibitory myelin molecules. We propose that it is not the presence or absence of
the nogo-A isoform contributing to this loss or gain of function in these organisms. It is
possible that inhibition was gained independently in anurans or inhibitory myelin is a
basal property to tetrapods, which is lost in urodele amphibians. It would be interesting to
pursue the evolution of nogo-A and inhibitory myelin further in lobe-finned vertebrates as
this would better resolve the ancestral amphibian condition.
Comparison of vertebrate Nogo-A Protein Sequences
Several conserved domains were found between salamanders and other
vertebrates. The most striking resemblance is within the RHD. The RHD is located at the
carboxyl end and is much more similar than the 970 aa amino end of the rat Nogo-A
predicted protein sequence (87% compared to 34%, respectively). The RHD contains two
>34 aa predicted transmembrane domains around a conserved 66 aa domain, the
extracellular Nogo-66 domain that inhibits neurite outgrowth through binding to Nogo
receptor (NgR; Fournier et al., 2001). The RHD in teleost fish are also highly similar and
seem to have similar transmembrane regions, suggesting similar orientation and function
(Diekmann et al., 2005). Interestingly, a mammalian NgR ortholog is also present in fish
(Klinger et al., 2004) and morpholino knockdown of NgR or the Nogo-66 region causes

47

defects in peripheral nervous system axon outgrowth to the head and lateral line
(Brösamle and Halpern, 2008). These results suggest that Nogo-66/NgR signaling is a
conserved pathway in vertebrates that regulates axon growth during development. A
second conserved motif in the RHD is a dilysine endoplasmic reticulum retention motif,
giving indication of the primarily intracellular location of Nogo proteins (Chen et al.,
2000; Grandpre et al., 2000; Van der Haar et al., 2003). The intracellular role of Nogo-A
is poorly understood in any vertebrate.
The ~800 aa Nogo-A-specific region (NAS) is more divergent with similarity
ranging from 32-36% between all vertebrates analyzed (Figure 3.2). The carboxyl 24 aa of
human NAS binds to NgR through an Isoleucine found at human amino acid 995 (Hu et.
Al. 2005). All other animals examined, except the frog, have a Valine at this position
(Figure 3.2). A highly inhibitory region found within the rat NAS termed ∆20 (Oertle et
al., 2003) shows higher similarity (45%) between rat and axolotl compared to the entire
NAS (34%). This suggests that the salamander ∆20 region may also have inhibitory
properties similar to the rat ∆20 domain. It will be important to identify whether the
amphibian ∆20 domain has inhibitory properties in order to know whether ∆20 inhibition
was a basal character of Nogo-A or a recently derived character in mammals.
A second unknown receptor binds within the first 172 amino acids of the rat nogoA/B region inhibiting fibroblast spreading (Oertle et al., 2003). This region is also
responsible for migration of endothelial and vascular smooth muscle cells in vitro and
vascular remodeling in vivo (Acevedo et al., 2004). A large proline-rich region is
predicted in both amphibians and mammals within this Nogo-A/B amino region. There are
multiple SH3-ligand motifs found within the proline-rich region suggesting proteinprotein interactions. It is conceivable that this region is responsible for binding to some of
these proteins and receptors in mammals as well as amphibians, mediating similar
signaling. Overall, low sequence similarity within this region is seen except for the
proline-rich motifs.
Nogo-A expression
To examine how nogo-A expression changes during development, we performed
RT-PCR using RNA isolated from whole embryos. Strong axNogo-A expression started
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between stages 27 and 36 (Figure 3.3b). The tail bud embryo starts to enlarge during this
developmental window, which correlates with the differentiation of neuronal circuits in
the spinal cord. Twitching also starts during these stages meaning that motor neurons have
innervated the musculature of the embryo (Armstrong and Malacinski, 1989). To illustrate
the independent regulation of nogo-A from the onset of myelination, RT-PCR analysis
was performed using primers specific to the myelin marker, myelin basic protein (MBP).
axNogo-A expression starts well before the onset of MBP transcription around hatching
(Figure 3.3), suggesting that Nogo-A has a role in development before oligodendrocyte
differentiation and myelination. Expression of Nogo-A in neurons before the onset of
myelination has been observed in chickens (Caltharp et al., 2007; O’Niell et al., 2004),
frogs (Klinger et al., 2003), rodents (Huber et al., 2002; Tozaki et al., 2002; Mingorance et
al., 2004), and humans (O’Niell et al., 2004). Nogo-A knockout mice show mild deficits in
neuronal migration during cortical development (Mingorance-Le Meur et al., 2007) and
increased neuronal plasticity (Montani et al., 2009). The expression of Nogo-A in neurons
before myelination in multiple tetrapods strongly supports a conserved neuron-specific
role during development. To define the localization of axNogo-A during development,
whole-mount in situ hybridization was performed on animals at developmental stages 36
and 38 (Figure 3.4), stages when Nogo-A mRNA is expressed (Figure 3.3). axNogo-A
mRNAs localized to multiple areas of the CNS including the developing brain, spinal
cord, and eye. Expression was also evident in a specific location near the developing
spinal ganglia. It is unknown if the developmental role of axNogo-A is related to Nogo66/NGR or the NAR. Morpholino knockdown studies of all Nogo isoforms compared to
the Nogo-A isoform should resolve the developmental function of Nogo-A. Regardless,
the broad expression of Nogo-A in the developing nervous system of axolotls and other
vertebrates strongly suggests a conserved role in early nervous system formation.
The adult distribution of Nogo-A was examined using RT-PCR and in situ
hybridization. RT-PCR showed that axNogo-A mRNA was most abundant in brain, eye,
spinal cord and heart tissues (Figure 3.3a). These results are consistent with observations
found in other amphibians and mammals (Figure 3.3a; Klinger et. Al., 2004; Oertle et al.,
2003). In situ hybridization localized mRNAs to neurons and oligodendrocytes according
to location in the brain, spinal cord, and dorsal root ganglia (Figure 3.5 and 3.6). Some
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neuronal populations had much stronger staining than others. To localize these regions in
the brain, darkly stained cells were highlighted on cross sections of the adult brain (Figure
3.5). Heavily stained regions corresponded to the medial pallium in the telencephalon,
habenula in the epithalamus, outer neurons of the optic tectum, and neurons of the
hindbrain. AxNogo-A transcripts were also localized to areas of differentiated neurons
throughout the spinal cord (data not shown), with strongest expression in the ventro-lateral
portion of the grey matter (motor neurons). Strong staining was also observed in neurons
of the dorsal root ganglia, as was observed in mammals (Huber et al., 2002). The
conservation in expression between salamanders and mammals suggest a conserved role
in neuronal development.
An interesting finding of the study was that Nogo-A transcripts were localized to
cells located in regions of oligodendrocytes. Figure 3.5 and 3.6 show that MBP and nogoA staining do not overlap in the forebrain, but are expressed in cells located in the same
regions as oligodendrocytes in the hindbrain and spinal cord. No Nogo-A staining was
observed in cranial nerves expressing high levels of MBP, suggesting that Nogo-A is not
expressed in Schwann cells. The large number of Nogo-A positive cells located in the
white matter of the CNS strongly suggest that axNogo-A is expressed in oligodendrocytes
in some portions of the adult CNS. This staining pattern was surprising because IN-1
antibody, an antibody that binds to the amino arm of Nogo-A (Fiedler et al., 2002), was
found to stain myelinated axon tracts in X. laevis, but was not observed in axolotl myelin
(Lang et al., 1995). This suggested that Nogo-A is not expressed in axolotl
oligodendrocytes, explaining the growth permissive nature of axolotl myelin. It may be
that IN-1 immunoreactivity is independent of the expression of Nogo-A mRNA and more
related to a conformation found at the cell surface, as suggested elsewhere (Klinger et al.,
2004). It is also possible that this cell surface conformation is necessary for inhibitory
activity in vivo. Understanding what this conformation may be and how it interacts with
other CNS components is necessary to design more effective therapeutics against the
inhibitory activity.
One hypothesis why the axolotl possesses such high CNS regenerative capacity is
that Nogo-A is down regulated following injury. Figure 3.7E shows that mRNA levels
decline only slightly during the first week of injury (Monaghan et al., 2007). Some
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neurons can be seen expressing Nogo-A at the injury plane following tail amputation
(Figure 3.7F and G). A similar gene expression pattern is observed after spinal cord
lesions in rats suggesting that Nogo-A is not a lesion-induced inhibitor of axon growth
(Huber et al., 2002). A second hypothesis of how the axolotl can circumvent myelin
inhibitors is that Nogo-A protein is cleared from the injury site following injury. This
hypothesis is supported by the observation that tenascin-R and MAG, both potent
inhibitors of neurite outgrowth in mammals, are cleared from an optic nerve injury lesion
within 8 days after injury in newts (Becker et al., 1999). Future studies are needed to
address the role of Nogo-A in neurons and why salamander myelin is not inhibitory even
though it likely contains Nogo-A.
Conclusions
We identified the ortholog of human reticulon 4/nogo in the Mexican Axolotl
(Ambystoma mexicanum). We illustrate that the long exon that is diagnostic of nogo-A and
encodes a highly inhibitory region in humans, is also coded for in the axolotl. We predict
protein structure and possible motifs, and characterize developmental and adult mRNA
expression. This is the first identification and characterization of nogo-A in a vertebrate
capable of functional regeneration of spinal cord axons throughout life.
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Figure 3.1 A) Cartoon of the predicted axolotl Nogo-A protein. Grey shading represents
the Nogo-A-specific portion of the protein. Black shading represents the two inhibitory
regions as predicted through homology with rat Nogo-A. Arrows indicate the location of
primers designed in the study. B) Gel electrophoresis of the nested RT-PCR product as
produced using primers F.1/R.1 followed by F.2/R.2.
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Figure 3.2. Predicted protein sequence alignment and motif comparison of several
tetrapod vertebrate Nogo-A proteins. Black shading represents 100% homology and grey
shading 100% similarity. Predicted transmembrane regions are underlined with dark,
black line. Presumptive inhibitory regions, human isoleucine at aa 995, and endoplasmic
reticulon-retention motifs are boxed. The nogo-A specific region is indicated with black
arrowheads. Predicted glutamic acid-rich regions are underlined with a thin grey line and
proline-rich regions with multiple carrots (^^^^).
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Figure 3.3. RT-PCR of Nogo-A in adult tissues and development. A) Nogo-A in adult
tissues compared to expression in adult human and X. laevis tissues. The top band is the
specific Nogo-A PCR product. The bottom band is the control EF-1 alpha PCR product.
The + and – found below indicate expression in humans and Xenopus modified from
(Klinger et al., 2004) B) Expression of Nogo-A during development. Staging was
according to Beetshcen and Gautier classification. C) Expression of EF-1 control gene
during development. D) Expression of myelin basic protein mRNA during development.
Notice that MBP is not expressed until hatching. H = heart, B = brain, E = eye, Sp =
spleen, Sk = skin, G = gill, SC = spinal cord, Lu = lung, M = muscle, Li = liver.
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Figure 3.4. Whole mount in situ hybridization of stage 38 embryos using an antisense
probe against axNogo-A. Three different embryos are represented. The embryo on the left
is viewed from the side, middle embryo is viewed from above, and right embryo viewed
from the front. Purple staining represents locations of Nogo-A mRNA. Arrows indicate
positive staining in locations of the possible lateral line ganglia. Arrowheads indicate the
eye premordia.
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Figure 3.5. Tracing of MBP and Nogo-A staining throughout the brain. The left
hemisphere represents positive staining of cells probed with anti-MBP. The right
hemisphere represents cells with strong expression of axNogo-A. Some light staining is
not presented in the Nogo-stained sections because it was found in most neuroncontaining regions. The images correspond from the middle of the telencephalon (A) to
the hindbrain (E). Dots represent positive cells. The black areas on the outside of the left
hemisphere are deeply stained cranial nerves. No staining was observed in cranial nerves
for Nogo-A. Close-up images can be seen in Figure 3.6.
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Figure 3.6. Positive staining for Nogo-A and MBP in the brain represented in Figure
3.5. A, C, and E represent antisense Nogo-A probe staining. B, D, and F represent sense
Nogo-A probe staining. G and I represent antisense MBP probe staining. H and J
represent sense MBP probe staining. Sections correspond to the top image in Figure 3.5
(A, B, G, and H), second from bottom image in Figure 3.5 (C, D, I, and J), and bottom
image in Figure 3.5 (E and F). No MBP staining was seen in the medial pallium of the
telencephalon. Scale bar = 200um
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Figure 3.7. Nogo-A and MBP positive staining in spinal cord and DRG tissue. A)
cells with positive Nogo-A staining. The arrow indicates possible motor neurons. Notice
the location of possible oligodendrocytes in the white matter. B) Positive MBP staining in
the adult spinal cord. C) Positive Nogo-A staining in an uninjured adult tail. Arrows
highlight possible motor neurons and the star indicates a dorsal root ganglia. D) Gene
expression pattern of Nogo-A in the spinal cord following tail amputation (Monaghan et
al., 2007). Minimal, but significant down-regulation was observed. E and F show Nogo-A
staining in regenerating tails 7 days following amputation. Positive staining is still
observed in motor neurons (arrows) and DRGs (stars).
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Introduction
Salamanders are fascinating vertebrate organisms because they routinely
regenerate complex tissues. In only a few weeks after losing a piece of limb to a hungry
predator or scalpel-welding scientist, a salamander perfectly reforms the missing structure.
In the early history of salamander regeneration research, scientists innovated elegant
experimental designs to probe the anatomical basis of regeneration (Dinsmore, 1991).
More recently and in parallel with the discovery of conserved, regulatory genes and
developmental pathways among metazoans, scientists have focused attention on candidate
molecules and signaling pathways whose functions were deduced first from studies of
model organisms. In particular, much research has been devoted to understanding aspects
of limb regeneration associated with wound healing that recapitulate limb development;
this strategy has yielded many useful insights and molecular probes (Carlson et al., 2001;
Christensen et al., 2001, 2002; Endo et al., 2004; Kumar et al., 2004; Mercader et al.,
2005; Schnapp et al., 2005; Levesque et al., 2007; Satoh et al., 2007, 2008; Theodosiou et
al., 2007; Villiard et al., 2007; Ghosh et al., 2008). Although it is clear that key regulatory
molecules play important roles in the development of all organisms, it is not clear that a
framework for understanding regeneration can be constructed using a generic and limited
molecular toolkit. There is a need to go beyond candidate molecules and use unbiased
approaches to characterize the molecular complexity underlying salamander regeneration.
Recent research resource development for the Mexican axolotl now allows classic
regeneration experiments to be re-examined with powerful and unbiased genomic
approaches. One particularly elegant experiment performed almost two hundred years ago
showed that salamander limb regeneration requires the presence of peripheral nerves.
Todd found in 1823 (Todd, 1823) that limb regeneration does not occur if the sciatic nerve
of the hindlimb is severed shortly before or immediately after, a more distal limb
amputation. Subsequent research showed that the brachial nerves entering the forelimb are
required to promote limb outgrowth and patterning of a new limb (Singer, 1952, 1978).
Within a few days after limb amputation, cells proximal to the amputation plane
dedifferentiate and accumulate to form a blastema. Blastema cells proliferate and
progressively differentiate during regeneration to give rise to all mesodermal structures of
a typical vertebrate limb (Bryant et al., 2002). Upon amputation, nerve fibers in the
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vicinity of the amputation plane extend into the blastema and play a supportive role in cell
proliferation (Mescher, 1996; Satoh et al., 2008). Transection of the spinal nerves that
enter the limb in the axolotl leads to a decrease in cycling cells and there is resorption of
distal tissues of the amputated limb. Histological and cell proliferation analyses suggest
that early cellular events are similar between denervated and innervated limbs, but
denervated limbs are incapable of blastema formation because they do not support
significant cell proliferation and outgrowth (Bryant et al., 1971; Mescher and Tassava,
1975; Geraudie and Singer, 1981; Olsen et al., 1984a, b; Barger and Tassava, 1985).
Although limb regeneration is a complex developmental process, nerve
dependency and other aspects of regeneration have often been conceptualized as having a
simple molecular basis, involving relatively few regulatory factors. For example, Ferretti
and Brockes (1991) hypothesized that in the absence of nerves, Schwann cells produce an
inhibitory factor that prevents blastema cell proliferation. This mechanism is supported by
experimental results although the hypothetical factor has not been identified (Irvin and
Tassava, 1998; Tassava and Olsen-Winner, 2003). Alternative mechanisms for nerve
dependency have also been proposed for several factors with growth promoting effects
(Brockes and Kintner, 1986; Smith et al., 1995; Mullen et al., 1996; Mescher et al., 1997;
Wang et al., 2000). A recent study identified newt anterior gradient protein (nAG) as a
blastema cell growth-promoting factor in vitro, whose over-expression was sufficient to
rescue regeneration of denervated and amputated limbs in vivo (Kumar et al., 2007). Most
recently, nerve-dependent expression of the transcription factor sp9 has been identified as
an early marker of dedifferentiation of the wound epithelium and the initiation of limb
regeneration (Satoh et al., 2008). While considerable progress has been made in
investigating the functions of candidate regulatory factors and signaling pathways, a
broader systems-level perspective is needed to understand why multiple aspects of limb
regeneration are dependent upon the presence of a nerve.
Genomic tools are now available that allow global characterization of the
regeneration process in salamanders. Expressed sequence tag (EST) information has
facilitated the development of an Ambystoma salamander Affymetrix microarray platform
(Monaghan et al., 2007; Page et al., 2007; Stewart et al., 2008). This platform and a highthroughput 454 cDNA sequencing approach were used in this study to compare transcript
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abundance among uninjured limbs, regenerating limbs, and limbs denervated at the time
of amputation. The results show that innervated (NR) and denervated (DL) limbs
exhibited similar (but not identical) gene expression patterns at 5 days post amputation
(dpa) but then diverged as a blastema formed under the influence of nerves. The results
are discussed within the context of previous studies of nerve-dependency, highlighting
specific genes and biological processes that are associated with blastema formation and
outgrowth, and more generally, the salamander’s unparalleled ability to regenerate limbs.
Materials and Methods
Animal procedures
Mexican axolotls were obtained from the Ambystoma Genetic Stock Center at the
University of Kentucky. Siblings were reared individually under ab libitum conditions to
60-70 mm snout to vent length. The 3rd, 4th, and 5th spinal nerves that enter the left limb
were severed at the brachial plexus behind the shoulder. Denervated left and innervated
right limbs were amputated at mid-stylopod and allowed to regenerate for 5 and 14 days.
Animal care and use procedures were approved by the University of Kentucky Internal
Animal Care and Use Committee.
Histology
Limbs were collected at 5 and 14 dpa and fixed in 4% paraformaldehyde, 1x PBS
overnight at 4°C. Tissues were cryoprotected in sucrose, embedded in TissueTek, and
sectioned at 16µm. Eosin Y and Gill’s hematoxylin #2 (Sigma-Aldrich, St. Louis, MO,
USA) were used to stain cytoplasm and nuclei. DIC and brightfield images were taken on
an Olympus AX80 microscope (Center Valley, PA, USA).
RNA extraction and microarray analysis
DL (left) and NR (right) limbs were collected approximately 1 mm proximal to the
amputation plane 5 dpa and 14 dpa. Nine animals were used for each time point and limbs
were pooled into three groups of three. Left and right limbs were paired within animals
when possible in making the pools for the 5 and 14 dpa time points. The day 0 pools were
created using only the right limbs of 9 different individuals that were collected within
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minutes following limb amputation. RNA was extracted using Trizol Reagent (Invitrogen,
Carlsbad, CA, USA) followed by RNeasy minicolumns (Qiagen, Valencia, CA, USA).
RNA quality was assessed by spectrophotometry using a Nanodrop ND-1000 (Nanodrop,
Wilmington, DE, USA) and run on a Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA).
The Ambystoma microarray platform was produced by the Voss lab and Affymetrix and
has been described elsewhere (Page et al., 2007; Monaghan et al., 2007). Total RNA was
used to produce cRNA probes for GeneChip hybridizations (Affymetrix, Santa Clara, CA,
USA) at the University of Kentucky Microarray Core Facility according to standard
Affymetrix protocols. Probe level quality control analyses were performed as described in
(Monaghan et al., 2007). Data processing and statistical analysis was performed using the
Affy Bioconductor package for the R statistical environment (Bolstad et al., 2005).
Background correction, normalization, and probe set summarization were performed via
the robust multi-array average (RMA) algorithm of (Irizarry et al., 2003). Correlation
matrices (Pearson’s r) for replicate GeneChips at the probe-set level were produced to
assess correlation between GeneChips (minimum r = 0.9787, maximum r = 0.9952).
Probe-sets were removed if mean signal intensity was less than the mean of the lowest
quartile across all 15 GeneChips (mean ± standard deviation = 7.748 ± 0.031). Some
microarray technologies may provide unreliable hybridization estimates for lowly
expressed genes (Draghici et al., 2006). For this reason, a stringent cut-off was applied
that removed the bottom quartile of genes for significance testing. Probe-set filtering
yielded 3656 probe-sets for significance testing.
Microarray analysis
The limma package (Smyth, 2004, 2005) available from Bioconductor was used to
conduct three analyses to statistically identify differentially expressed genes. In the first
analysis, linear models were fit to each gene. These models used coefficients to denote
each of the five treatments by sampling time combinations. The following coefficients
were contrasted: Day 0 versus NR 5 dpa (NR5), Day 0 versus DL 5 dpa (DL5), Day 0
versus NR 14 dpa (NR14), Day 0 versus DL 14 dpa (DL14), NR5 versus NR14, and DL5
versus DL14. The other two analyses were equivalent to paired t-tests and compared NR5
versus DL5, and NR14 versus DL14. Multiple testing was corrected using an FDR cutoff
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of 0.05 and then a fold-change filter (≥ 1.5-fold change) was implemented to derive final
gene lists. All microarray data are available at (www.ambystoma.org). The identity of
differentially expressed salamander transcripts was inferred from presumptive human
orthologs. Orthology was assumed for all salamander transcripts that exhibited significant
sequence similarity to protein coding sequences from human RefSeq and nr databases
(BLASTx, e < 1 x 10-7). K-means gene clustering was performed using the Genesis
software package (Sturn et al., 2002). Presumptive human-salamander orthologs were
further annotated using GO terms and tools provided by the Database for Annotation,
Visualization, and Integrated Discovery (Dennis et al., 2003). Significantly overrepresented GO terms (EASE score p < 0.01) were identified for specific
treatment/sampling time combinations. Certain GO terms were excluded from the results
if similar information was represented by a similar GO term. The null expectation for GO
term representation was obtained by assigning GO terms to 3271 EST contigs from
Ambystoma ESTdb.
454 cDNA Sequence Analysis
The same total RNA samples that were used in the microarray analysis were used
to produce cDNA templates for 454 pyro-sequencing. cDNA libraries were generated for
Day 0, NR5, NR14, DL5, and DL14 RNA samples using the Super SMART cDNA
Synthesis protocol (Clontech, Mountain View, CA). Single stranded cDNA template was
amplified using the Advantage 2 PCR Kit (Clontech) and size selected according to
manufacturer’s instructions. cDNAs were sequenced using the Genome Sequencer FLX
System (Roche Applied Science, Indianapolis, IN). SeqClean was used for vector/poor
quality trimming, bacterial contaminant screening, and identification of A. mexicanum
mitochondrial

DNA

and

rDNA

sequences

(http://

compbio.dfci.Harvard.edu/

tgi/software/). Retained sequences were pre-clustered using PaCE and then assembled
using CAP3 with a 90% sequence similarity threshold (Kalyanaraman et al., 2003; Huang
and Madan, 1999). Contigs (including singletons) were searched using BLAST algorithms
against the Ambystoma ESTdb, human and nr RefSeq databases, and Xenopus laevis and
X. tropicalis Unigene sets. Annotated queries that returned a significant BLAST hit were
assigned the gene identifier of the best matching subject sequence. All of these new 454
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sequence reads have been submitted to the Short Read Archive (SRA) at the National
Center for Biotechnology Information (NCBI), accession SRA004195.2. New 454
Sequences were assembled with previous EST data and are available at Sal-Site
(www.ambystoma.org).
The number of times each 454 DNA sequence read matched a unique EST contig
from the Ambystoma ESTdb was recorded, and these count data were used to estimate
mRNA abundances for presumptive axolotl genes. The following method was used to
identify differentially expressed genes among 10,275 contigs that were sampled ≥ 5 times
across all five cDNA libraries. First, 5000 random draws were taken from a multinomial
distribution to derive expected count data for each gene (k = 5 cDNA libraries, n = the
sum of counts across all libraries for a given gene, and p1, p2, p3, p4, and p5 = expected
proportion of counts per library given unequal sampling among cDNA libraries). Then, χ2
statistics were calculated, on a gene-by-gene basis, for each of these random draws. Pvalues for each gene were estimated by calculating the proportion of randomized χ2
statistics that were ≥ to the χ2 statistic associated with the observed data. Contigs with Pvalues ≤ 0.001 were considered differentially expressed. Upon examination of this dataset,
it was noticed that 589 of the significant EST contigs were uniquely derived from
different cDNA libraries and these tended to form small (< 250 bp) contigs that did not
match previous sequences in the Ambystoma ESTdb. These sequences were considered
cloning/sequencing artifacts and removed from the dataset. This yielded a final dataset of
1150 significant genes. GO analyses were performed as described above with the
exception that human default GO term frequencies were used to establish null
expectations (EASE score p < 0.02).
Results
Morphology and histology of denervated and innervated limbs
Histological staining verified our experimental procedures for creating innervated
and denervated limbs on the same individual. Previous studies found few morphological
or histological differences between innervated and denervated limbs during the first few
days of regeneration (Singer, 1978; Deck, 1961; Carlone and Mescher, 1985). Consistent
with these observations, denervated and innervated limbs at 5 dpa (NR5 and DL5) were
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histologically indistinguishable (Figure 4.1a, 4.1c). Histological staining (H & E) showed
hemorrhaging directly beneath the epithelium containing Leydig cells, squamous cells,
and basal keratinocytes (Figure 4.1b, 4.1d). All 5 dpa limbs resembled the wound healing
phase or early phase of dedifferentiation according to the staging of (Tank et al., 1976). A
blastema was visible on innervated limbs 14 dpa (NR14) and histological staining showed
an accumulation of blastemal cells under the wound epithelium. These structures were not
observed in denervated limbs at 14 dpa (DL14; Figure 4.1e-h). These results indicate that
blastema formation and outgrowth only occurred in NR limbs. An apical thickening of the
epithelium characterized the distal end of NR14 limbs and this layer consisted of
keratinocytes and Leydig cells. These histological traits indicate that 14 dpa limbs in this
experiment corresponded to the early to mid bud stage of limb regeneration (Tank et al.,
1976). Immunological staining using RT-97 was performed to detect the presence or
absence of nerve axons at 5 and 14 days after injury. At both time-points, neurofilament
staining was positive in the NR limbs, but negative in DL limbs. In pilot experiments, we
determined that >20 days is required for nerves to re-innervate limbs after denervation
surgery (data not shown). Thus, DL and NR limbs were created successfully and histology
showed that 5 and 14 dpa time points correspond to wound-healing and early-mid bud
phases of regeneration, respectively.
Transcription during normal limb regeneration: Deviations of NR limbs from
baseline
At both 5 and 14 dpa, mRNA levels for hundreds of genes were significantly
different from baseline levels of genes expressed in whole limbs at Day 0 (Table 4.1).
Many of the same genes (n = 215; up = 111; down = 104) were identified as significant in
NR5 and NR14 limbs; the deviation from baseline was in the same direction for all but
one of these genes (fabp2). Four matrix metalloproteinases (mmp1, mmp3/10a, mmp9, and
mmp13) that are known to function during wound healing in many organisms were
upregulated at both 5 and 14 dpa (Figure 4.2), while collagens (col4a1, col4a2, col8a1,
col9a3, and col11a1; Figure 4.3) and muscle specific genes (Figure 4.4) were
downregulated (Table 4.1). Upregulation of collagen catabolism genes coupled with
downregulation of collagen structural genes suggests that transcriptional activation and
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repression are integrated to efficiently remodel the extracellular environment of damaged
tissues. Downregulation of muscle genes at both time points suggests that the
differentiated muscle gene expression phenotype changes by 5 dpa, and changes more
dramatically by 14 dpa.
Although many genes exhibited similar deviations from baseline at 5 and 14 dpa,
unique gene expression changes were identified at each time point (Table 4.1;
Supplemental file 1 and 2). The unique NR5 genes were associated with gene ontology
(GO) terms that implicate extracellular protein changes and signal transduction pathways
of the early wounding response. These terms included response to stimulus, signal
transduction, extracellular region, and ion transport. The unique NR14 genes were
associated with GO terms that implicate cell division and DNA metabolism including
ccnd2, ccnb1, rrm1, rrm2, nasp, rrc1, and cdc20. The unique gene expression changes
that were identified at 5 and 14 dpa support the idea of temporal progression from an early
wound-healing phase to a blastema outgrowth phase during normal limb regeneration.
Transcription within denervated limbs: Deviations of DL limbs from baseline
As was observed in NR limbs, hundreds of genes were identified as significant
when comparing DL5 and DL14 mRNA levels to baseline levels measured at Day 0
(Supplemental Tables 1 and 2). Some of the same or similar GO terms that were
associated with NR limbs were identified as significantly enriched in DL limbs (Table
4.1). This was not unexpected because both DL and NR limbs undergo tissue histolysis at
the limb stump and carry out an early wound healing response (Figure 4.1a, 4.1b). For
example, extracellular region and MMP genes were upregulated at 5 and 14 dpa, as was
seen in NR limbs (Figure 4.2; Supplemental Table 1). As in NR limbs, muscle contraction
(Figure 4.4), cytoplasmic, and collagen genes (Figure 4.3; col4a1, col4a2, col8a1) were
downregulated in both DL5 and DL14 limbs (Supplemental Table 2). Moreover, 83% of
the genes that were identified as significant in NR5 limbs were also significant (and in the
same direction) in DL5 limbs. These results indicate that many transcriptional events are
nerve-independent during early regeneration.
Denervated limbs are known to cease growth following limb amputation. Several
groups of genes may explain this observation including the downregulation of genes
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associated with the M phase of cell division, mitochondrial transcripts, and genes
associated with glucose metabolism (Table 4.1; Supplemental Table 2). Furthermore,
DL14 limbs were morphologically similar to DL5 limbs because denervation prevented
blastema formation (Figure 4.1g, 4.1h). Consistent with this observation, many of the
genes that were identified as upregulated in DL5 limbs were also identified as significant
in DL14 limbs (69%). These genes are associated with the following GO terms: lysosome,
response to stress, hydrolyse activity, signal transducer activity, and ion transport. Overall,
these terms suggest protraction and expansion of wound-healing responses in DL14 limbs,
as well as changes in cellular metabolism and cell division.
Transcript abundance differences between NR and DL limbs
In the preceding two sections, transcriptional patterns of NR and DL limbs were
described relative to baseline levels at Day 0. Here, significant genes are reported between
NR and DL limbs. In general, few significant changes in gene expression were observed
when NR and DL transcripts were compared directly. Transcripts for 16 genes were more
abundant in NR5 limbs and 17 were more abundant in DL5 limbs, and these differences
were small in terms of fold-level change (< 2.82 fold difference between NR5 and DL5;
Supplemental Table 3). Eighteen of these genes exhibited significant sequence similarity
to human or salamander presumptive gene sequences; the others are unknown. The genes
with significantly more transcripts in NR limbs are associated with intracellular (e.g.
dnase1l3, uap1, acy3, nans, myl4) and extracellular functions, including membrane
proteins (e.g. psca, umod, and emp1) and collagen binding (serpinh1). The genes with
significantly more transcripts in DL limbs are associated with extracellular functions or
the immune response (e.g. igll1, CD74, hmox1, neil1, marco, sftpd, mmp9, mrc1). All but
one of the significant 5 dpa genes showed the same directional deviation at 14 dpa;
myl1was 1.5 fold higher in the NR limb at 5 dpa, but 2.2 fold lower at 14 dpa. Thus, as
was observed when comparing DL5 and NR5 mRNA abundances to baseline levels,
relatively few gene expression differences were identified between NR and DL limbs at 5
dpa, and the magnitude of these differences was small. These results further support the
idea that transcription during limb regeneration is predominantly nerve-independent at 5
dpa.
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Whereas

only

33

transcriptional

differences

were

observed

between

morphologically similar DL and NR limbs at 5 dpa, 282 differences were detected at 14
dpa (Supplemental Table 4). K-means cluster analysis of these genes with significant
human protein hits highlight three clusters wherein genes exhibited similar patterns of
expression (Figure 4.5). Genes in Cluster 1 presented expression patterns with transcript
abundances above baseline in NR14 limbs and abundances below baseline levels in DL14
limbs. Genes associated with cell cycling, a well-established characteristic of blastemal
cells, were highly enriched in Cluster 1 (n=26). Over 50% of the genes in Cluster 1 are
predicted to localize to the nucleus including several transcriptional regulators (msx2, id3,
tmpo, atf5, rbm15, spen, parp1, and tardbp). Thus, many of the genes in Cluster 1 have
functions that are consistent with blastema formation and outgrowth in NR limbs.
Genes from Clusters 2 and 3 were generally expressed in the same direction
between NR14 and DL14 limbs, however the magnitude of expression differed. Genes in
Cluster 2 presented transcript abundances that generally exceeded baseline levels, with
higher levels observed in DL14 limbs. This pattern suggests that most of these genes were
activated in the same direction in the presence or absence of nerves, but denervation
caused higher transcript abundances. Twenty two percent of the genes in Cluster 2 are
associated with the GO term cellular response to stimulus (N =14) and a significant
proportion localized to the lysosome (n=6), including lgmn, ctsk, ctss, asah, atp6v0d1, and
neu1. Genes in Cluster 3 presented transcript abundances that were generally lower than
baseline levels, with much lower levels observed in NR14 limbs. Given relatively few
genes in this cluster, no biological process was identified as significantly enriched.
However, inspection of the genes in Cluster 3 again supports the idea that some genes
may function in muscle contraction (actc1, myh7, and fhl1) and tissue repair (hsp27 and
hebp2). In summary, mRNA levels for genes from Clusters 2 and 3 were quantitatively
affected by the presence or absence of a nerve.
454 cDNA sequence analysis of nerve dependency
To further explore nerve dependency and generate an unbiased collection of
molecular probes for regenerating limbs, we sequenced cDNAs derived from the same
RNA samples that were used in the microarray analysis. Over 1.7 x 106 reads were
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generated and this yielded approximately 90,000 – 230,000 high quality sequence reads
for each limb treatment with an average of 215 base pairs in length (Table 4.2). More than
half of the sequence reads correspond to mitochondrial transcripts and ribosomal RNA.
This frequency of mtDNA transcripts (30%) approximates the number sampled in an
earlier EST screen of the Ambystoma genome (Putta et al., 2004). The number of rRNA
transcripts was higher than expected. Assembly of all high quality cDNA reads yielded
429,086 unique sequences. These sequences were assembled with previous EST contigs to
produce 61,127 contigs containing at least two overlapping sequences. The distribution of
contig lengths is shown in Figure 4.6. All contigs and singletons were searched against
NCBI databases to identify significant similarity matches that would suggest presumptive
gene identities. Ambystoma contigs and singletons yielded 25,446 significant hits to
sequences in the human RefSeq database (BLASTx, e < 1 x 10-7), including 9411 unique
human genes. Figure 4.7 shows the distribution of percent coverage to predicted human
RefSeq proteins. Interestingly, 7,130 Ambystoma queries that did not show significant
amino acid sequence identity to a human reference sequence did show significant
nucleotide identity to a Xenopus sequence. Assembly of new 454 cDNA sequences with
existing EST contigs from the Ambystoma ESTdb more than doubled (3935 to 9411) the
number of non-redundant human-A. mexicanum orthologous sequences. This increase in
sequence content was even among ten GO functional categories that are relevant to
salamander wound healing and regeneration (Table 4.3). Assuming that many of the
anonymous 454 contigs and singletons (> 300,000) that were generated correspond to
functional genes, significantly more than 10,000 different transcripts are expressed during
the first two weeks of axolotl limb regeneration.
mRNA abundance estimates and gene discovery from 454 cDNA sequence data
The number of times that a non-redundant transcript was sampled by 454 cDNA
sequencing was used to estimate mRNA abundances. The transcript counts for 1150
Ambystoma EST contigs (genes) differed significantly among limb cDNA pools that were
created for each of the limb types (Supplemental Table 5). It was possible to assign a
putative ortholog to 563 of these genes; the remaining genes were considered anonymous.
This final list of genes was compared to the significant gene lists from the microarray
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analysis. It was determined that for 271 of the 1150 significant genes from the 454 cDNA
sequencing analysis, a portion of the gene sequence was represented by a probe set on the
Ambystoma GeneChip. Of these, 104 genes were identified as significant by both
methodologies and mRNA abundances for these genes were highly positively correlated
(Supplemental Table 6; median Spearman’s correlation = 0.87). The 167 genes found to
be significant by 454 cDNA sequencing, but not by microarray analysis, were mostly
characterized by low fold changes from baseline (median fold change as estimated from
454 cDNA sequencing counts = 1.75); or conversely, registered low hybridization
intensities in the microarray analysis (median rank among 4844 probe sets = 343).
Gene functions that were identified as significantly enriched by microarray
analysis were also identified as significant by 454 cDNA sequencing. For example, the
muscle contraction GO term was identified as highly enriched and the underlying genes
were similarly downregulated relative to baseline (Table 4.4; Figure 4.4; Supplemental
Table 6). Also, genes sampled most often from NR14 limbs were associated with DNA
metabolism, a biological process associated with cell cycling (Table 4.4), and transcripts
for genes associated with cell proliferation and cell cycle progression (e.g. pcna,
smc1,ctps, umod, psca, smc1l1, rad21) were either sampled more often among NR limbs
or were only sampled from NR limbs (Supplemental Table 5). Thus, 454 cDNA
sequencing also identified genes in NR limbs that are consistent with blastema formation.
Several functional terms that were not identified by microarray analysis were identified as
enriched by 454 cDNA sequencing. Transcripts for 40 genes associated with
macromolecule metabolism were most abundant in NR5 limbs compared to other limbs.
Transcripts for 12 genes associated with macromolecule catabolism were most abundant
in DL5 limbs including mmp1, mmp3/10a, mmp3/10b, mmp9, and mmp13. This suggests
that the presence or absence of nerves differentially affects transcriptional responses and
regulation at 5 dpa. Also, 454 cDNA sequencing identified additional psca-like genes that
were not represented on the GeneChip and these were also differentially expressed
between NR5 and DL5 limbs. These and other examples suggest that 454 cDNA
sequencing complimented the microarray analysis by providing deeper sampling of
transcriptional programs and associated biological processes. This revealed more
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candidate nerve-dependent gene expression changes at the earlier 5 dpa time point than
was revealed by microarray analysis.
In addition to providing estimates of mRNA abundance, 454 cDNA sequencing
also discovered new gene sequences for the Mexican axolotl. These include genes that are
known to affect developmental processes in other vertebrate models: notch (1,2,3,4), nrg1,
bmp1, wnt4, ctnna1, btnna1, dkk1, axin 1, nrg1, fgf10, sirt (1,2,5,6), stats (1, 2, 3, 5, 6),
sema4f, tf, sfrp (1,2,5), rara, rarg, rxr, pdgf, acvrI (IB, IIA, IIB), bmprI, bmprII, smad (1,
2, 4, 5, 7, 9), efna1, ntn1, slit2, slit3, robo1, and robo2. Most of these genes were sampled
less than 10 times and thus appear to be expressed at low levels. Other developmental
genes that have not been previously associated with limb regeneration were sampled many
more times than these candidates, and for the following examples, counts varied
significantly among limb cDNA libraries. These include mdk, fliI, tagln2, ddx5, umod, and
cnot1 (Supplemental Table 5). Also, numerous retroelement-associated sequences were
sampled differentially between DL and NR limbs (Table 4.5). Overall, the 454 sequencing
approach verified the primary results from the microarray analysis and identified many
new candidate genes and functional pathways that are associated with limb regeneration.
Discussion
Microarray analysis and 454 cDNA sequencing were used to identify nervedependent and independent gene expression changes during limb regeneration in the
Mexican axolotl. The results show that limb regeneration is associated with thousands of
transcriptional changes. Considerable similarity was observed between the DL and NR
transcriptional programs at 5 and 14 dpa. For example, genes that are critical to wound
healing were upregulated in both limb types (Table 4.6) while genes that are associated
with muscle structure and function were downregulated (Figure 4.4). Many of the
transcriptional changes that were observed at 5 dpa were also observed at 14 dpa. Thus,
many aspects of early limb regeneration are accomplished in the absence of nerves.
However, gene expression differences were identified between DL and NR limbs at 5 and
14 dpa. Many of the transcriptional differences correlated with blastema formation; cell
numbers increased in NR limbs after 5 dpa and this yielded a distinct transcriptional
signature of cell proliferation in NR14 limbs. Overall, this study identified genes that are
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associated with wound healing, early events of blastema formation, and subsequent
blastema cell proliferation and outgrowth. Below, we discuss and expand upon these
primary results and highlight genes whose functions appear to be important for
understanding the basis of nerve dependency and limb regeneration.
Early wound healing response during limb regeneration
Previous studies have documented anatomical similarities between innervated and
denervated limbs at early stages of regeneration (Bryant et al., 1971; Schotte and Butler,
1941; Thorton, 1953). This study shows that there are also many transcriptional
similarities. This suggests that many aspects of the early wound-healing phase of limb
regeneration are not dependent upon post-amputation, nerve-derived factors (Table 4.6).
Instead, humoral immune and local tissue responses appear to be key. Many genes that are
associated with wound healing and tissue repair, including stress, inflammation, cell
survival, immunity, and extracellular matrix remodeling were upregulated from baseline
in 5 dpa limbs (Figure 4.2; Table 4.6). It is probably no coincidence that essentially all of
the early stress-associated genes that were previously identified as significantly regulated
(using the same Ambystoma GeneChip) during early spinal cord regeneration (Monaghan
et al., 2007), and during the innate immune response of axolotls to a deadly viral pathogen
(Stewart et al., 2008), were also identified as significant in this study. Many of these genes
appear to be expressed similarly in all vertebrates in response to stress, including junb,
irf1, hmox1, apoE, mmps, ptx3, gal3, gadd45g, and tgfb. Additionally, significantly more
“extracellular” genes were identified at 5 dpa than expected by chance, including genes
that code for matrix remodeling proteins and secreted molecules whose functions are
associated with growth factor binding, cell signaling, survival, death, adhesion, migration,
and proliferation. The early wound healing response initiates local environmental changes
of the injury site that are pivotal to subsequent phases of regeneration.
The 5 dpa time point was chosen in this study to identify critical nerve-dependent
signaling events that are stimulated within the first few days of regeneration (see Satoh et
al., 2008). Comparison of DL5 and NR5 data revealed few overall gene expression
differences. The 5 dpa time point captured many transcriptional responses that are induced
by injury/amputation but relatively few that are associated with known or suspected
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neurotrophic signaling pathways. More comprehensive sampling and deeper sequencing is
needed to detail early nerve-dependent transcriptional responses because several genes
that are known to be nerve-responsive during the wound-healing phase were not identified
in this study (e.g. sp9; prrx1, tbx5, Satoh et al., 2007, 2008).
Downregulation of genes associated with differentiated muscle
This study documented dramatic decreases in the relative abundance of mRNAs
coding for skeletal muscle contractile proteins, including myosins, actins, actinins, titin,
tropomyosins, and troponins. Many of these changes were also detected by 454 cDNA
sequence analysis (Figure 4.4). This strong, muscle-specific transcriptional signature was
observed because approximately half of uninjured forelimb nuclei in 7-9 cm axolotls, and
likely more than half the cross-sectional area, derive from muscle (Tank and Holder,
1979). It is unlikely that the down-regulation of muscle genes is due to retraction of the
muscle towards the shoulder because muscle transcripts are much more downregulated at
14 dpa than 5 dpa in both denervated and innervated limbs. Considering that limb tissue
samples in this study included ~ 1 mm of un-damaged tissue proximal to the amputation
plane, the results suggest that injury to skeletal muscle induces tissue-wide loss of muscle
contractile transcripts. It is possible that the decrease in muscle transcripts is due to
muscle wasting, caused by a lack of mechanical stress. It is interesting to speculate that
this response maybe associated with the degeneration or cellularization of multinucleated
muscle fibers into mononucleated cells, which occurs in both denervated and innervated
amputated limbs (Tank et al., 1976; Hay, 1959; Petrosky et al., 1980; Lo et al., 1993;
Kumar et al., 2000; Echeverri et al., 2001). It is interesting to note that muscle specific
genes, including actc1, actn2, atp2a2, my1pf , tncc, tnni2, tnni3, are downregulated during
early stages of mammalian skeletal muscle regeneration (Goetsch et al., 2003), and this is
accomplished without blastema formation. Skeletal muscle regeneration in mammals and
other vertebrates involves resident stem (satellite) cells (Morrison et al., 2006; Cameron et
al., 1986). It is possible that muscle specific genes are downregulated as an integral step of
a conserved, skeletal muscle regeneration program of vertebrates. Candidate
transcriptional repressor genes were identified in this study including id3 (Iwasaki et al.,
2008), tardbp (Buratti and Baralle, 2008), cnot (Winkler et al., 2006), msx1 (Kumar et al.,
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2004; Schnapp and Tanaka, 2005) and msx2. It will be important in future studies to
determine if the dramatic decrease in muscle transcripts is due to activation of muscle
stem (satellite) cells, muscle loss, muscle dysfunction/wasting, or whether these
transcriptional patterns have an active role in regeneration.
Genes associated with epigenetic reprogramming and genomic stability
Blastema formation requires a large number of progenitor cells derived from
quiescent stem cells or differentiated cell types. It is generally known that reprogramming
of differentiated cells is accompanied by epigenetic changes such as histone and DNA
modifications (Costa and Shaw, 2007; Maherali et al., 2007). Few candidates have been
identified previously as bringing about epigenetic changes necessary for cellular
reprogramming during regeneration (Yakushiji et al., 2007; Palacios and Puri, 2006). This
study identified several genes whose functions are associated with epigenetic phenomena,
including chromatin remodeling, DNA methylation, and transcriptional regulation. These
include uhrf1 (Sharif et al., 2007), lmnb2, parp1 (Guastafierro et al., 2008), thymopoietin
(Dorner et al., 2007), and a gene with high sequence identity to SAM-dependent
methyltransferases (Cluster_227434_Contig1; SRV_05867_a_at).
After cellular reprogramming and during limb outgrowth, blastemal cells undergo
tremendous cell proliferation. During blastema cell proliferation, telomere lengths and
overall genome stability must be maintained to prevent cell death. This study identified
several candidate genes from NR14 limbs that are known to function in genome stability,
telomere homeostasis, and DNA repair. These include parp1 (Shrivastav et al., 2008),
hmgb2 (Thomas, 2001), fen1 (Saharia et al., 2008), aurka (Yang et al., 2004), aurkb
(Monaco et al., 2005), and pif1, a DNA helicase that maintains genome stability and binds
to telomerase from yeast to humans (Mateyak et al., 2006). It is also important to note that
many transcripts were identified from NR and DL limbs that code for retroelement
components (Table 4.5; e.g. polyproteins, gag proteins, reverse transcriptases, and
recombinases). Retrotransposons are normally transcriptionally silenced in differentiated
somatic cells by epigenetic mechanisms, but become active upon changes in epigenetic
status; these may also regulate nearby gene expression (Kano et al., 2007; Cropley and
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Martin, 2007). It is unclear if upregulation of retroelement transcripts affects genome
stability and/or is necessary for regeneration.
Genes associated with nerve dependent blastema outgrowth
In this study, blastemas were not observed in NR5 limbs or DL14 limbs, and only
formed on NR14 limbs. Nerve dependent limb outgrowth occurs as a result of blastemal
cell proliferation. Two early cell proliferation biomarkers, umod and psca, were identified
as significantly different between NR5 and DL5 limbs. umod probably locates to the
wound epithelium as it is upregulated in apical skin cells during thyroid hormone induced
metamorphosis of axolotl epidermis (Page et al., 2009). It is possible that psca is a
membrane receptor of blastema cells because it shows structural similarity to prod1, a
surface protein that is implicated in proximal-distal positional identity of blastemal cells
during newt limb regeneration (da Silva et al., 2002). Most of the cell proliferation
biomarkers were identified at 14 dpa, when a blastema was present in NR limbs but absent
in DL limbs. Thus, between 5 and 14 dpa, blastemal cells underwent considerable cell
proliferation in the presence of nerves. Because the limb blastema continues to expand
after 14 dpa, the blastema-specific genes that were identified in this study are probably
transcribed at much higher levels at later time points. A clear signature of cell
proliferation, including genes that function in the cell cycle, mitosis, and nucleotide
synthesis, was observed in NR14 limbs. In contrast, these genes were slightly
downregulated in denervated limbs at this time (Table 4.1; Figure 4.5). Thus, transcripts
associated with cell proliferation are maintained at steady state (no increased proliferation)
in NR and DL limbs for at least five days. This early, nerve-independent portion of the
limb regeneration program may allow time for re-innervation of the injury site and
production of nerve-derived molecules in sufficient quantity to initiate and sustain
blastemal cell proliferation.
Multiple gene products have been hypothesized to be neurotrophic factors
provided by nerves to sustain blastema cell proliferation. These include growth-promoting
factors like fibroblast growth factors (Mullen et al., 1996; Satoh et al., 2008), substance P
(Globus et al., 1991), neuregulin (Wang et al., 2000), and transferrin (Mescher et al.,
1997). Transferrin and neuregulin were sampled by 454 sequencing, but were not
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identified as differentially expressed by our analysis. fgf8 and fgf10 were screened out of
the microarray analysis due to low expression, but post-hoc analysis suggested that both
are upregulated in NR14 limbs compared to control and DL14 limbs (Table 4.7).
Expression of these molecules is known to be nerve-dependent in blastemas of Xenopus
(Suzuki et al., 2005) and axolotls (Christensen et al., 2001, 2002; Han et al., 2001). Other
molecules that have previously been associated with the blastema during limb
regeneration were not included in our statistical analyses due to low hybridization
intensity, but later found to be differentially expressed in NR14 limbs including hoxd10,
hoxa13, hoxa11, and msx1 (Table 4.7). Recently, Kumar et al. (Kumar et al., 2007)
identified a growth promoting extracellular ligand (newt anterior gradient; nAG) that
rescues aspects of nerve-dependency of limb regeneration in newts. Probesets for nAG are
represented on the Ambystoma GeneChip and transcripts for this gene were sampled by
454 cDNA sequencing. nAG mRNA was transcribed at a high level in all tissues, but did
not differ significantly between NR, DL, or control limbs. It is possible that the effects of
nAG and other neurotrophic candidates are associated with quantitative variation of
mRNA transcript abundances over fine temporal and spatial scales. Such variation would
have been missed in this analysis of three time points and sampling of mRNAs from
heterogeneous tissues. Furthermore, it is possible that the increase in nAG
immunoreactivity observed by Kumar et al. (2007) is regulated at the level of translation
and would not be observed using microarray or sequencing approaches. Overall, we found
that several, but not all, genes previously shown to be directly downstream of
neurotrophic factors are expressed at higher mRNA levels in the blastema versus control
and denervated samples.
Singer (1978) emphasized that the neurotrophic factor underlying nerve
dependency was growth promoting and quantitative in effect. He showed that the trophic
effect of nerves could be titred by surgically manipulating the number of nerves
innervating the limb (Singer, 1952). Other lines of research showed that nerve-derived
factors were not necessary for traversing cell cycle checkpoints, as an equivalent number
of presumptive blastema cells are initially observed to enter S-phase in denervated and
innervated limbs (Mescher and Tassava, 1975; Tassava and Bennett, 1974). Instead, the
neurotrophic factor appears to be necessary to complete the cell cycle and this may be

77

non-trivial considering the cost of replicating a large salamander genome. These studies
suggest that nerves either directly or indirectly provide limiting macromolecules that are
needed to accomplish cell division. According to this reasoning and assuming a
correlation between transcript and protein abundance for specific mRNA species,
transcripts associated with nerve dependency would be expected to exceed baseline levels
in NR limbs during regeneration, and decrease in abundance in DL limbs. This study
identified many human-axolotl presumptive orthologs and anonymous axolotl transcripts
that showed this pattern. For example, psat codes for a protein that regulates the second
enzymatic step of the phosphorylated pathway in mammals, which produces L-serine (de
Koning et al., 2003). PSAT expression (protein and mRNA) is high among cell types with
high rates of proliferation, including cancer cell lines (Martens et al., 2005; Vie et al.,
2008). Strikingly, psat registered the largest mRNA abundance difference between NR14
and DL14 limbs among probesets on the Ambystoma GeneChip (8.2 fold change), and this
result was verified by both 454 cDNA sequencing (NR14=20.1, DL14=3) and real-time
PCR (8.37 fold change; data not shown). We also found that the third enzyme in the
phosphorylated pathway, psph, was 3.58 fold higher in NR14 versus DL14 by real-time
PCR (data not shown). PSAT and PSPH may have neurotrophic potential but more likely
function to provide proliferating cells with a limiting, and conditionally important
substance (L-serine) that is required for synthesis of macromolecules, amino acids, and
purines that are needed to accomplish mitosis (de Koning et al., 2003). The fact that
macromolecular synthesis and cell proliferation are both depressed in denervated limbs
(Dresden, 1969; Lebowitz and Singer.,1970; Singer and Cason., 1972) supports the idea
that PSAT activity is associated with nerve-derived factors that contribute to blastema
outgrowth.
Comparison of microarray and cDNA sequencing approaches
Microarray analysis and 454 cDNA sequencing offer different advantages for
dissecting complex biological processes. The strength of microarray analysis is the
precision that this approach provides for estimating transcript abundances for a specific
panel of genes. Such gene panels provide standardized markers for identifying shared and
unique patterns of transcription among experiments. In turn, identification of such patterns
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provides systems-level insight. For example and as was discussed above, acrossexperiment comparisons of axolotl transcription helped distinguish general stress
responses from local regenerative responses. A relatively conservative fold level threshold
(> 1.5 fold) was used in this study to identify significant genes in the microarray analysis
and lowly expressed genes (in the lowest quartile) were removed from consideration.
These conservative approaches potentially exclude important genes but likely discover
‘real’ transcriptional differences between samples. A lower threshold could be applied to
extract more information from the dataset and future studies would likely benefit by
increasing replication of GeneChips to detect significant differences for lowly expressed
genes. With respect to 454 cDNA sequencing, two goals were accomplished: gene
discovery and estimation of transcript abundance. However, accomplishment of both
goals required a trade-off in the allocation of resources toward deep sequencing versus
replication. Sequencing resources were used to deeply sequence Day 0, NR, and DL
cDNA libraries instead of shallowly sequencing replicate libraries for these time points.
This strategy identified thousands of new gene sequences that will greatly enrich future
regeneration studies. Future studies will benefit from experimental designs that replicate
deep sequencing of cDNA libraries and this will be possible as sequencing costs decrease.
Still, it was encouraging to find in this study that 38% of genes that were identified as
differentially expressed by 454 cDNA sequencing and found on the microarray GeneChip
were identified as significant by both of these technologies, and transcript abundances for
these genes were highly positively correlated.
Conclusions
This study addressed the nerve-dependency of limb regeneration by characterizing
downstream cellular events that are affected when an intact nerve supply is removed from
an amputated salamander limb. Microarray analysis showed that the early wound response
is largely nerve-independent, but transcriptional profiles diverge between denervated and
innervated limbs when the innervated limb starts to regenerate. Pyro-sequencing
supported these microarray results while substantially increasing sequence information
from the salamander transcriptome. This study shows the utility of next-generation
sequencing platforms for gaining transcriptome information (Emrich et al., 2007; Toth et

79

al., 2007; Vera et al., 2008). This new DNA sequence information will greatly enrich
future regeneration studies using the axolotl.
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Table 4.1. Significant gene ontology terms for changed genes.
Upregulated
NR5 and NR14 (N=111)
extracellular region (N=14)
collagen catabolism (N=5)

Downregulated
NR5 and 14 (N=104)
muscle contraction (N=13)
cytoplasm (N=51)
collagen (N=6)
ion transport (N=12)

p-value
9.05E-07
4.35E-06

p-value
1.81E-10
8.41E-07
4.05E-05
9.44E-06

NR5 only (N=110)
extracellular region (N=15)
response to stimulus (N=17)
signal transduction (N=21)
Ion transport (N=9)

p-value
1.23E-05
1.00E-02
2.89E-03
2.57E-03

NR5 only (N=49)
extrinsic to membrane (N=3)

p-value
6.10E-03

NR14 only (N=53)
DNA metabolic process (N=8)

p-value
4.41E-04

NR14 only (N=93)
muscle contraction (N=18)
calcium ion binding (N=11)

p-value
5.43E-19
4.98E-04

DL5 and DL14 (N=170)
extracellular region (N=23)
lysosome (N=11)
ion transport (N=13)

p-value
6.64E-10
3.04E-08
1.42E-05

DL5 and 14 (N=109)
muscle contraction (N=15)
cytoplasm (N=53)
mitochondrial membrane
(N=12)

p-value
6.62E-13
1.46E-06
3.49E-04

hydrolase activity (N=26)
response to stress (N=21)
signal transduction (N=22)
collagen catabolism (N=5)

3.60E-05
1.02E-03
5.40E-03
5.09E-05

DL5 only (N=68)
extracellular region (N=9)
response to stimulus (N=12)

p-value
3.68E-04
3.70E-03

DL5 only (N=58)
extrinsic to membrane (N=3)

p-value
4.64E-03

DL14 only (N=69)
extracellular region (N=7)
immune response (N=5)

p-value
4.10E-03
7.80E-03

DL14 only (N=111)
muscle contraction (N=9)
mitochondrion (N=27)
cytoplasmic (N=43)
M phase (N=9)
glucose metabolic process

p-value
4.26E-05
6.71E-07
2.58E-03
1.40E-03
2.97E-03
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Table 4.1. Significant gene ontology terms for changed genes. Significant genes were
identified by microarray analysis and gene ontology terms were sampled more often than
expected in NR5, NR14, DL5, and DL14 limbs. P-value is calculated by DAVID (Dennis
et al., 2003).
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Table 4.2. 454 DNA sequence reads that were generated for each cDNA limb library.
Day 0

NR5

DL5

NR14

DL14

totals

Total Reads

312258

216281

220561

393012

578787

1720899

Filtered

19459

14390

18918

22679

88387

163833

mtRNA/rRNA 168954

111490

92136

171046

256684

800310

123845

90401

109507

199287

233716

756756

Final Reads
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Table 4.3. Gene ontology breakdown of the 9411 salamander genes with presumptive
human orthologs. The number of Ambystoma ESTdb contigs with gene ontology
annotations before and after 454 DNA sequencing. The total is less than the sum of each
category because several genes may belong to multiple categories. Bp = biological
process.

Ontology

GO
Level

Before 454
Sequencing

After 454
Sequencing

cell cycle

bp3

226

438

metabolism

bp2

1889

3982

cell motility

bp3

62

126

morphogenesis

bp2

109

272

development

bp1

342

795

response to stress

bp2

219

469

cell death

bp3

142

312

catalytic activity

bp1

1275

2855

transcription factor activity

bp2

112

344

kinase activity

bp4

159

456

Total (3935)

Total (9411)
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Table 4.4. Gene ontology results from 454 sequencing. Gene ontology analysis of 465
genes with presumptive human orthologs identified by 454 DNA sequencing. Only the
most significant gene ontology category was selected for the table.

cDNA library

Most significant GO terms

e-value

Day 0 (N=127)

striated muscle contraction (N=17)

1.75E-27

NR5 (N=84)

macromolecule metabolism (N=40)

1.37E-5

DL5 (N=59)

macromolecule catabolism (N=12)

6.21E-8

NR14 (N=54)

DNA metabolism (N=6)

2.00E-2

DL14 (N=43)

protein biosynthesis (N=14)

1.44E-17
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Table 4.5. Significantly changed retrovirus genes. Genes identified as differentially
expressed by 454 sequencing analysis that have high sequence similarity to retrovirus
genes.
Contig
10177_Contig1
10435_Contig1
10953_Contig8
109875_Contig1
110157_Contig5
126954_Contig17
12813_Contig1
154450_Contig16
174946_Contig1
185474_Contig140
195627_Contig1
218328_Contig1
2194_Contig1
23276_Contig1
23893_Contig1
32735_Contig1
331680_Contig1
352970_Contig1
39722_Contig1
42238_Contig456
42238_Contig60
89909_Contig1
94735_Contig1

Gene Name
rev. transcriptase-like
envelope polyprotein
end. retroviral family w
rev. transcriptase-like
hyp. protein LOC57523
polyprotein
zinc finger protein 9
retrotransposon-like 1
pol-like protein
helitron-like trans.
Gypsy 1 polyprot.
retrotransposon-like 1
pol polyprotein
chromobox homolog 1
NBB2750 hyp. protein
rev. transcriptase-like
lambda-recombinase
reverse transcriptase
rev. transcriptase
paternally expressed 10
paternally expressed 10
reverse transcriptase
lambda-recombinase
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NR5
10
19
5
0
7
12
14
5
0
81
0
0
17
14
12
12
2
0
98
41
7
0
0

DL5
3
8
15
0
20
22
37
27
0
276
0
0
0
0
0
0
12
0
117
3
35
12
12

NR14
0
0
0
10
42
32
67
12
12
314
12
13
0
0
0
0
30
0
138
10
37
0
0

DL 14
0
2
1
0
6
6
20
2
0
106
0
0
0
0
0
0
11
0
51
3
10
0
0

D0
0
0
0
0
0
8
37
10
0
59
0
0
0
0
0
0
6
12
92
12
28
0
0

Probe ID
Symbol
NR5/C
SRV_01351_at
JUNB
4.6
SRV_10702_at
CYBB
2.84
SRV_00330_at
CYBB
2.39
SRV_03054_at
MARCO
2
SRV_00130_a_at
APOE
1.9
SRV_00442_at
SLC11A1
1.95
SRV_01821_at
TYROBP
1.98
SRV_03023_a_at GADD45G
1.96
SRV_02588_a_at LGALS3BP
1.91
SRV_01177_a_at
ENTPD1
2.39
SRV_02586_at
LGALS3BP
1.79
SRV_11767_a_at
IFITM5
1.75
SRV_02724_at
MAT2A
2.6
SRV_01617_a_at
PTX3
4.3
SRV_02002_at
CES1
2.36
SRV_03221_a_at
DMBT1
1.81
SRV_07036_at
IL1B
1.7
SRV_02516_at
HSPA5
1.65
SRV_02965_at
TFPI2
2.22
SRV_12417_at
NDRG1
2.57
AH_at
HSPA8
1.52
SRV_01846_at
UMOD
2.27
SRV_01294_at
FTH1
SRV_01385_at
LECT2
SRV_01840_at
UCP2
SRV_11406_at
LYN
SRV_11583_at
MAPK12
SRV_07726_a_at
MPEG1
SRV_04367_a_at
IGLL1
SRV_04710_at
NEIL1
SRV_10936_at
PTGDS
SRV_00002_s_at
IGLL1
SRV_00078_at
IGLL1
SRV_01199_a_at
CLU
SRV_02442_a_at
G1P2
SRV_02611_a_at
SGK
SRV_13637_a_at
IFITM3
SRV_01323_a_at
HMOX1
10.05
SRV_00444_a_at
GPX1
1.67
SRV_01423_a_at
MMP1
26.65
SRV_01428_x_at
MMP10
22.86
Table 4.6 continued on next page
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NR14/C
2.35
1.73
1.58
1.83
2.36
1.58

1.56
1.78

DL5/C
4.74
4.11
3.46
3.11
2.49
2.76
2.45
2.29
2.37
2.23
2.25
1.63
1.6
3.78
3.01
2.5
1.53

1.67
2
1.67
3.93
1.53
1.74
2.04
1.77

5.13
2.94
2.87

2.56
1.57
1.51
18.24
1.51
37.91
30.96

DL14/C function
3.46
SR
2.46
SR
2.23
SR
3.01
SR
4.28
SR
3
SR
2.65
SR
2.01
SR
1.59
SR
1.58
SR
1.81
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
SR
2.01
SR
7.38
SR
2.13
SR
1.72
SR
1.92
SR
2.27
SR
2.29
SR
1.93
SR
4.19
SR
2.09
SR
2.43
SR
2.36
SR
SR
SR
SR
8.53
A
A
11.41
ECM
ECM

Table 4.6 continued
Probe ID
Symbol
SRV_01430_at
MMP13
SRV_01425_at
MMP13
SRV_11420_at
MMP27
SRV_02399_a_at
MMP9
SRV_11423_at
MMP13
SRV_11417_a_at
MMP1
SRV_12016_at
MMP2
SRV_02241_at
MMP2
SRV_10485_at
MMP2
SRV_00453_a_at
TGFB1
SRV_00328_at
CTSK
SRV_00327_a_at
CTSK
SRV_00326_a_at
CTSK
SRV_02600_a_at
LGMN
SRV_05534_at
RAB7B
SRV_02353_a_at
LITAF
SRV_01134_at ATP6V1B2
SRV_02294_at ATP6V0D1
SRV_14287_a_at
CTSL
SRV_02601_at
LGMN
SRV_05336_a_at
CTSL
SRV_00294_s_at
PPGB
SRV_01135_a_at ATP6V0C
SRV_01242_a_at
CTSD
SRV_01559_a_at
PSAP
SRV_00355_at
NEU1
SRV_02141_at
ASAH1
SRV_09661_at
CTSC
SRV_01558_at
PSAP
SRV_00334_a_at
GLB1
SRV_10701_at
CTSK

NR5/C NR14/C DL5/C DL14/C function
22.54
9.04
34.09
24.97
ECM
19.64
3.1
23.46
2.6
ECM
16.71
23.32
4.52
ECM
15.22
3.51
23.05
15.69
ECM
6.79
8.48
2.2
ECM
6.42
8.48
ECM
1.71
2.49
ECM
1.66
2.34
ECM
2.11
ECM
2.4
2.32
1.93
GR
7.03
4.86
8.07
19.35
L
3.72
2.94
4.73
8.23
L
3.19
2.84
3.78
6.47
L
2.16
1.8
2.81
3.66
L
1.91
1.99
1.83
L
1.88
2.29
1.75
L
1.83
2.24
1.96
L
1.73
2.33
2.73
L
1.66
2.23
2.03
L
1.66
1.58
2.09
2.44
L
1.75
1.69
L
1.67
2.12
L
1.62
L
1.62
2.25
L
1.58
1.61
L
1.57
1.87
L
1.56
2.15
L
1.52
1.99
L
2.71
L
1.64
L
1.58
L

Table 4.6. Significantly changed wound-healing genes. Fold-level change of upregulated
genes that have functions associated with a wounding response (identified by microarray
analysis). SR = stress response gene; A = antioxidant; ECM = extracellular matrix
remodeling; GF = growth factor; L = lysosome.
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Table 4.7 Lowly-abundant genes expressed in the blastema. NR14/C = Fold change of
NR14 compared to control. NR14/DL14 = Fold change of NR14 compared to DL14.

Probe ID
SRV_00099_at
SRV_00025_at
SRV_00107_at
SRV_00102_at
SRV_00091_at
SRV_00011_at

Gene
FGF8
FGF10
HOXD10
HOXA13
HOXA11
MSX1

NR14/C
3.36
2.32
3.52
2.26
2.00
2.31

NR14/DL14
3.47
1.79
2.77
2.57
1.71
2.19
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NR14vsDL14 students t-test P
value
0.0052
0.0031
0.0014
0.0066
0.0235
0.0068

Figure 4.1. Histology of innervated and denervated limbs at 5 and 14 dpa.
Eosin and hematoxylin staining of DL5 (A), NR5 (C), DL14 (E), and NR14 (G) limbs.
Higher magnification inset pictures are provided for each image (B,D,F,H). Scale Bar A =
500 µm; B = 50 µm
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Figure 4.2. Schematic of matrix metalloproteinase gene expression.
Matrix metalloproteinase gene expression is represented in each box. A) Microarray
results are represented by fold change (FC) from day 0. B) Normalized counts are
represented from the 454 cDNA sequencing experiment. Figures 2 – 4 were created using
GenMAPP (Dahlquist et al., 2002). Figure 2 was modified from a MAPP originally
created by Gladstone Institutes.
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Figure 4.3. Schematic of collagen gene expression.
Collagen gene expression is represented in each box. A) Microarray results are
represented by fold change (FC) from day 0. B) Normalized counts are represented from
the 454 cDNA sequencing experiment.
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Figure 4.4. Schematic of down-regulated muscle contraction genes.
Striated muscle contraction genes that were downregulated during limb regeneration. Each
gene is represented by two boxes that denote proportional expression among Day 0, NR5,
DL5, NR14, and DL14 samples. The left box reports hybridization intensity from the
microarray experiment and the right box reports normalized count data from the 454
cDNA sequencing experiment. Figure 2 was created using GenMAPP (Dahlquist et al.,
2002) and was modified from a MAPP originally created by Joanna Fong and Nathan
Salomonis.
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Figure 4.5. Clustering of genes identified as significant from the comparison of NR14
and DL14 limbs.
Fold change values are relative to baseline levels at Day 0. Blue coded genes are cell cycle
associated; orange coded genes localize to the lysosome; green coded genes are associated
with inflammatory responses; red coded genes are matrix metalloproteinase’s; purple
coded genes are associated with muscle. Genes coded with an * are associated with
inflammation and localize to the lysosome.
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Figure 4.6. Bar graph showing contig lengths.
Distribution of sequence lengths for each of the 61,127 contigs.
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Figure 4.7. Bar graph showing percent coverage of human proteins.
The distribution of the percent coverage for each of the unique 9411 human proteins with
presumptive salamander orthologs.

Copyright © James Robert Monaghan 2009
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Introduction
Salamanders are the only tetrapods capable of regrowing limbs as adults.
Following amputation of a limb, cells proximal to the amputation surface are recruited to
form a mass of highly proliferative mesenchymal-type cells termed the blastema. The
blastema is the fundamental and necessary element of a regenerating limb. It is a selforganizing structure that eventually re-differentiates into an almost perfect replica of the
missing limb. By focusing on events that contribute to blastema formation, we aim to
understand how the salamander can regenerate entire limbs.
Blastema formation is dependent upon an adequate supply of nerves. If the limb
nerve supply is compromised, a blastema fails to form and hence limb regeneration. This
phenomenon has been known since 1823 (Todd), but the role nerves play in blastema
formation is still poorly understood. Nerves are intimately connected to the early
blastema. Anatomical, immunological, and retrograde staining of neurons has shown that
a large number of nerve fibers quickly grow into injured limb tissues and wound
epithelium following amputation (Figure 5.1; Singer 1949; Thornton, 1970; Koussoulakos
et al., 2003; Satoh et al., 2008). These nerve fibers supply a neurotrophic factor (NTF) or
set of NTFs, independent of electrical transmission, that support the proliferation of
blastemal cells during the early phases of regeneration (Singer, 1978 for review;
Monaghan et al., 2009). Multiple gene candidates have been proposed to be the NTF
including fibroblast growth factors (Mullen et al., 1996, but see Dungan et al., 2002; Satoh
et al., 2008), substance P (Globus, 1991), neuregulin (Wang et al., 2000), and transferrin
(Mescher, 1997), but none have fulfilled all the requirements to identify these molecules
as the NTF. It is unclear whether these molecules do not completely rescue regeneration
because their mitogenic properties are unrelated to the critical role nerves play during
regeneration. Alternatively, these and other factors may act synergistically to support limb
regeneration. Unbiased genomic approaches were used here to identify possible new gene
candidates that may explain the vital role of nerves during salamander limb regeneration.
Several properties are known about the NTF(s) that may assist in identifying
candidate molecules in future studies. The NTF(s) is produced in the neuronal cell body,
transported down the axon, possibly by fast axonal transport, and released at the synapse
(Scadding, 1988; Wallace, 1972; Kiffmeyer et al., 1991). The mitogenic affect of nerves is
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increased following nerve injury or limb amputation, possibly due to an increase in NTF
production (Singer, 1952; Maier et al., 1984; Boilly and Albert, 1988; Boilly and Bauduin,
1988). Lastly, the NTF(s) is produced by sympathetic, motor, and sensory nerves
innervating the limb (Singer, 1952, 1974). A minimum threshold of these nerves is
necessary for the limb to regenerate and can be met by innervation of only sensory axons.
This is likely explained by the large contribution of sensory nerve axons to the early
blastema (Singer, 1978; Koussoulakos et al., 2003).
Sensory nerves that innervate the salamander hindlimb originate from brachial
nerves 15, 16, and 17. The cell bodies that supply the brachial nerve axons are located in
dorsal root ganglia (DRG) found lateroventrally to the spinal cord (figure 2.7). The
accessibility of DRGs to surgical removal and culture has made them useful for
understanding the signaling involved in axon outgrowth. Furthermore, the substantial role
sensory nerves play in blastema formation make DRGs an obvious choice for identifying
candidates for the NTF(s). The aim of this study was to use microarray analysis to detect
gene expression changes in DRGs during blastema formation in order to identify
regeneration-associated genes (RAGs) as well as possible gene candidates for the NTF(s).
We identified 109 genes as differentially regulated in DRGs during hindlimb blastema
formation engrossing several aspects of neuronal physiology including axon outgrowth,
mitogenic factors, and neuronal signaling. Many of the changed genes identified in this
study have also been identified in mammalian models of peripheral nerve injury,
suggesting a common transcriptional response to nerve injury. However, multiple RAGs
were identified in this study that may be specific to salamander nerve regeneration.
Several up-regulated genes were also localized to sensory neurons of the DRG suggesting
that we sampled gene expression changes in sensory neurons during regeneration.
Materials and Methods
Animals, tissue collection, and RNA isolation
The handling and surgical manipulation of all salamanders was carried out
according to the University of Kentucky Animal Care and Use guidelines (IACUC
#00609L2003). Mexican axolotls were housed in the Voss lab on a 12 hour light/dark
cycle and fed California blackworms (Lumbriculus variegates) ad libitum. Eight adult
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animals were anesthetized in 0.01% Benzocaine (Sigma) and both hindlimbs amputated
mid tibia/fibula. Limbs were allowed to regenerate for 14 days before right and left DRGs
(15, 16, and 17) were collected and frozen on liquid nitrogen. Four biological replicates
were made by pooling six DRGs isolated from two animals. Tissues were crushed under
liquid nitrogen using a mortar and pestle, suspended in RNAlater (Qiagen), and further
homogenized by running through a Qiashredder (Qiagen). A second group of eight
animals had DRGs collected without limb amputation and the same tissue pooling scheme
was performed. RNA was isolated using Trizol Reagent (Invitrogen) followed by RNeasy
mini columns (Qiagen). RNA quality was assessed using an ND-1000 Spectrophotometer
(Nanodrop; Wilmington, DE) and a Bioanalyzer 2100 (Agilent; Santa Clara, CA). Probe
labeling, hybridization, and scanning for the eight RNA samples were performed by a
single staff member of the University of Kentucky Microarray Core Facility.
Microarray analysis
Data processing and statistical analysis was performed using the Affy
Bioconductor package for the R statistical environment (Bolstad et al., 2005). Background
correction, normalization, and probe set summarization were performed via the robust
multi-array average (RMA) algorithm of (Irizarry et al., 2003). The limma package
(Smyth, 2008) available from Bioconductor was used to conduct the equivalent of
unpaired t-tests between the control and regenerating groups. Genes were identified as
differentially expressed if they passed a false discovery rate set at 5% and changed at least
>1.5 fold from baseline.
Quantitative real-time PCR
Significantly changed genes and genes previously hypothesized to be the NTF
were chosen for quantitative real-time PCR analysis. A BioRad iScript cDNA synthesis
kit (Hercules, CA) was used to synthesize cDNA templates from three Day 0 and three
Day 14 RNA samples collected from animals not used for microarray analysis. Primers
were designed with Primer3 (Rozen and Skaletsky, 2000) to amplify 80-100 base pair
PCR products. Reactions included cDNA that was synthesized from 10ng total RNA,
150nM primers, and SYBR Green Reaction Mix (Roche; Switzerland) and run on a
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StepOne Real-Time PCR System (Applied Biosystems; Foster City, CA). The three
replicates were normalized against a gene that showed no significant gene expression
change in the microarray experiment (glyceraldehyde-3-phosphate dehydrogenase,
MC01187). Fold change estimates were calculated using the ∆∆Ct methodology (Livak
and Schmittgen, 2001). Real-time PCR primers used include: ANGPTL2_F, 5’- TCA
AGC TCC TAC GCA AGG-3’ and ANGPTL2_R 5’- CGG ATG ATT TCG TGG AGA3’; ANKRD1_F 5’- TGG CGC AAA CCT AAC AGT-3’ and ANKRD1_R 5’- TCC TTT
GTG CCA TTC TGC-; CSRP_F 5’- CAC GGT GTG GGA AGT CTG-3’ and CSRP_R
5’- TTC CCA CAA AAG GCA CAC-3’; GAP43_F 5’- GGC TAA CGG AGA GGC
TGT-3’ and GAP43_R 5’- TCG CAG ACG TGT CAG ATG-3’; GGF_F 5’- ACA CCG
ACC ATT GGA ACA-3’ and GGF_R 5’- AAG CAC TCG CCA CCA TT-3’; LECT3_F
5’- GGA GGG GTC CTC GTA CTG-3’ and LECT3_R 5’- GGT TTC CGG TGA AAG
GAG-3’; LEPTIN_F 5’- TGC CAA AAA CCT CAC CAG-3’ and LEPTIN_R 5’- CTA
AGC CGC TCA CCT TCA-3’; SODEFRIN_F 5’- AAG GTT GCA GAC CCC AGT-3’
and SODEFRIN_R 5’- GAA GAA CCC CCA CAG TCC-3’; TRANSFERRIN_F 5’GGC GTG TTA CGA CAC CAT-3’; TRANSFERRIN_R 5’- CCT AAT GGC AAC GAG
CTG-3’
In situ hybridization
In situ hybridization was performed as described by Hirota et al. (1992) with
minor modifications. PCR products were used as probe templates ranging from 400-700
base pairs. Forward primers were appended with T3 (AAT TAA CCC TCA CTA AAG
GGA G) and reverse primers with SP6 (ATT TAG GTG ACA CTA TAG AAG AG)
RNA polymerase promoters. PCR products were cleaned using Qiagen PCR purification
columns (Qiagen) before performing in vitro transcription using Roche DIG-labelling kits
(Roche). Probes were cleaned up with Sigmaspin columns (Sigma) and diluted to 50 ng/ul
in THE RNA Storage Solution (Roche). DRGs were collected from adult axolotls on Days
0, 14, and 28 dpa and fixed at 4ºC in 1x PBS, 4% paraformaldehyde overnight. Tissues
were cryoprotected in successive washes of 10%, 20%, and 30% sucrose, 1xPBS. Tissues
were sectioned to 16µm using a Microm 500HM cryostat. Differential interference
contrast microscopy was performed using an Olympus AX80 microscope and images
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were acquired with an Olympus DP70 camera. Primers (without RNA promoters)
included: ANKRD1_F_ISH 5’-AAT TAA CCC TCA CTA AAG GGA GTT CCG TTC
CGT CTC TTT GTC-3’ and ANKRD1_R_ISH 5’-ATT TAG GTG ACA CTA TAG AAG
AGG TAC AAG AGA ACC GCC TTG C-3’; HRAS_F_ISH 5’-AAT TAA CCC TCA
CTA AAG GGA GCC GGG GAG TAA ACT TCT GAG-3’ and HRAS_R_ISH 5’-ATT
TAG GTG ACA CTA TAG AAG AGG CGT TGG CAA GTC ACA TTT-3’;
SRV_02399_T3_S 5’-AAT TAA CCC TCA CTA AAG GGA GAG CGC ACG ATG
TCT TTC TGT A-3’ and SRV_02399_SP6_AS 5’-ATT TAG GTG ACA CTA TAG
AAG AGG CGG TGG TAC TCC AAC TCA T-3’; MBP_5.1_ISH 5’-TAA TAC GAC
TCA CTA TAG GGA GGC CAG AAC CTT GGA ATC TGA and MBP_3.1_ISH AAT
TAA CCC TCA CTA AAG GGA GGA CAA CGG GGT TAT CCT CAA.
Results
Peripheral nerve regeneration in early blastemas
We chose 14 dpa for harvesting DRGs because this time point represented the
early limb bud stage of regeneration. It is known that extensive innervation takes place
during the early stages of blastema formation. In order to verify that axons are innervating
the early blastema, immunohistochemical staining of axons using the antibody RT-97 was
performed in limbs collected 14 dpa as well as 28 dpa. Figure 5.1 shows there is a large
number of axons throughout the epidermis and blastema at 14 dpa. These results indicate
that 14 dpa is an appropriate time point to harvest DRGs to detect mRNA changes
associated with axon outgrowth and support of early blastema growth.
Identification of differentially expressed genes and similarities to mammalian studies
To identify gene expression alterations in DRGs following limb amputation,
custom axolotl Affymetrix microarrays were used to compare mRNA abundances
between DRGs isolated from uninjured and regenerating limbs (14 dpa). 109 of 4844
probe sets were identified as significantly different in mRNA abundances between 0 and
14 dpa. Changes from baseline mRNA levels ranged from 29.45 fold up-regulation
(ankyrin repeat domain 1; ANKRD1) to -2.39 fold down-regulation (Na+/K+ transporting
ATPase beta 2 protein). The majority of genes exhibited subtle fold level changes with
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only 11 genes changing > 5 fold up-regulation and only two genes >2 fold downregulation from baseline. 63% of the differentially regulated genes (n = 69) correspond to
salamander sequences (genes) that show high sequence identify to a presumptive human
protein-coding locus; the remainder correspond to anonymous EST contigs. Fold changes
are summarized for up-regulated genes with presumptive human orthologs in Table 1 and
down-regulated genes in Table 2. The genes found in Table 2 are potential candidates for
participating in the re-growth of sensory neurons into an early blastema or as possible
candidates for the elusive NTF(s).
In order to identify similarities and differences between salamander and
mammalian peripheral nerve gene expresssion, we compared results from this study to
studies performed on mice and rat DRGs after peripheral nerve injury. Of the 30 most upregulated salamander genes that have a presumptive human ortholog, almost half (n = 13)
are up-regulated following mammalian peripheral nerve injury (Table 5.3). Three other
genes are well-recognized regulators of neurite outgrowth in mammalian neurons (PAK1
and HRAS). These results suggest that the transcriptional response following limb
amputation in salamander DRGs is similar to the DRG response produced following
mammalian peripheral nerve injury.
Down-regulated genes are less similar to the transcriptional response for
mammalian peripheral nerve injury. The most striking similarity is that much fewer genes
are downregulated than upregulated in both salamanders and mammals. Another similarity
is the down-regulation of genes coding for NA+/K+ and calcium ion channels (Valder et
al., 2003; Xiao et al., 2002). Although the changed genes are not identical, both Na+/K+
transporting ATPase beta 2 protein and ATPase, class VI, type 11A were down-regulated
in salamander DRGs.
Several genes identified by microarray analysis were validated using real-time
PCR on independent samples (Figure 5.2). In general, we found that genes identified as
significant by microarray analysis were also found to change in the same direction by realtime PCR. In situ hybridization was used to localize gene transcripts within DRGs
because gene candidates may be expressed in other cell types including Schwann cells,
immune cells, and support satellite cells. We found that ANKRD1, MMP9, and HRAS
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were all expressed in cells resembling neurons. A probe specific to myelin basic protein
was used to identify Schwann cells and myelinated regions (Figure 5.3).
Similarities to retinal and spinal cord injury
To determine whether gene expression changes that take place following
peripheral nerve injury are similar to transcriptional events following other nervous
system injuries, we compared the gene list from this study to changed genes following
salamander spinal cord injury (Monaghan et al., 2007) and optic nerve transection
(Elizabeth Debski, unpublished). Table 5.4 contains 24 genes that were significantly
regulated in all three injury models. This list includes genes shown to be up-regulated
after mammalian peripheral nerve injury including ankyrin repeat domain-containing 1,
MMP9, GADD45 as well as genes involved in the mitogen-activated protein kinase
(MAPK) signaling pathway including H-RAS, C-MYC, PAK1, and GADD45.
Potential candidates for nerve outgrowth and the neurotrophic factor(s)
Gene ontology analysis was performed on 69 unique genes in order to identify
possible signaling pathways regulated in DRGs following limb amputation as well as
possible NTF(s) candidates (Dennis et al., 2003). We found that the majority of
differentially regulated genes were intracellularly located (n = 40). These intracellular
gene products are involved in multiple signal transduction pathways and cellular processes
associated with neuron growth included the MAPK signaling pathway (n = 6; p = 4.2E-3),
apoptosis (n = 13; p = 7.4E-3), and transport (n = 18; p = 2.8E-2). Only eleven gene
products were identified as being found extracellularly located, ten of which are predicted
to be secreted (bolded in Tables 5.1 and 5.2). One salamander-specific gene, Sodefrin, is
known to be secreted as a mating pheromone in some salamander species and is thus
recognized as a secreted molecule in this study (Nakada et al., 2007).
Previous experiments have shown that the NTF(s) is made in the cell body,
transported down axons to be secreted into the blastema, and may increase during
blastema formation. We identified eight gene candidates that may fit this profile including
matrix metalloproteinase 9, sodefrin, angiopoietin-like 2, leptin, 26 serine protease,
follistatin, leukocyte cell-derived chemotaxin 2, and latent transforming growth factor
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beta binding protein 3. Six of these gene products have also been shown to have
mitogenic activity on certain mammalian cell types (Zhang et al., 2006; Hiraki et al.,
1996; Mori et al., 1997; Koli et al., 2008; Jenne et al., 1991; Maumus et al., 2008; Edqvist
et al., 2008). Unfortunately, the expression of secreted genes is often low and in situ
hybridization failed on all but MMP9. MMP9, sodefrin, ANGPL2, and leptin are also upregulated following spinal cord injury and optic nerve transection. In order to address
whether previously identified gene candidates increased expression in our injury model,
we performed real-time PCR on neuregulin (GGF2) and transferrin. Both genes increased
mRNA abundance in DRGs at 14 dpa (Figure 5.2). Singer hypothesized (1978) that all
nerves are capable of supporting regeneration if in great enough quantities. These genes
that are up-regulated in multiple injury paradigms make promising candidates for
supporting salamander limb regeneration.
Discussion
The present study identified differentially regulated genes in DRGs during early
blastema formation. The aim of the study was to identify regeneration-associated genes as
well as possible candidates for the NTF(s). We compared the changed gene lists to
changed genes in mammalian DRGs to identify an evolutionarily conserved set of genes
that are associated with peripheral nerve regeneration. This comparison gave 12 genes that
may be necessary for peripheral nerve regeneration in vertebrates. We also compared gene
expression changes in the present study with differentially regulated genes following
spinal cord injury and optic nerve transection. This analysis identified 24 genes associated
with both central and peripheral nerve regeneration in the salamander. Interestingly, three
of these genes, ANKRD1, MMP9, and GADD45, were also up-regulated in mammalian
peripheral nerve injury. Lastly, eight up-regulated genes were predicted to be secreted
from neurons, making them good candidates for the NTF. These genes will be important
targets for functional analysis in order to understand the relationship between nerves and
the early blastema.
One aim of the study was to identify possible genes responsible for inducing and
supporting axon regeneration. Measuring mRNA level changes is appropriate for this task
because de novo transcription is necessary for axon outgrowth of DRG neurons in
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mammals and frogs (Plunet et al., 2002; Smith and Skene, 1997; Tonge et al., 2008). Two
transcriptional regulators that were up-regulated more than 20 fold in this study, ANKRD1
and CGRP3, are also highly up regulated in rat DRGs for at least 14 days following sciatic
nerve crush (Stam et al., 2007). Over-expression of ANKRD1, but not CGRP3, enhanced
neurite outgrowth in vitro; knockdown of ANKRD1 had the opposite effect. These results
indicate that ANKRD1 is involved in neurite outgrowth of rat neurons. ANKRD1 was not
expressed in embryonic rat spinal cords or following a dorsal root nerve crush, an injury
that does not induce substantial neurite outgrowth. This suggests that ANKRD1 expression
is associated with neurite regeneration and not just neurite outgrowth. We found ANKRD1
to be up-regulated following salamander spinal cord injury, optic nerve transection, and
peripheral nerve transection; all tissues that will eventually regenerate (Table 5.4). It is
possible that ANKRD1 up-regulation regulates downstream transcriptional targets to
promote axon regeneration in multiple injury paradigms. It is also possible that ANKRD1
up-regulation following spinal cord injury and optic nerve crush may be related to the
uncommon regenerative abilities of the salamander CNS. These results justify further
investigation of ANKRD1 during salamander regeneration.
Regeneration-associated genes, including GAP-43 (Bomze et al., 2001), RARβ
(Corcoran et al., 2000, 2002), Cap23 (Bomze et al., 2001), α7 integrin (Gardiner et al.,
2005), and cJun (Raivich et al., 2004), have been identified in mammalian peripheral
nerve injury models and shown to promote intrinsic growth ability. We found that GAP43 and CAP23 significantly changed according to microarray analysis (p = 4.46E-5 and
2.0E-3, respectively), but did not meet fold level criteria (fold change = 1.46 and 1.18).
The other RAGs above are not represented on the Ambystoma GeneChip. Real-time PCR
showed that GAP-43 is up regulated and at 14 dpa, suggesting that the GAP43 probe-set
underestimated mRNA level changes. GAP-43 and CAP23 are both highly expressed in
uninjured DRGs (ranks 205 and 272 of 4844 probe sets), suggesting that salamander
DRGs may express high levels of RAGs under normal conditions. Even though cJun is
not included on the GeneChip, a closely related gene JunB was upregulated (fold change
= 3.75; p = 3.35E-8). It is possible that JunB has a similar role to cJun because it has also
been found to be up regulated in several mammalian peripheral nerve injury studies
(Buschmann et al., 1998; Kenney and Kocsis, 1997). Fourteen up regulated genes were
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associated with apoptosis. It is unknown whether programmed cell death takes place in
DRGs following limb amputation in salamanders, but it is known that peripheral nerve
injury in neonatal mice induces DRG neuron death (Himes and Tessler, 1989).
Interestingly, sensory neuron cell death does not take place in adult mice, possibly due to
up-regulation of HSP27 (Benn et al., 2002). It is possible that a similar protective
mechanism takes place in salamander sensory neurons following limb amputation.
The comparison of changed genes between three nervous system injury models
identified a list of 30 genes that changed in all three studies. Four of these genes, H-RAS,
C-MYC, PAK1, and GADD45 are known to function in the mitogen-activated protein
kinase (MAPK) signaling pathway. The MAPK signaling pathway is activated by the
binding of extracellular growth factors at the cell surface and leads to multiple cellular
responses including cell proliferation, differentiation, and survival of neurons. The small
GTPase, H-RAS is an up-stream component of the MAPK signal transduction cascade that
is a major contributor to the survival of neurons through multiple signal transduction
pathways including PI-3Kinase/AKT and MAPK pathways (Kaplan and Miller, 2000 for
Review). One target of the MAPK pathway is the phosphorylation and activation of the
transcription factor C-MYC. Phosphorylated C-MYC then transcriptionally activates a
wide range of target genes that regulate cell behavior (Pelengaris et al., 2002). PAK1
(Smith et al., 2008) and GADD45 (Takekawa and Saito, 1998) are also involved in
regulating MAPK signaling. PAK1 is upregulated in zebrafish retinal ganglion cells after
optic axon injury (Veldman et al., 2007) and can control neurite outgrowth by regulating
actin dynamics in neurons (Daniels et al., 1998; Rashid et al., 2001). The up-regulation of
these genes in three nervous system regeneration models suggests that the MAPK
pathway plays a role in nervous system regeneration in salamanders. The lack of upregulation of H-RAS, C-MYC, and PAK1 (data not shown) during limb regeneration
supports the hypothesis that the role of these genes is specific to nervous system
regeneration.
One criteria of the NTF(s) is that it is a secreted peptide or set of peptides (Singer,
1952). Co-culture experiments of injured and uninjured spinal ganglia with blastema cells
suggest that this secreted peptide(s) increases in regrowing neurons (Boilly and Bauduin,
1988). Lastly, the NTF is thought to be found in all nervous tissue (Globus and Liversage,
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1975; Globus and Vethamany-Globus, 1977; Kamrin and Singer, 1959; Singer et al.,
1976; Carlone and Foret, 1979; Choo et al., 1978; Deck, 1971; Lebowitz and Singer,
1970). Several genes were identified as secreted and up-regulated in DRGs during
blastema formation, spinal cord regeneration, and optic nerve transection including
MMP9, Sodefrin, angiopoietin-like 2, and leptin (Table 3). MMP9 is likely not the NTF
because it is highly expressed in all salamander injury models studied to date (Monaghan
et al., 2009; Monaghan et al., 2007; Elizabeth Debski, personal communication; Cotter et
al., 2008). It is possible that MMP9 activates growth factors or releases them from the
blastema extracellular matrix (McCawley and Matrisian, 2001 for Review), but MMP9
activity is also known to promote neurite elongation (Shubayev and Myers, 2004).
A sequence (SRV_10508_a_at) with 33% amino acid homology to the sodefrin
precursor-like factor found in the salamander Desmognathus monticola, was upregulated
7.18 fold in DRGs and also upregulated in other nervous system injury models (Table
5.4). Sodefrin is a sex pheromone in plethodontid salamanders that is secreted from male
glands and influences female behavior (Palmer et al., 2007; Kiemnec-Tyburczy, 2009).
We find that the axolotl sodefrin contains a secretion signal sequence (TargetP;
Emanuelsson et al., 2000) and contains a Phospholipase A2 (PLA2) inhibitor domain.
PLA2s play roles in inflammatory pathways and disease (Touqui and Alaoui-El-Azher,
2001) and are found as toxic components of snake and insect venoms (Huang and Kini,
1997). PLA2 inhibitors are expressed in snakes to block toxic PLA2 enzyme activity
(Dunn and Broady, 2001 for Review). It may be that sodefrin’s role in limb regeneration
is to decrease local inflammation by inhibiting PLA2 activity. There is support for
sodefrin’s role in the nerve dependence of limb regeneration, because it belongs to the Ly6 family of proteins, the same protein family as prod1. Prod1 is the receptor to newt
anterior gradient 2, a gene that can rescue regeneration in denervated limbs when
overexpressed (Kumar et al., 2007). It will be interesting to see if either of these
hypotheses is supported by functional analyses.
The gene product of angiopoietin-like 2 (ANGPTL2) is a possible candidate for the
NTF. ANGPTL2 is a member of the angiopoietin-like family of orphan ligands that are
involved in angiogenesis and lipid, glucose, and energy metabolism (Hato et al., 2008).
Morpholino knockdown of ANGPTL1 and ANGPTL2 in zebrafish cause severe vascular
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defects because they increase endothelial cell death during development (Kubota et al.,
2005). Angiogenesis takes place early during blastema formation in newts, (Rageh et al.,
2002), which is not surprising considering that all growing tissues, including developing
limbs require oxygen and nutrients normally supplied by vasculature (Vargesson, 2003).
Smith and Wolpert (1975) proposed that vascularization is necessary for regeneration to
take place and that denervation inhibits vascularization of the regeneration stump. Tassava
(personal communication) has since shown that angiogenesis does take place in
denervated newt stumps, but further characterization is needed. It is possible that
ANGPTL2 is secreted by nerves into the early blastema and promotes angiogenesis.
ANGPTL2 has also been shown to be a potent stimulator of hematopoietic stem cell
expansion ex vivo (Zhang et al., 2006). Furthermore, a related molecule, ANGPTL6,
promotes mouse keratinocyte expansion in vivo and increases epidermal regeneration
(Oike et al., 2003). It will be interesting to find whether ANGPTL2 plays a mitogenic role
in early blastema tissues.
The last of the up-regulated, secreted molecules in all nervous system injuries is
leptin. Leptin is a major regulator of energy metabolism in mammals normally expressed
in adipose tissue (Zhang et al., 1994). A closely related salamander species, the Tiger
salamander, also shows leptin expression in nervous system tissue (Boswell et al., 2006).
It is possible that leptin is secreted from peripheral nerves to regulate energy expenditure
in the blastema. The probe set for leptin gives a very low signal in all studies, suggesting
that leptin mRNA levels may be low. Regardless, it may have a very focused affect on the
innervated blastema tissue.
In order to address whether previously identified NTF candidates change in our
injury model, real-time PCR was performed on genes previously proposed to be the NTF
including neuregulin-1 (Wang et al., 2000) and transferrin (Mescher, 1997). Both of these
genes were up regulated in our injury model, supporting the hypothesis that these may be
the NTF(s). In conclusion, this study indicates that changes in mRNA levels of at least
100 genes take place in DRGs following limb amputation. The results provide a set of
new gene candidates for understanding the role of nerves during salamander limb
regeneration. Intracellular genes such as ANKRD1, signaling pathways such as the
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MAPK pathway, and extracellular candidates for the NTF(s) need to be followed up by
experiments designed to assess the function of these genes during limb regeneration.
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Table 5.1. Up-regulated genes in DRGs following limb amputation.
Probe ID
Human ortholog
SRV_03532_at
ANKRD1
SRV_02024_at
ADRP
SRV_00853_at
CGRP3
SRV_00344_at
Keratin 5
SRV_02399_a_at MMP9
SRV_03023_a_at GADD45γ
SRV_10508_a_at SODEFRIN
SRV_01031_at
HSP27
SRV_01466_at
NMB
SRV_04693_a_at DESMOCOLLIN 1
SRV_01351_at
JUN B
SRV_03250_a_at ANGIOPOIETIN-LIKE 2
SRV_03753_at
GADD45β
SRV_01323_a_at HMO1
SRV_00259_a_at LEPTIN
SRV_05557_at
TMEM52
SRV_02773_at
26 SERINE PROTEASE
SRV_11456_at
HRAS
SRV_01488_at
PAK1
SRV_02611_a_at GLUCOCORTICOID REG. KINASE
SRV_02866_a_at TUMOR SUSCEPTIBILITY 101
SRV_02973_at
IGF-LIKE 2 MRNA BINDING 3
SRV_09706_at
GLUTAMINE SYNTHETASE
SRV_01307_a_at GLUTAMINE SYNTHETASE
SRV_03871_a_at SAR1
SRV_03246_at
6-PHOSPHOGLUCONOLACTONASE
SRV_03390_a_at FOLLISTATIN
SRV_01385_at
LECT2
SRV_04964_a_at TUBULIN, BETA 6
SRV_01467_a_at GLYCOPROTEIN NMB
SRV_00140_at
CDK1C
SRV_05752_at
SYNCYTIN
SRV_05081_a_at SORTING NEXIN 18
SRV_00332_a_at G6PD
SRV_02600_a_at LEGUMAIN
SRV_04911_at
TXNDC2
SRV_04735_at
NUCLEAR PROTEIN UKP68
SRV_04996_at
SOLUTE CARRIER FAMILY 7, 3
SRV_04524_at
SOLUTE CARRIER FAMILY 30, 1
Table 5.1 continued on next page
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FC
29.45
21.76
21.14
11.38
10.98
7.19
7.18
4.4
4
3.81
3.75
3.23
2.97
2.95
2.77
2.72
2.7
2.68
2.67
2.59
2.56
2.32
2.1
2.07
2.05
2.04
2.01
1.97
1.91
1.91
1.78
1.76
1.76
1.75
1.75
1.75
1.71
1.71
1.71

p-value
6.83E-09
1.21E-10
3.32E-08
1.60E-07
5.74E-06
4.63E-08
2.66E-07
4.55E-07
1.34E-04
1.48E-08
3.35E-08
3.72E-10
6.29E-05
3.19E-05
1.90E-05
2.11E-05
2.49E-05
3.36E-08
8.17E-08
4.40E-06
1.28E-06
7.76E-05
1.94E-05
1.14E-03
9.63E-08
1.93E-07
2.74E-03
1.59E-03
1.40E-05
1.16E-04
9.70E-05
1.67E-03
1.83E-05
3.89E-06
3.68E-05
6.76E-07
2.83E-06
2.02E-03
2.48E-06

Table 5.1 continued
Probe ID
SRV_03758_a_at
SRV_02687_s_at
SRV_04819_a_at
SRV_04501_a_at
SRV_03383_a_at
SRV_09231_at
SRV_00867_a_at
SRV_01305_at
SRV_00515_at
SRV_03108_a_at
SRV_05100_at
SRV_00744_a_at
SRV_01442_at
SRV_01651_a_at
SRV_02584_a_at

Human ortholog
ARRESTIN DOMAIN CONTAINING 2
M6PRBP1
TRANSMEMBRANE PROTEIN 49
LATENT TGFB BINDING PROTEIN 3
PDCD61P
ADRP
DEFENDER AGAINST CELL DEATH 1
GLUTAMATE-CYSTEINE LIGASE
FLJ16008 PROTEIN
SPLICING FACTOR 2
GLUCURONOSYLTRANSFERASE P
ADRP
CMYC
RGS2
STATHMIN 1
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FC
1.69
1.69
1.66
1.6
1.57
1.55
1.55
1.54
1.54
1.54
1.54
1.53
1.51
1.51
1.51

p-value
2.78E-05
1.07E-05
3.27E-04
2.14E-03
1.40E-06
3.65E-05
2.53E-06
2.67E-04
3.33E-03
1.09E-04
1.56E-04
1.56E-03
3.13E-04
8.63E-04
1.04E-05

Table 5.2. Downregulated genes in DRGs following limb amputation.
Probe ID
SRV_01118_a_at
SRV_03357_at
SRV_01275_at
SRV_02395_a_at
SRV_02948_a_at
SRV_04213_at
SRV_02599_a_at
SRV_02792_at
SRV_02442_a_at
SRV_05046_at
SRV_02421_at
SRV_01225_at
SRV_00038_at
SRV_01281_at
SRV_03517_a_at
SRV_05108_a_at

Human ortholog
ATPASE, NA+/K+ TRANSPORTING, β2
CD69 ANTIGEN
FIBULIN 1
JUMONJI
FIBULIN 1
RHO GTPASE ACTIVATING 27
ATPASE, CLASS VI, TYPE 11A
SEMAPHORIN 3D
INTERFERON, ALPHA-INDUCIBLE
HORNERIN
PLASTIN 3
CRYSTALLIN, ALPHA B
KIT LIGAND
FK506 BINDING PROTEIN 4, 59KDA
TNF, ALPHA-INDUCED PROTEIN 8
PSAT1
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FC
-2.39
-2.32
-1.96
-1.93
-1.79
-1.78
-1.75
-1.71
-1.67
-1.65
-1.6
-1.57
-1.55
-1.54
-1.54
-1.51

p-value
1.55E-06
3.01E-03
7.50E-04
5.10E-05
9.16E-06
7.70E-06
2.59E-05
3.84E-03
9.07E-04
2.55E-03
1.85E-03
5.24E-05
8.19E-04
2.93E-03
1.05E-03
3.04E-03

Table 5.3. Upregulated genes that are also upregulated after mammalian peripheral
nerve injury
Probe ID

Human
ortholog

FC

Other studies
Valder 2003 (U44948); Newton et al.,
SRV_00853_at
CGRP3
21.14 2000; Costigan et al., 2002; Xiao et al.,
2002
SRV_03023_a_at
GADD45G
7.19 Tanabe et al., 2003; Befort et al., 2003;
Nilsson et al., 2005;
SRV_03753_at
GADD45B
2.97 Tanabe et al., 2003
SRV_01466_at
NMB
4
Takeuchi et al., 2008
SRV_03532_at
ANKRD1
29.45 Stam et al., 2007; Boeshore et al., 2004;
Costigan et al., 2002
SRV_02399_a_at
MMP9
10.98 Shubayev and Myers, 2004
SRV_03390_a_at FOLLISTATIN 2.01
Nilsson et al., 2005
SRV_01323_a_at
HMO1
2.95 Magnusson et al., 1999; Takeuchi et al.,
2008; Boeshore et al., 2004
Costigan et al., 2002; Tandrup et al.,
2000; Lewis et al., 1999; Williams et al.,
SRV_01031_at
HSP27
4.4
2006; Costigan et al., 1998; Xiao et al.,
2002
SRV_04964_a_at TUBULIN B6
1.91
costigan et al., 2002
Buschmann et al., 1998; Kenney and
SRV_01351_at
3.75
JUNB
Kocsis, 1997
SRV_09706_at
2.1
Boeshore et al., 2004
GLUL
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Table 5.4. Changed genes in three nervous system injury studies.
Probe ID
SRV_03532_at
SRV_02024_at
SRV_08647_a_at
SRV_02399_a_at
SRV_03023_a_at
SRV_10508_a_at
SRV_09432_at
SRV_01466_at
SRV_04693_a_at
SRV_03250_a_at
SRV_00259_a_at
SRV_11456_at
SRV_01488_at
SRV_09852_at
SRV_09045_at
SRV_04964_a_at
SRV_01467_a_at
SRV_04911_at
SRV_02687_s_at
SRV_04819_a_at
SRV_09231_at
SRV_03108_a_at
SRV_00744_a_at
SRV_01442_at

Gene Name
ANKYRIN REPEAT DOMAIN 1
AP1S3
NO KNOWN ORTHOLOG
MMP9
GADD45γ
SODEFRIN
NO KNOWN ORTHOLOG
GLYCOPROTEIN NMB
DESMOCOLLIN 1
ANGIOPOIETIN-LIKE 2
LEPTIN
H-RAS
PAK1
NO KNOWN ORTHOLOG
NO KNOWN ORTHOLOG
TUBULIN, BETA 6
GLYCOPROTEIN NMB
TXNDC2
M6PRBP1
TMEM49
ADFP
SPLICING FACTOR 2
ADFP
C-MYC
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DRG
FC
29.45
21.76
16.96
10.98
7.19
7.18
4.24
4
3.81
3.23
2.77
2.68
2.67
2.13
1.94
1.91
1.91
1.75
1.69
1.66
1.55
1.54
1.53
1.51

Retina
FC
4.04
2.97
4.36
1.99
3.57
21.53
1.59
4.62
2.31
1.5
5.01
2.34
2.28
1.59
1.55
3.84
3.92
2.28
1.54
2.11
1.99
2.31
1.94
1.86

SC
FC
4.13
2.74
6.49
5.53
2.4
1.75
1.54
20.65
1.8
5.33
2.18
2.05
1.68
1.92
4.88
3.2
7.54
1.96
1.69
3.98
3.43
1.56
3.85
1.54

Figure 5.1 Immunohistochemical staining of neurites in a blastema at 14 dpa. RT-97
antibody (Red) was used to stain axons in a regenerating limb and Hoescht 33258 was
used to stain nuclei. The WE is seen on the right overlying a small blastema.
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Figure 5.2. Real-time PCR of genes that change in DRGs following limb amputation.
Grey bars represent log2 transformed fold changes according to real-time PCR. White
bars represent log2 transformed fold changes according to microarray analysis. Error bars
= + standard error of the mean. GGF and Transferrin were not represented on the
microarray platform.
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Figure 5.3 In situ hybridization of changed genes in DRGs during limb regeneration.
DRGs collected at 14 dpa are represented in A,C,D,F,G,I,J, and K. Sense probes are
represented in C,F,I, and K. DRGs collected at 0 dpa are represented in B,E, and H. A-C)
ANKRD1, D-F) MMP9, G-I) HRAS, J-K) MBP. Scale bar = 100µm.

Copyright © James Robert Monaghan 2009
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Introduction
Salamanders have an unusual ability to repair injuries and regenerate missing
appendages. This ability traces, in part, to cellular responses that modify the extracellular
environment in a way that promotes cell survival, proliferation, differentiation, and
patterning. Matrix metalloproteteinases (MMPs) are a family of proteolytic enzymes that
regulate cell-cell and cell-extracellular matrix (ECM) interactions by cleaving
extracellular substrates. These proteolytic events alter the structural composition of the
ECM and regulate the availability of growth factors and cytokines (Page-McCaw et al.,
2007; McCawley and Matrisian, 2001). Studies using rodent models have implicated
MMP function in development, tissue remodeling, immunity, and disease (Nagase et al.,
2006). MMPs also participate in regenerative responses across a wide range of animals
including hydra foot and head regeneration (Leontovich et al., 2000; Shimizu et al., 2002),
drosophila imaginal disc regeneration (McClure et al., 2008), sea cucumber intestinal
regeneration (Quiñones et al., 2002), zebrafish fin regeneration (Bai et al., 2005),
amphibian limb regeneration (Vinarsky et al., 2005), and mouse liver regeneration
(Alwayn et al., 2008). However, it is unclear exactly when MMPs participate, which
MMPs participate, or how MMPs are regulated in these regeneration paradigms. It will be
important to address these issues in order to assess the therapeutic potential of MMPs in
regenerative medicine.
MMPs are regulated at multiple cellular levels (reviewed by Yan and Boyd, 2007).
Following transcription and translation into an inactive enzyme, MMPs are held inactive
through binding of the pro-peptide domain to the catalytic site via a zinc ion (Figure 6.2;
6.3). MMPs are then activated by proteolytic cleavage of the pro-peptide domain, freeing
the catalytic domain (HEXXHXXGXXH) to cleave substrates. Some MMPs also contain
domains thought to evoke substrate specificity such as fibronectin-like and hemopexinlike domains (Nagase et al., 2006; Clark and Cawston, 1989, Chung et al., 2004). Lastly,
endogenous inhibitors of MMPs termed tissue inhibitors of MMPs (TIMPs) bind to MMP
proteins and regulate their local activity (Nagase et al., 2006). The multi-level nature of
MMP regulation ensures that they are only activated when and where they are needed.
The importance of MMP regulation is evident in diseases associated with unchecked
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MMP activity such as cancer, rheumatoid arthritis, cardiovascular disease, vanishing bone
syndrome, atherosclerosis, fibrosis, and ulcers (reviewed by Visse and Nagase, 2003).
MMP activity was first detected in regenerating salamander tissues over 40 years
ago (Grillo et al., 1968). Since then, a handful of studies have characterized MMP mRNA
levels or protein activity during salamander regeneration (Dresden and Gross, 1970; Yang
and Bryant, 1994; Vinarsky et al., 2005; Kato et al., 2003; Chernoff et al., 2000; Yang et
al., 1999; Miyazaki et al., 1996; Park and Kim, 1999; Kato et al., 2003). Vinarky et al.
(2005) also showed that newt limb regeneration can be partially inhibited if treated with a
wide-spectrum MMP inhibitor for 60 days. These data suggest that MMPs are necessary
for appendage regeneration, but it is unkown which MMPs are necessary for regeneration
or when they may participate in the process. In order to address these questions, we
collected MMP sequences from newly-developed salamander genomic databases and
characterized their expression throughout regeneration (Putta et al., 2004; Monaghan et
al., 2009).
Materials and Methods
Sequence identification and alignments
Matrix metalloproteinase sequences were identified for the axolotl by searching
the Ambystoma EST database (www.ambysoma.org) and NCBI databases. These
sequences were assembled with annotated vertebrate MMPs to develop gene models.
Sequence assembly was accomplished using Seqman (DNASTAR). As many of these
gene models were partial sequences, it was necessary to extend sequences by PCR and 5’
or 3’ RACE (Invitrogen). All gene models have been deposited in the NCBI nonredundant nucleotide database.
Animal model, RNA extraction, and real-time RT-PCR
All surgical manipulations were carried out on Ambystoma mexicanum according
to the University of Kentucky Animal Care and Use guidelines (IACUC #01088L2006).
Tail amputations were made at the bottom 1/3 of the tail. Total RNA was isolated from
three tails collected 1 mm proximal to the injury plane at 0, 3, 6, 12, 24 hpa, 7, and 14 dpa
(mass = 10.34 + 1.97 standard deviation [SD]; snout-vent length [SVL] = 6.42 + 1.40)
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using TRIzol Reagent (Invitrogen) followed by Qiagen Mini columns (Qiagen). cDNA
was produced using poly-T primers provided in the iScript Select cDNA synthesis Kit
(Bio-Rad). Real-time PCR was performed in 10 µl reactions including 300 pM forward
and reverse primers, 10 ng cDNA, and FastStart Universal SYBR Green Master Mix
(Roche). Primers used are shown in Table 6.1. PCR reactions and melt curve analysis
were run on a StepOne Real-time PCR System (Applied Biosystems). Gene expression
values (Ct) were produced for three biological replicates by averaging Ct values for two
technical replicates. The ∆∆Ct method was chosen to calculate ratios (Livak and
Schmittgen, 2001). Ct values were normalized to a control gene (GAPDH) and then a
ratio (R) was calculated using the mean of the 0 hpa samples. R-values were log2
transformed for statistical analysis and graphical presentation (Fig. 4,5,7). One-factor
analysis of variance was performed followed with Fisher’s PLSD tests to test for
significance between time points (Stat-View).
In situ hybridization and histology
Tail tissues were sectioned in the transverse and coronal planes for histology and
in situ hybridization. Figures 6.4L, 6.5M, 6.6H, and 6.7G show cartoons of a typical
transverse section through an axolotl tail. In the middle of the axolotl vertebral column is
the centrum, containing remnants of the notochord. The spinal cord lies dorsal to the
centrum within the neural arch. The hemal arch lies ventral to the centrum, containing the
caudal artery and vein. Processes (apophyses) are represented as circles at the dorsal or
ventral end of the arches. It was difficult to distinguish between cartilagenous and ossified
vertebral tissues. For this reason, cells lying within matrix lacunae of processes were
referred to as osteocytes, multinucleated cells surrounding processes were referred to as
osteoclasts, other cells within the centrum or arches were referred to as chondrocytes, and
cells on the external surface of vertebrae were referred to as perichondrial fibroblasts.
Probe templates were created from PCR products produced by either M13 primers
(cloned MMP fragments into a pGEM-T vector) or MMP-specific primers appended with
SP6 and T3 promoters (cDNA produced from regenerating tail RNA). PCR products were
cleaned up using Qiagen PCR purification kits (Qiagen). 200-500 ng of PCR product was
incubated at 37 ºC for 2 hrs in a 10 µl digoxygenin-labeling in vitro transcription reaction
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(Roche DIG-RNA labeling kit). DNA was degraded for 20 min. with 10 U DNase I,
stopped with 2 µl 200 mM EDTA, and cleaned up on Sigmaspin Sequencing Reaction
Clean-up columns (Sigma). RNA was quantified on a nanodrop spectrophotometer,
diluted to 50 ng/µl in THE RNA storage solution (Ambion), and stored at -80°C. Tissue
samples were fixed in freshly made 4% paraformaldehyde / 1XPBS at 4 °C overnight,
cryoprotected at 4 °C by immersion in 10% sucrose / 1xPBS for 1 hr, 20% sucrose /
1xPBS for 1hr, and 30% sucrose / 1xPBS overnight. Tissues were mounted in OCT
medium, sectioned at 16 µm, and used after 2 hr of drying at room temperature.
Hybridization mix included 50% formamide, 10 mM Tris-Cl (pH 8.0), 200 µg/ml yeast
tRNA, 10% dextran sulfate, 1x Denhardts’s solution, 0.25% SDS, 1 mM EDTA, and 1
µg/ml of DIG-labelled RNA probe. Incubations were performed at 64 °C overnight in a
humidified chamber and detected with an overnight incubation in an NBT/BCIP solution
(Roche). Sections were mounted with Permount, imaged using an AX-80 Olympus
microscope, and photographed using an Olympus DP-70 camera. Figures were assembled
using Photoshop 7.0 and brightness and contrast were changed to whole figures. Tissues
were treated identically up to sectioning for histology except tissues were decalcified with
500 mM EDTA for 2 days. Tissues were then sectioned at 16 µm and stained with Eosin
Y and Gill’s hematoxylin #2 (Sigma-Aldrich).
Results and Discussion
Identification of MMPs in the salamander
To identify MMPs in the Mexican axolotl, the Ambystoma EST database
(www.ambysoma.org) and NCBI databases were searched for presumptive salamander
MMPs. These sequences were assembled into 16 contiguous sequences (contigs) and
extended using PCR, 5’ RACE, and 3’ RACE. Contigs then were used as query sequences
to search the NCBI human RefSeq protein database (BLASTX; Table 6.2). Eight of the 16
contigs yielded full-length protein coding sequences (relative to human proteins). The
other contigs ranged from 96.7% (MMP2) to 15.5% (MMP16) coverage of human MMP
protein sequences. Table 6.2 shows the best human hit and best non-redundant hit for each
of the 16 presumptive MMP sequences. Sequence similarity alone was insufficient to
determine the orthology of many MMP sequences so contigs were named according to
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their best human hit or their presumptive orthologs previously identified in the Japanese or
American newts. Overall, sequences similar to four collagenases (aCola, aColb, aColc,
aCol3), two gelatinases (aMMP2, aMMP9), four stromelysins (aMMP3/10a, aMMP3/10b,
aMMP3/10c, aMMP11), three membrane-type MMPs (aMMP14, aMMP17, aMMP23),
three other MMPs (aMMP7, amphMMP, aMMP19), and a tissue inhibitor of MMP
(atimp1) were identified. Approximate coverage of each predicted protein sequence to its
most similar human MMP is shown in Figure 6.3. Alignment of predicted protein
sequences for MMPs with > 50% coding sequence coverage shows the high conservation
among the MMPs in the propeptide domain, catalytic domain, and hemopexin-like domain
(Figure 6.2). Notice the fibronectin-like repeats in aMMP2 and aMMP9 that define
vertebrate gelatinases. Also notice the highly variable hinge domain located between the
catalytic and hemopexin-like domains. Below, we show the association of the identified
MMPs with aspects of tail regeneration. Each MMP family is treated separately and a
summary of expression patterns is provided in Table 6.3.
Wound epithelium formation and function
The wound epithelium (WE) is a critical element of salamander appendage
regeneration because preventing WE formation inhibits regeneration (Goss, 1956;
Mescher, 1976; Tassava and Garling, 1979; Thornton, 1957; Lheureux, 1983). It is
possible that MMP activity in the WE is necessary for regeneration. We found that four
MMPs were strongly expressed in the WE basal keratinocytes during the first 24 hpa
including aMMP9 (Fig. 6.5A,C), aCola (Fig. 6.4A,D,J), aColb (Fig. 6.4B,E), and
aMMP3/10a (Fig. 6.6A,C,G). aMMP9 expression was seen only at 12 hpa in basal
keratinocytes of the epidermis and was lost by 24 hpa (Figure 6.5C,E,G). It is possible that
aMMP9 expression in the epidermis is associated with keratinocyte migration and is not
needed for downstream WE function. Similar observations have been made by others
(Yang et al., 1999; Satoh et al., 2007, 2008). Indeed, MMP9 is up-regulated in migrating
keratinocytes in mammals (Mohan et al., 1999) and it can cleave collagen type IV, the
major constituent of basement membranes. Collagen IV proteolysis has been shown to
expose cryptic sites that promote cell migration (Giannelli et al., 1997; Xu et al., 2001).
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Thus, it is possible that the role of MMP9 is to cleave collagen IV located in the basement
membrane, leading to epithelial cell migration.
aCola, aColb, and aMMP3/10a expression were all observed at 24 hpa. The
strongest expression was always observed in basal keratinocytes, but some expression was
observed where migrating epithelial sheets overlay the wound surface (Figure 6.4D,E,
6.6C,G). Six hypotheses have been proposed for the function of MMP expression in the
WE: 1) MMPs may initiate and support keratinocyte migration and wound closure. This
hypothesis is supported by mammalian studies showing defects in wound closure after
disrupting MMP function (Bullard et al., 1999; Agren et al., 1999, 2001; Lund et al.,
1999; Mirastschijski et al., 2002, 2004; Pilcher et al., 997; Dumin et al., 2001) 2) MMPs
may participate in phagocytosis of wound debris from the wound epidermis (Singer and
Salpeter, 1961; Reviewed by Carlson, 2007). 3) MMPs may prevent basement membrane
formation under the WE, promoting epithelial/mesenchymal interactions (Yang et al.,
1999). Epithelial/mesenchymal interactions are thought to be necessary to support
blastemal growth (Tsonis, 1996). 4) MMPs may initiate blastema formation by promoting
histolysis of underlying tissue. This is supported by experimental evidence showing that
histolysis does not take place if the WE is not formed (reviewed by Singer and Salpeter,
1961). 5) MMPs may release growth factors such as FGFs from the ECM to make them
available to blastemal cells (Hondermarck and Boilly, 1992; Boilly et al., 1991).
Mammalian studies have shown that MMPs 1 and 3 can cleave ECM components to make
FGF bioavailable to cells (Whitelock et al., 1996). 6) MMP activity may promote
regeneration by preventing scar formation. This is supported by the association of scar
formation and regenerative ability in fetal mammalian skin (Bullard et al., 1997; Ferguson
and O’Kane, 2004) and the observation that a scar-like epidermis formed when newt
limbs were treated with GM6001 (Vinarsky et al., 2005). It is likely that these MMPs may
have redundant roles and work synergistically in WE formation and function. The exact
function of the WE is just starting to be appreciated during appendage regeneration, but it
is clear that MMPs will be intimately involved in these functions (Campbell and Crews,
2008).
Histolysis and blastema formation
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One surprising observation in this study was the low MMP expression in muscle
cells undergoing histolysis versus strong staining in cartilage, bone, and epidermis.
Similar observations were made during limb regeneration for MMP3/10b and MMP9 in
the Japanese newt (Kato et al., 2003) and MMP9 in larval axolotls (Yang et al., 1999), but
strong expression was observed in blastema cells for MMP9 and collagenase in the
American newt (Vinarsky et al., 2005). We found some expression of aCola (Figure
6.4D,J), aColb (Figure 6.4E), aMMP9 (Figure 6.5G), and TIMP1 (Figure 6.7D) transcripts
in areas of tissue histolysis. In particular, aColb was expressed in cells resembling
neutrophils and leukocytes throughout the early wound site (Fig. 4B,K). Human MMP8,
or neutrophil collagenase, is expressed in neutrophils following injury, suggesting that
aColb and human MMP8 play similar functions (Van Lint and Libert, 2006). Regardless,
muscle fibers seemed to be stained the least of all tissues. It is possible that the WE, bone,
and inflammatory cells are secreting the necessary MMPs to promote muscle histolysis
and blastema formation. Further investigation is needed to see if MMP activity is needed
for muscle histolysis.
Bone and cartilage remodeling
One of the most striking expression patterns observed was broad MMP expression
in bone and cartilage found throughout the vertebrae. We observed expression in cells
resembling osteocytes, osteoclasts, perichondrial fibroblasts, periosteal fibroblasts, and
chondrocytes. By 24 hpa, strong expression was observed by aMMP9 (Figure 6.5E),
aCola (Figure 6.4D,J), and aCol3 (Figure 6.4F) in vertebrae. Expression of these genes
extended out to 14 dpa, suggesting that they play roles in bone and cartilage remodeling.
Indeed, knockout mice of MMP9 and Col3 show growth-plate defects (Vu et al., 1998;
Stickens et al., 2004; Inada et al., 2004), suggesting that the function of these genes may
be conserved between development in mammals and regeneration in salamanders.
Two MMPs were found to be up-regulated only during later stages of regeneration
including aMMP2 (Figure 6.5B) and aMMP14 (Figure 6.7A). aColc showed a similar
gene expression pattern, but was also expressed earlier (Figure 6.4C). Each of these genes
was also expressed in similar cell types including chondrocytes and perichondrial
fibroblasts of the centrum (Figure 6.4O,6.5K,6.7C). Interestingly, aMMP3/10b was also
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found to be expressed in osteocytes at 14 dpa. Given the short time frame studied here,
these mRNAs likely continue to increase beyond 14 dpa. Mouse knockouts of MMP2 and
MMP14 have defects in bone and/or connective tissue formation and remodeling (Stickens
et al., 2004; Inada et al., 2004; Holmbeck et al., 1999; Zhou et al., 2000; Inoue et al.,
2006; Page-McCaw et al., for Review). Also, two out of three human skeletal diseases
caused by loss-of-function MMP mutations are associated with coll3 and MMP2
(Martignetti et al., 2001; Kennedy et al., 2005). MMP14 is also known to activate MMP2
in vivo and function redundantly (Nagase and Woessner, 2000; Oh et al., 2004). This
evidence suggests that aCol3, aMMP2, and aMMP14 may participate similarily during the
reformation of vertebrae, especially the cartilage tube, during tail regeneration. Other
studies are needed to test whether these MMPs are critical at the cartilage-forming stages
of salamander appendage regeneration.
Nervous system and vascular MMP9 expression
aMMP9 transcripts were localized to multiple tissues including the nervous system
and the vasculature (Fig. 5H,J). aMMP9 has previously been localized to spinal cord
tissue during the early stages of spinal cord regeneration in the axolotl (Monaghan et al.,
2007) as well as dorsal root ganglia neurons during limb regeneration (personal
observations). MMP9 has been shown to be involved in neurite elongation in mammals
(Shubayev and Myers, 2004). aMMP9 expression in multiple CNS injury paradigms
suggest that it may have a role in nervous system injury or regeneration. Functional
analyses are necessary to test this hypothesis.
aMMP9 was also expressed in areas resembling vascular formation at 21 dpa. It
was surprising to find that aMMP9 was not expressed elsewhere in the regenerating tail at
this time point. Support for the role of aMMP9 in vascular remodeling comes from mouse
studies showing that MMP9 mutant mice have defects in angiogenesis as well as MMP9
mutants causing defects in smooth muscle cell blood vessel ensheathment (Vu et al., 1998;
Chantrain et al., 2004). Overall, aMMP9 was expressed in a wide array of cell types in
this study and likely is associated with multiple functions during tail regeneration.
Other MMPs and TIMP1 expression during tail regeneration
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Several other MMPs were identified that may further studies of axolotl
development and regeneration. A novel sequence was identified that contains all predicted
MMP protein domains (Fig. 2; amphMMP); this sequence shows poor alignment to
previously characterized mammalian and salamander MMPs. This sequence was named
amphMMP (amphibian-specific MMP) because it had homology to a hypothetical
Xenopus tropicalis protein (60% similarity; AAI55488), a translated EST sequences from
Xenopus laevis (BJ032306), and an MMP protein found in the domesticated silkworm
(Bombyx mori; NP_01116499; 37% similar). amphMMP may be the Xenopus genes
XMMP (NP_001079285; 26% similarity) or collagenase 4 (AAH84654; 38% similar), but
their low homology to these MMPs suggests that a yet unidentified MMP is present in the
amphibian genome. Another sequence named aMMP7 showed similarity to H. sapiens
collagenase 3 (57/% similar) but contained a stop codon sequence at predicted amino acid
291. An identical transcript has been previously characterized and named collagenase 3
(Yang et al., 1999). aMMP7 is 59% similar to aMMP3, suggesting that it is transcribed
from a different genomic loci. Multispecies alignments of the predicted aMMP7 protein
sequence shows that it truncates at a similar region in the H. sapiens and X. laevis
matrilysin proteins (Fig. 2; Harrison et al., 2004; NP_002414; NP_001079682). Further
work is needed to confirm orthology, including possibly genome mapping. Contigs
similar to several other MMPs including membrane type MMPs 17 and 23, stromelysin
MMP11, and MMP19 were identified, but were either not expressed during tail
regeneration or did not change expression (data not shown). It will be necessary in the
future to address whether these genes are pseudogenes and transcribe functional MMPs.
These sequences will be valuable for comparisons to MMPs in other vertebrates.
Conclusion
In summary, this study identified several previously unidentified MMPs in the
Mexican axolotl and showed when and where these genes are expressed during
regeneration. Our results suggest that most MMPs are highly orchestrated - they are
expressed during regeneration in specific tissue types and only at certain times. The
overlaping expression patterns of MMPs also suggest that MMPs have redundant
functions during regeneration. The results presented here suggest hypotheses for how
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MMPs participate in regeneration, when they participate, and upon which tissues they
may target. These insights bring us closer to understanding the roles of MMPs in complex
tissue regeneration.
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Table 6.1. Primers used for real-time PCR and in situ hybridization. RT-PCR stands
for real-time PCR. ISH stands for in situ hybridization. Each ISH primer contained either
a T3 or SP6 promoter sequence appended to the 5’ end of the primer.
Gene
aCola_F
aCola_R
aColb_F
aColb_R
aCol3_F
aCol3_R
aMMP9_F
aMMP9_R
aMMP2_F
aMMP2_R
aMMP3/10a_F
aMMP3/10a_R
aMMP3/10b_F
aMMP3/10b_R
aMMP14_F
aMMP14_R
aTimp1_F
aTimp1_R
aMMP16_F
aMMP16_R
aMMP23_F
aMMP23_R
aMMP11_F
aMMP11_R

RT-PCR
ISH
CACCCGAAATCTGTGACAA AGTTCAGTCTTCCCCAGGATG
CGGCGCCAGAAGAATC
AAGAACGTTTTCCCTGTTGC
TGGACCAAGTTCGCTTGT ACAGGAGCTCAGGGAAGAATG
GCTTGCGGATGTTCTTTG
AAGTGGACGTCTCCACCAAC
GTGTGGAGCGAGGTTACG
CTGCATCGATGGATAGCTCA
TCGGGTTCCAAAGGAGAT
GGCAAACTCGACGAAGAGAC
GAATGCACATGGACCAGAA AGCGCACGATGTCTTTCTGTA
TTGGCACAGAACATTGGAG
GCGGTGGTACTCCAACTCAT
ACCCGTTGCAAGAAAGAAG
CGTTATGTTCGACGTTCCCT
GTGTTGGAGTCCAGCTTCC
CTTGGACTGGTGTCCCTGAT
ACCCGTTGCAAGAAAGAAG
clone
GTGTTGGAGTCCAGCTTCC
clone
TGGAAGAAGACTGCGTTGA ACCTTCCACTCCTGCTGCTAC
ACACTTTGAAGGCCCTTTG
GCCCGTCAAATGGATAGAAA
AGGACTTCCCAGCGACAT
ACACGCGGTTATCTCGTACC
CGTCAAACACCCAATGCT
TCCGTGATGGACATGAGAAA
CGAAGAGCCAAGCTGGA
AAGACGGCCTTCTGCTATTCA
CATCGGGGTGTAGAGGAAC
TAGATATGGGCCAGTCCTCG
ACTGGCGCTATGACGAGA
GGCTAGGGAGGTGTGTCC
AGGACCGTGTTCTCACCA
GCACAAGGAGGGGAAAAG
TCAGCCAGACAGCCAGAT
GGTCAGGTGGGTCCTCTC
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Table 6.2. Best human protein hits for 16 axolotl MMPs. % Cov. = Percent coverage of
the salamander sequence compared to the human protein. % Id. = Percent identical/similar
between axolotl and human protein. Best NR hit = best non-redundant NCBI protein
database hit. Nv = Notophthalamus viridescence, Cp = Cynops phyrrhogaster, Xt =
Xenopus laevis, Xt = Xenopus tropicalis, R = Rabbit, Rr = Rattus rattus, Op = Opossum.

Name
Human hit
aCola
MMP1
aColb
MMP1
aColc
MMP10
aCol3
MMP13
aMMP2
MMP2
aMMP9
MMP9
aMMP3/10a
MMP3
aMMP3/10b
MMP3
aMMP3/10c
MMP3
amphMMP
MMP19
aMMP7
MMP13
aMMP11
MMP11
aMMP14
MMP14
aMMP17
MMP17
aMMP19
MMP19
aMMP23
MMP23B

% Cov.
100
100
96.6
100
96.7
88
100
100
100
100
100
23.6
72.6
15.5
27.4
51.8

E-value
Best NR hit % Id.
5.00E-156
Nv coll
83/91
4.00E-143
Nv coll
63/78
9.00E-132
Nv coll
61/75
2.00E-176
Cp col3
81/89
0
Xl MMP2
82/90
0
Nv MMP9 90/95
3.00E-147
Nv 3/10a
80/89
1.00E-141
Cp 3/10b
72/83
3.00E-148
Nv 3/10a
75/85
3.00E-53
Xt hyp.
60/74
2.00E-83 R MMP13 59/74
1.00E-46 Xl MMP11 86/92
5.00E-172 Xt MMP14 78/86
8.00E-19 Rr MMP17 42/60
8.00E-50
Xt hyp.
81/92
5.00E-80 Op MMP23 78/89
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E-value
0
8.00E-175
3.00E-165
0
0
0
0
0
0
0
1.00E-86
3.00E-56
2.00E-178
1.00E-19
7.00E-64
5.00E-90

Table 6.3. Summary of MMP and Timp1 gene expression patterns. This table
summarizes in situ hybridization results for MMPs and timp1. Figures 6.4-6.7 show how
strong each gene is expressed in particular tissue types. E, Epidermis; F, perichondrial
fibroblasts; MH, area of muscle histolysis; M/N, macrophage/neutrophils; Ch, centrum
chondrocytes; Oc, osteoclast; N, neuron; V, vasculature; O, osteocytes; Na, was not
assayed; --, no expression observed.
Name
12 hpa
24 hpa
7 dpa
14 dpa
21 dpa
aCola
E,F
E,F,MH
Oc
Oc
Na
aColb
E,M/N
E,F,M/N
Ch
Ch
Na
aCol3
Na
Ob,F
Ob,F
Ob,F
Na
aMMP2
--Ch
Ch
Na
aMMP9
E,Ob,F, F,M/N,MH,Ob,Ch O,Oc,F,Ch O,Oc,F,Ch V,N,F
aMMP3/10a
E
E
--Na
aMMP3/10b
--Ob
Ob
Na
aMMP14
--Ch,F
Ch,F
Na
atimp1
Na
E,MH,F
Ch,F
Ch,F
Na
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Figure 6.1. Hematoxylin-Eosin staining was performed on cryosections at 3 hpa (A),
6 hpa (B), 12 hpa (C), 24 hpa (D), and 21 dpa (E). Scale bar 200 µm
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Figure 6.2. Predicted protein sequence alignment of axolotl MMPs. Sequences
covering >50% of the presumptive protein coding sequence were used for the multiple
sequence alignment. The top box shows the conserved cysteine switch region in the
propeptide domain. The second box highlights the putative zinc-binding domain necessary
for catalytic activity. The top sequence underlined highlights the catalytic domain and the
bottom sequenced underlined represents the hemopexin domain. Notice the large insert
within the catalytic region of aMMP2 and aMMP9 that represents the fibronectin-like
repeats.
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Figure 6.3. Cartoon showing all 16 MMPs identified in this study. Black lines
represent approximate coverage of the predicted coding sequence and amino acid (aa)
lengths are presented to the right. The top cartoon represents the prototypical MMP
protein. Other cartoons represent domains found in each family of MMPs including
collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs, and others.
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Figure 6.4. Temporal (A,B,C) and spatial (D-K,M-O) expression of aCola
(A,D,G,J,M), aColb (B,E,H,K,N), and aCol3 (C,F,I,O) during tail regeneration.
Temporal gene expression patterns assayed by real-time quantitative PCR are shown in A,
B, and C. All y-axes are log-2 fold changes from the average day 0 samples. Spatial
expression is shown at 24 hpa (D-K) and 14 dpa (M-O). Note the specific staining when
antisense probes were used (D,E,F,J,K,M,N,O) and the lack of staining when sense probes
were used (G,H,I). J and K are close-up photos of D and E. L represents a tail cross
section showing approximate locations of images. Dorsal is upward. Horizontal lines
represent coronal sections (D-K) and boxes represent cross sections (M-O). SC, spinal
cord. Error bars = + standard error of the mean (SEM). Scale bar = 100 µm.
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Figure 6.5. Temporal (A,B) and spatial (C-L) expression patterns of aMMP9 (A,C-J)
and aMMP2 (B,K,L) during tail regeneration. Temporal gene expression patterns
assayed by real-time quantitative PCR are shown in A and B. All y-axes are log-2 fold
changes from the average day 0 samples. Spatial expression is shown at 6 hpa (C,D), 24
hpa (E-H), 14 dpa (I,K,L), and 21 dpa (J). Sense probes were used on sections shown in
D, F, and L. G is a close-up of E. Arrows indicated neuron-like cells and arrowheads
indicate vasculature. M represents a tail cross section showing approximate locations of
images. Horizontal lines represent coronal sections (C-H) and boxes represent transverse
sections (I-L). Error bars = + SEM. Scale bar = 100 µm.
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Figure 6.6. Temporal (A,B) and spatial (C-G) expression patterns of aMMP3/10a
(A,C,E,G) and aMMP3/10b (B,D,F) during tail regeneration. Temporal gene
expression patterns assayed by real-time quantitative PCR are shown in A and B. All yaxes are log-2 fold changes from the average day 0 samples. Spatial expression is shown
at 24 hpa (C,G) and 14 dpa (D). Sense probes are shown in E and F. G) close-up of C. The
horizontal line in H represents a coronal section (C,E,G) and the box represents a
transverse section (D,F). SC = spinal cord. NC = notochord. Scale bar = 100 µm.
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Figure 6.7. Temporal (A,B) and spatial (C-F,H) expression patterns of aMMP14
(A,C,E) and aTIMP1 (B,D,F,G) during tail regeneration. Temporal gene expression
patterns assayed by real-time quantitative PCR are shown in A and B. All y-axes are log-2
fold changes from the average day 0 samples. Spatial expression is shown at 24 hpa
(D,F,H) and 14 dpa (C,E). Sense probes were used on sections shown in E and F. H is a
close-up of D. The horizontal line in G represents a coronal section (D,F,H) and the box
represents a transverse section (C,E). Scale bar = 100 µm.
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CHAPTER 7
CONCLUSIONS AND FUTURE DIRECTIONS
The studies presented in this dissertation describe the physiological genomics of
spinal cord and limb regeneration in the salamander. These studies are some of the first to
use unbiased genomic technologies to identify gene candidates for salamander limb
regeneration. Below I highlight some of the interesting gene candidates and possible
future directions to address their roles in regeneration.
Spinal cord regeneration is likely the most relevant model of salamander
regeneration to the human condition. For this reason, we performed our first microarray
analyses on the regenerating spinal cord (Chapter 2). In this study, we found that spinal
cord injury changes thousands of genes from baseline suggesting that regeneration is a
global process. Among these genes, we were interested in ones that may contribute to the
activation or maintenance of ependymoglia. Ependymoglia are thought to act as neural
precursors during regeneration and understanding how they are maintained and activated
is critical to our understanding of regeneration. Gene pathways known to regulate neural
precursors were identified including BMP, FGF, and Wnt signaling pathways. Several
genes that code for molecules involved in these pathways were differentially regulated
during regeneration included follistatin, secreted frizzled-related protein 2, wnt5a, and
fibroblast growth factor-binding protein 1. Although this work is important for identifying
genes candidates that regulate ependymoglia activation, over-expression and knockdown
experiments of these genes during spinal cord regeneration will be needed to see if they
disrupt ependymoglia function.
One of the most interesting results from this study was the extreme change in
mRNA abundance of matrix metalloproteinases (MMPs). The dramatic upregulation of
MMPs motivated us to extend these studies to the entire MMP gene family, the results of
which are presented in Chapter 6. Overall, we found that MMP9 was expressed in the
spinal cord during regeneration. Further analysis showed that it was mostly expressed in
cells resembling neurons, but also ependymoglia (Figure 2.4C; Figure 6.5; data not
shown). Chapter 5 shows that MMP9 is also expressed in dorsal root ganglia neurons
during limb regeneration and in the retina following optic nerve injury (Elizabeth Debski,
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personal communication). The similar MMP9 expression patterns in these three injury
paradigms suggest that MMP9 is specifically associated with regenerating or injured
neurons. In mammals, MMP9 has been associated with increased axon outgrowth in
spinal cord injury models (Duchossoy et al., 2001), retinal ganglion cell axon regeneration
(Ahmed et al., 2005), and peripheral nerve regeneration (Ferguson and Muir, 2000).
MMP9 may facilitate nervous system regeneration by breaking down inhibitory neurite
outgrowth molecules including CSPGs (Ferguson and Muir, 2000) and myelin-inhibitory
products (Milward et al., 2008), promote remyelination (Larsen et al., 2003), or release
growth factors that could then support neuron survival and growth (Pizzi and Crowe, 2007
for review). It will be interesting to find out if disrupting MMP9 activity in neurons in
vitro affects neurite outgrowth. The identification and characterization of Nogo-A in the
salamander nervous system (Chapter 3) also raises the possibility that MMPs clear the
injury site of Nogo-A and other inhibitory molecules after injury. Indeed, the inhibitory
molecules tenascin-R and myelin-associated glycoprotein are quickly cleared from the
salamander optic nerve after injury, and this is correlated with axon regeneration (Becker
et al., 1999). It is possible that neuronal expression of MMP9 mediates this process.
A second gene that showed an interesting expression pattern across multiple
nervous system injury paradigms was ankyrin repeat domain-containing 1 (ANKRD1). It
was found to be upregulated in all neural injury models and was highly expressed in
dorsal root ganglia neurons 14 days after limb regeneration (Figure 5.2 and 5.3). Realtime PCR also found this gene to be upregulated by 3 dpa, suggesting that the expression
of this gene is expressed throughout regeneration (data not shown). This transcription
factor has traditionally been thought of as muscle specific gene, but recent data in a rat
injury model have associated ANKRD1 with dorsal root ganglia neuron outgrowth (Stam
et al., 2007). It is possible that the large upregulation of ANKRD1 in regenerating neurons
may explain the high axon regenerative capacity of axolotl neurons. Localization of this
gene in regenerating spinal cord and retinal ganglion neurons would support this
hypothesis. Knockdown of ANKRD1 is also needed in vitro, possibly using morpholino
technologies, to address whether ANKRD1 mediates axon outgrowth.
The role of nerves in limb regeneration is one of the most perplexing questions in
the regeneration field. We attempted to address this question by identifying the
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downstream targets of nerves during limb regeneration as well as molecules expressed by
sensory neurons during limb regeneration (Chapters 4 and 5). Chapter 4 shows that many
differences were found between denervated and regenerating limbs. Many of these genes
were associated with the presence of a blastema in the innervated limb and absence in the
denervated limb. The utility of this experiment is that we now have a gene expression
signature of a limb blastema. Understanding what the blastema is at the cellular and
molecular level will be necessary in future experiments to address whether we can
experimentally perturb this process. The next step is to locate the expression of these
genes between denervated and regenerating limbs in order to identify where they are
expressed. For example, expression in the WE would suggest that the WE is the primary
target of the regenerating nerves, which then creates a regeneration competent
environment. An interesting candidate gene pathway identified in Chapter 5 that may fit
this profile is the L-serine synthesis pathway. The three enzymes involved in this pathway
were differentially regulated between denervated and regenerating limbs at 5 and 14 days
after limb amputation. Attempting to rescue regeneration in denervated limbs with local
administration of L-serine would functionally link L-serine to limb regeneration. Such a
simple model for how nerves support limb regeneration may be directly relevant to
wounding in mammalian systems.
Chapter 5 highlighted up-regulated genes in the DRG during limb regeneration.
We suggest that these could be involved in axon regeneration, upstream of the NTF, or
possibly be the NTF. All of this work is correlative in nature, but sets the groundwork for
functional analysis of these genes. It will be important to localize expression of these
genes to sensory neurons and show secretion from peripheral nerves. It will also be
important to over-express gene candidates in denervated, amputated limbs.
The successes of these early experiments provide optimism that we may soon
understand the underlying mechanisms of regeneration. Regardless, some major hurdles
need to be met before we can understand how complex regeneration is accomplished. For
example, we need to know how important the wounding/immune response is in both
spinal cord and limb regeneration. Is there something unique about the salamander
immune response that supports regeneration? It will also be necessary to understand the
relationship between nerves, the wound epidermis, and their support of blastema
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formation during limb regeneration. These three elements are essential for creating a
regeneration-permissive environment, but little is known about their specific function or
relationship with one another. Thirdly, it is necessary for us to know how plastic
salamander cells are following injury. Are salamanders able to regenerate spinal cord and
limb tissue because they have a large supply of resident stem cells or are they capable of
creating a local supply of stem cells by dedifferentiating cells after injury? Once each of
these questions is answered in the salamander system, it may be plausible to replicate the
salamander “injury” environment at a mammalian injury site. It is also plausible that
knowledge gained from the salamander system may be useful for tissue engineering.
Tissue engineering is the process of growing tissue or organs in vitro and implanting this
tissue in the human patient. The salamander regeneration model gives a unique example
of the environment necessary to support complex adult tissue growth and may aid in the
engineering of these in vitro systems. The descriptive work provided in this dissertation is
an important step towards these goals. The next challenge will be to identify which of the
descriptive observations presented here is necessary for regeneration.
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